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Abstract
MHC class I antigen presentation to cytotoxic T cells (CTLs) is critically important to 
maintain immunity against pathogens and tumour-transformed cells. In this conventional 
class I pathway, peptides generated from endogenous proteins in the cytosol by 
proteasomes are transported into the ER lumen and loaded onto class I heavy chain- 
P2microglobulin heterodimers with the assistance o f peptide loading complex (PLC) to 
form MHC class I complexes, which then traffic to the cell surface for the inspection by 
CTLs. The PLC contains transporter associated with antigen processing (TAP), tapasin, 
calreticulin (CRT), ERp57, and possibly calnexin. CRT is a glycoprotein chaperone and 
can be divided into three structural and functional domains: N-terminus domain, central P 
domain and C-terminus domain. CRT plays a critical role in MHC Class I antigen 
processing and presentation and can elicit peptide-specific CD 8 + T cell responses against 
tumours when exogenously administered with peptides. However, how CRT contributes 
to class I antigen presentation and the mechanism of its adjuvant effect in anti-tumour 
responses remain to be elucidated.
To study the conventional MHC class I pathway, the protein antigen of interest has to be 
expressed inside cells. First, a novel method was described to deliver protein antigen 
directly into the cell cytosol. Mouse fibroblasts, lymphoma cell line RMA and its mutant 
counterpart cell line RMA-S were permeabilized with streptolysin O (SLO) first and 
chicken ovalbumin (OVA) was successfully introduced into both adherent and 
suspension cells. The OVA was properly processed and OVA-derived peptide OVA258- 
265 (or SIINFEKL) was successfully presented via MHC class I molecule (Kb) to 
SIINFEKL- Kb specific T cell hybridoma-B3Z, while in RMA-S cell with TAP-2 
deficient, the defect for MHC class I antigen processing was demonstrated.
Next, using the SLO antigen delivery system, OVA was introduced into the cytoplasm of 
both CRT deficient mouse fibroblasts (K42) and CRT competent cells (K41), and K42 
cells transfected with full length human CRT to investigate how CRT contributes to class 
I antigen presentation and the mechanism of its adjuvant effect in anti-tumour responses.
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It was showed that reduced class I expression in CRT deficient cells can be restored by 
the direct delivery o f peptides into the ER or by incubation at low temperature. CRT 
deficient cells exhibit a TAP deficient phenotype in terms o f class I assembly, without 
loss o f TAP expression or functionality. Furthermore, a higher concentration o f antigen in 
the cytosol is required for specific T cell stimulation in CRT deficient cells than that in 
wild type cells. The data indicates that CRT has a functional role in the maintenance of 
the low peptide concentration threshold required in the ER for efficient antigen 
presentation to T cells.
Finally, to investigate the functional role of CRT related to its structure and the possible 
mechanism of CRT lowering the peptide concentration threshold required in the ER for 
efficient class I antigen presentation, I have made a series of constructs containing P-, 
NP-, PC-domains and full length CRT and established their expression in both K42 and 
K41 cells. While full length CRT restores MHC class I surface expression on K42 cells 
to the levels seen in the wild-type K41 cells, the expression of P-, NP-, PC-domains of 
CRT down-regulates MHC class I expression in K42 cells. In contrast, K41 cells 
transfected with truncated CRT exhibits a normal class I surface expression, indicating 
that disruption to MHC class I assembly only happens in the absence of CRT. In further 
experiments, I have demonstrated that the defect is due to empty or peptide suboptimally 
loaded class I complex while direct delivery of peptides into the ER or incubated at 26 
where class I stabilized the class I surface expression recover to nearly normal level. 
After excluding several possible defects during antigen processing and presentation, such 
as negative effects on expression of components of PLP, TAP function, class I assembly, 
I propose that calnexin may compensate for the loss of CRT function in cells without 
CRT. The expression of truncated forms of CRT in CRT deficient cells might block the 
redundant function of calnexin, leading to further reduced cell surface MHC class I 
expression.
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Chapter 1 Introduction
Humoral (antibody-mediated) and cellular (T cell-mediated) immunity are the two main 
lines of defence used by higher organisms to combat pathogens. While antibodies 
recognize free antigens, T cells distinguish foreign from self-materials through 
presentation of antigen fragments by cell surface major histocompatibility complex 
(MHC) molecules. There are two main types of T cells, CD4 T cells and CD 8  T cells. 
Initially it was believed that CD4 T cells recognize antigenic peptide derived from 
exogenous proteins that have been internalised, processed and presented by class II MHC 
molecules, while CD 8  T cells recognize antigen fragment derived from endogenous 
proteins and presented by MHC class I molecules(Townsend et al., 1985). However, 
there are some exceptions that are in contradiction to the classical view, which will be 
discussed later when appropriate.
CD8 + T cells represent an important branch of immune system in non-self immune 
recognition. Each CD 8 + T lymphocyte produced in the thymus carries a different T cell 
receptor (TCR) capable of recognising peptide/MHC class I complexes. Once stimulated 
by interacting with specific peptide bound MHC class I molecules through their 
receptors, CD8 + T cells will be activated and, with the help from CD4 T cells, they will 
proliferate and differentiate into cytotoxic T cells (CTLs), which will take action against 
the target cells. In this way CTLs can eradicate cells carrying foreign, mutated or in some 
cases over-expressed proteins(Shastri et al., 2002). How proteins are processed and 
bound to MHC class I molecule capable of interacting with T cell receptors has been and 
still is one of core themes in modem immunology.
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1.1 MHC class I complex
The term major histocompatibility complex (MHC) actually refers to a region of DNA 
spanning some 4Mbp (base pair) and containing over 100 genes. It is located on 
chromosome 6  in the human and chromosome 17 in the mouse. Each species has a unique 
name for its MHC. In human the MHC is called human leukocyte antigen (HLA), and in 
mouse it is called histocompatibility-2 (H-2).
The MHC class I complex is made up o f a 45 kDa transmembrane heavy chain (HC) 
glycoprotein (also called a-chain), a 12 kDa soluble light chain protein called |32- 
microglobulin (P2m), and a short peptide of 8-10 residues derived from endogenous 
proteins as well as virus- and tumor-specific proteins. The a-chain has three domains, 
called a l ,  a 2  and a 3 . The membrane-distal a i  and a 2 domains are highly polymorphic. 
Diversity in these domains is very important in that these two domains form the antigen 
binding cleft (ABC) o f the MHC class I molecule (Fig 1.1). The sides o f the ABC are 
formed by a i  and a 2, while the floor of ABC is comprised of eight anti-parallel p 
sheets(Bjorkman et al., 1987). The 0 3  domain is situated under the a i and a 2 domains 
and anchors the class I HC to the cell membrane. The p2m non-covalently associates with 
class I HC and is proximal to the cell membrane. The antigenic peptide binds to the ABC 
in an extended conformation and interacts with MHC residues along the binding site with 
relatively low specificity but high stability(Rammensee et al., 1995). The interactions are 
important to maintain the stability of MHC class I molecules assembled(Bouvier and 
Wiley, 1998; Paulsson et al., 2001). For example, the affinity between HC and p2m is 
enhanced at least 10-fold in the presence o f peptide ligand(Elliott et al., 1991), and upon 
peptide dissociation, there is loss o f both p2 m and conformation-sensitive epitopes within 
the HC(Smith et al., 1992; Smith et al., 1993).
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Fig. 1.1: HLA-A2 diagram top view
Showing the antigen-binding cleft, formed at its base by the /3-sheet and at the sides by 
the a-helices o f the a l  and a2 domains (cyan). a3 domain shown in blue.
Adapted from - Cellular and Molecular Immunology 1 No.l; Flutter,B. Gao, B. MHC 
Class I Antigen Presentation - Recently Trimmed and Well Presented
1.2 MHC class I antigen processing and presentation
MHC class I antigen processing starts in the cytosol, where peptides are generated by 
proteasomes(Cascio et al., 2001; Kloetzel, 2001) and/or other proteases(Reits et al., 2004; 
Saric et al., 2004; Stoltze et al., 2000) from endogenously synthesized proteins (Fig 1.2). 
Peptides produced are then transported into the lumen of endoplasmic reticulum(ER) via 
TAP(Attaya et al., 1992) and, if necessary, they are further trimmed by ER-associated 
aminopeptidases (ERAAP) to 8-10 amino acids(Serwold et al., 2002; Saric et al., 2002;
York et al., 2002), the length that is generally required for association with MHC class I 
molecules.
The MHC class I assembly occurs in the ER and begins with the translation of the class I 
HC in the ER membrane-associated ribosome, which is then co-translationally inserted in 
the ER membrane through the translocon, Sec61p complex— a channel through which the 
nascent chain enters the ER lumen or the ER membrane(Corsi and Schekman, 1996; 
Rapoport et al., 1999). The folding and assembly o f the MHC class I complex is assisted 
by a variety of molecular chaperones and folding enzymes. Calnexin (CNX) interacts 
transiently with the newly synthesized class I HC, promoting folding and assembly with 
P2m(Degen and Williams, 1991; Jackson et al., 1994; David et al., 1993; Nossner and 
Parham, 1995). In human cells, CNX is exchanged for calreticulin (CRT) after HC binds 
p2m(Sadasivan et al., 1996). But in mouse cells, CNX can also associate with HC-|32m 
heterodimer(van Leeuwen and Kearse, 1996a).
The association o f CNX and/or CRT with class I HC recruits the folding enzyme, ERp57, 
which then promotes the formation of disulfide bonds in the HC(Molinari and Helenius, 
1999; High et al., 2000; Zapun et al., 1998; Oliver et al., 1997). The HC-p2m 
heterodimer is conformational unstable(Bouvier and Wiley, 1998) and requires the 
binding o f antigenic peptide to complete the maturation process(Paulsson et al., 2001). 
Efficient peptide loading of MHC class I molecules requires peptide-loading complex 
(PLC), which includes CRT, ERp57, TAP and tapasin (Cresswell et al., 1999; Cresswell, 
2000; Momburg and Tan, 2002; Meunier et al., 2002). The interactions among these 
molecules stabilize HC-p2m heterodimers and retain them in the ER until the binding of 
an antigenic peptide completes the assembly process. Upon peptide binding, MHC class I 
complexes are released from the PLC(Ortmann et al., 1994; Suh et al., 1994; Li et al., 
1999) and traffic via the Golgi apparatus to the cell surface(Germain, 1994), where they 
are surveyed by CD8+ T cells (Fig 1.2). This MHC class I antigen processing and 
presentation pathway has been regarded as the ‘classical’ or ‘conventional’ endogenous 
class I pathway. However, recent progress in the understanding of the mechanisms of
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antigen presentation and activation o f T-cell responses suggests that there are other 
pathways for loading epitopes onto MHC class I molecules(Rock and Shen, 2005), which 
will be mentioned when appropriate.
Expression o f self peptide/MHC complexes in the thymus is crucial for T cell positive 
and negative selection, which is important for the development of self-tolerance(Goldrath 
and Bevan, 1999). Furthermore, MHC class I antigen processing and presentation of 
foreign proteins at the cell surface for inspection by CD8+ T cells is critical for immune 
system to eliminate the pathogens(Germain, 1994). Cell surface abundance o f MHC class 
I complex is related to many factors, such as the availability of peptides produced and 
provided, class I assembly and its subsequent export from the ER, as well as its rate of 
removal from the cell surface(Elliott and Williams, 2005). However the factors affecting 
the rate o f removal of class I molecules are poorly understood, other factors relating to 
MHC class I antigen processing and presentation will be discussed in detail in the 
following sections.
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Fig. 1.2 -Class I antigen processing and presentation pathway.
A) HC disulfide bridges form and association with frm occurs allowing CRT to bind.
B) The class I molecule enters the mature complex and binds to peptides provided by 
TAP (T1 and T2). Tapasin is found disulfide bonded to ERp57.
C) Once loaded with peptide, class I is released from the loading complex and traffics to 
the cell surface via the Golgi network
Plasma M embrane
GolgiB
Apparatus
Imported
Protein
Cross Priming
ERp 57
ERAAP
Tapasin
MHC Class I
Peptides
Cytosolic
Protein
Adapted from - Cellular and Molecular Immunology 1 No.l; Flutter,B. Gao,B. MHC 
Class I Antigen Presentation - Recently Trimmed and Well Presented
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)
1.2.1 Components of MHC class I assembly machinery
1.2.1.1 TAP
TAP belongs to the family of ATP-binding cassette transporters that translocate a broad 
spectrum of solutes across the ER membrane in an ATP-dependent manner(Ortmann et 
al., 1994; Suh et al., 1994; Attaya et al., 1992). The TAP complex located in the ER 
membrane is a heterodimer comprised o f TAPI and TAP2 whose genes are located in the 
MHC class II region of chromosome 6(Kelly et al., 1992; Spies et al., 1992). Both 
subunits can be divided into a transmembrane domain (TMD) that binds peptides and 
forms the translocation pore within the ER membrane, and a cytosolic nucleotide-binding 
domain (NBD), which energizes peptide translocation across the ER membrane by ATP 
hydrolysis(Gorbulev et al., 2001). Both TAP subunits are required for peptide transport. 
Lack of one TAP subunit leads to a non-functional transporter and inefficient peptide 
loading o f MHC class I molecules(Powis et al., 1991).
Although TAP can transport a broad spectrum of peptides across the ER membrane, it 
exhibits some degree of peptide size and sequence specificity. For example, Momburg et 
al showed that the minimal size o f peptides binding to TAP is 8 amino acids, 
corresponding to the minimal size o f class I-associated peptides(Momburg et al., 1994). 
Furthermore, Koopmann and colleagues demonstrated that peptides of 9-12 amino acids 
are best translocated by TAP; they also showed that TAP can handle longer peptides as 
well, but less efficiently(Koopmann et al., 1996; Momburg et al., 1994). Additionally, 
Neeljes and associates showed that peptides with proline at position 2 or 3 are very 
poorly translocated by TAP(NeeIjes et al., 1995; van Endert et al., 1995).
In addition to its role as a peptide transporter, TAP has been proposed as a docking 
station for assembly o f class I molecules at the center o f the PLC. In support of this 
hypothesis, Koch et al showed that TAP plays a role in recruiting the adapter protein 
tapasin by its N-terminal transmembranne segments(Koch et al., 2005; Koch et al., 2004). 
Moreover, Ortmann et al found that TAP associates with HC-P2m heterodimer to retain it
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in the ER(Ortmann et al., 1994). Conversely, in TAP deficient cells, most class I 
molecules fail to assemble with stably bound peptide due to the shortage of peptide 
supply and are retained in the ER by tapasin(Grandea, III et al., 2000; Schoenhals et al., 
1999). These empty class I molecules that accumulate in the ER are eventually 
translocated to the cytoplasm for degradation(Van Kaer et al., 1992; Wiertz et al., 1996). 
Consequently, TAP deficient cells are unable to present intracellular antigens on the cell 
surface(Hosken and Bevan, 1990; Spies et al., 1992). However, a small number of empty 
class I molecules do exit the ER in these TAP deficient cells and can be stabilized at the 
cell surface by addition o f class I binding peptides to the culture medium(Townsend and 
Bodmer, 1989; Cerundolo et al., 1990; Ljunggren et al., 1990; Van Kaer et al., 1992). 
Moreover, when peptide is delivered directly to the ER in a signal-dependent way, class I 
molecules o f TAP deficient cells become loaded with peptide, dissociate from tapasin in 
the normal way and traffic to the cell surface(Paulsson et al., 2001). Additionally, these 
peptide-receptive MHC class I molecules in the absence o f TAP can be expressed at the 
same level as TAP competent cells when they are cultured at 26°C, as the cell surface 
empty class I molecules become stable at 26°C, whereas they are thermolabile and are 
degraded at physiological temperature(Ljunggren et al., 1990; De Silva et al., 1999).
Nevertheless, in the absence o f TAP, few MHC class I alleles (HLA-A2 and HLA-E 
molecules) have been showed to bind peptides, which have been proposed to represent 
signal sequence fragments o f secreted/membrane proteins that are cleaved by signal 
peptidases and loaded in the ER(Henderson et al., 1992; Wei and Cresswell, 1992; 
Huczko et al., 1993). Another source of TAP-independent peptides presented by class I 
molecules in TAP deficient cells is the degradation of particular antigen by 
endolysosomal proteases in antigen presenting cells (APCs). The resulting peptides then 
bind to MHC class I molecules recycling through, or delivered to the endocytic 
compartment rather than in the ER, which is regarded as cross-presentation(Shen et al., 
2004; Jondal et al., 1996; Ackerman and Cresswell, 2004).
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1.2.1.2 Tapasin
Tapasin has been characterized as a member o f immunoglobulin superfamily(Ortmann et 
al., 1997). It is a 48 kDa type I membrane glycoprotein encoded by a gene located within 
the MHC class II region o f chromosome 6 in humans. Structurally, it is comprised o f a 
large N terminal region localized in the lumen o f the ER, a single transmembrane 
domain, and a short C-terminal cytosolic tail, which bears an ER-retention 
motif(Ortmann et al., 1994; Li et al., 1997; Jackson et al., 1990).
The specific function o f tapasin for MHC class I processing is striking. Unlike other 
chaperones in the ER, such as CNX, CRT, and ERp57, which participate in the general 
quality control of newly synthesized glycoproteins(Zhang et al., 1997; Peterson et al., 
1995; Wada et al., 1995), MHC class I is the only known target molecule for tapasin. 
Tapasin has been proposed to have several functions in the assembly o f MHC class I. (1) 
It forms a bridge between class I molecules and TAP(Sadasivan et al., 1996). The C- 
terminal site o f tapasin binds to TAP(Momburg and Tan, 2002) and the N-terminus of 
tapasin(Bangia et al., 1999; Momburg and Tan, 2002) interacts with the a2  domain of 
human leukocyte antigen-A2 (HLA-A2) [best defined by a mutation in residue 134 of 
HLA-A2](Peace-Brewer et al., 1996; Lewis et al., 1996) and the a3 domain of the class I 
HC(Suh et al., 1999; Kulig et al., 1998); (2) It influences the efficiency of peptide binding 
to TAP in the cytosol(Li et al., 2000), stabilizes TAP, and enhances its ability to transport 
peptides(Garbi et al., 2003; Lehner et al., 1998); (3) It functions to retain class I 
molecules in the ER to facilitate peptide loading and optimize the quality o f the peptide 
repertoire(Zarling et al., 2003; Schoenhals et al., 1999; Bamden et al., 2000).
The requirement o f tapasin for antigen presentation is well documented(Wright et al., 
2004; Momburg and Tan, 2002; Ortmann et al., 1997; Grandea, III and Van Kaer, 2001; 
Grandea, III et al., 2000). In human and murine tapasin deficient cells, both CRT and 
ERp57 exhibit reduced association with class I heterodimers(Grandea, III et al., 2000), 
and the interaction between MHC class I and TAP is impaired(Sadasivan et al., 1996). 
Furthermore, both TAP expression level and TAP peptide transport are reduced(Garbi et
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al., 2003; Grandea, III et al., 1995; Greenwood et al., 1994). As a consequence, MHC 
class I molecules in tapasin deficient cells are more rapidly transported but at the cost of 
optimal folding. These empty or sub-optimally loaded MHC class I molecules that reach 
the surface o f tapasin deficient cells rapidly fall apart and the ill-conformed chains are 
then internalized and degraded. Accordingly, MHC class I surface expression is reduced 
by 80-90%. However, cell surface expression o f MHC class I in human tapasin knockout 
cell lines is allele specific(Greenwood et al., 1994). For instance, the HLA-B44 allele is 
highly tapasin dependent, and surface expression o f this allele is almost completely lost 
in tapasin deficient LCL721.220 cells, whereas HLA-B27 allele is partially dependent on 
tapasin, and seems to be normally expressed at the surface o f cells without tapasin. The 
classical murine MHC class I molecules investigated so far depend on tapasin for surface 
expression and stability(Peh et al., 1998).
Cell surface peptide receptive class I on tapasin deficient cells can be stabilized by 
addition o f class I binding peptides to the culture medium(Williams et al., 2002b; 
Ljunggren et al., 1990). Moreover, the antigen presentation defect in tapasin deficient 
cells can be rescued by reintroduction o f tapasin by transfection(Ortmann et al., 1997; 
Lehner et al., 1998; Bangia et al., 1999). Finally, studies have showed that tapasin- 
negative mice had reduced selection o f CD8+ T cells and impaired CTL viral responses, 
which again demonstrated that tapasin is critical for peptide-loading and peptide 
selection(Garbi et al., 2000; Grandea, III et al., 2000).
The requirement for tapasin in the assembly o f class I molecules seems due to a 
decreased TAP expression and peptide translocation into the ER. Evidence for this comes 
from the work done by Garbi and colleagues who showed that targeting some epitopes 
into the ER o f tapasin7' cells by a signal sequence rescues the surface class I expression 
and cytolytic activity by CTLs to the same extent as in wild-type cells, while expression 
o f these epitopes targeted into the cytosol is reduced in the absence o f tapasin(Garbi et 
al., 2003). By contrast, other studies found that a mutant tapasin (N-terminal deletions) 
that binds TAP but not MHC class I restores peptide supply but fails to restore surface
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class I expression(Bangia et al., 1999; Peh et al., 2000). It was argued that tapasin may 
have functions beyond enrichment o f peptides supplier through TAP. This notion is 
supported by the work of Lehner et al, who demonstrated that mutant tapasin engineered 
to bind class I not TAP (C-terminal deletions) fails to restore peptide supply to the ER but 
fully restores the cell surface expression o f the tapasin dependent alleles HLA-B8 and 
HLA-B4402 (Lehner et al., 1998).
Tapasin, as discussed above, is required for the interactions of different components 
within the PLC. Bangia et al used TAP or p2m deficient cells to study how these 
interactions within the PLC affect tapasin stability. They found that tapasin is stable in 
the absence o f either TAP or MHC class I interaction. They proposed that tapasin 
stability may be aided by multiple interactions, any one o f which may be sufficient. 
Furthermore, they demonstrated that, in the absence o f TAP, tapasin and class I 
molecules interact in a prolonged and stable manner(Bangia and Cresswell, 2005), which 
are consistent with reports that tapasin retains MHC class I HCs in the ER of invertebrate 
cells(Schoenhals et al., 1999). Thus, although class I molecules in TAP deficient cells do 
not bind peptide, they are more stable compared with cells lacking tapasin(Grandea, III et 
al., 1997).
1.2.1.3 ERp57
ERp57 is a member o f the protein disulfide isomerase (PDI) family whose function 
includes disulfide bond isomerisation, reduction and oxidation(Lindquist et al., 2001; 
Ferrari and Soling, 1999). ERp57 has been identified as a component o f the MHC class I 
peptide-loading complex, and it interacts with other members o f PLC(Hughes and 
Cresswell, 1998; Morrice and Powis, 1998). For instance, ERp57 and tapasin are 
connected by a disulfide bond between Cys 95 o f tapasin and Cys57 o f ERp57, and this 
interaction is independent o f CRT and CNX, or availability o f monoglucosylated N- 
linked glycans(Peaper et al., 2005; Dick et al., 2002). Garbi et al have suggested that the 
interaction o f ERp57 with tapasin may induce a conformational change in the N-terminus
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of tapasin, which enables the latter to bind MHC class I molecules and bridges them to 
TAP(Garbi et al., 2006). Furthermore, ERp57 has been demonstrated to associate with 
the tip o f an arm-like P-domain o f CRT and CNX(Leach et al., 2002; Frickel et al., 2002; 
Pollock et al., 2004). Both CRT and CNX interact with class I HC via their N-linked 
glycans(Hammond et al., 1994; Peterson et al., 1995; Wada et al., 1995; Ware et al.,
1995). Therefore, ERp57 has been proposed to function as a ‘co-chaperone’ o f CNX and 
CRT. It forms one to one complexes with both CNX and CRT to modulate glycoprotein 
folding(01iver et al., 1997; Oliver et al., 1999; Elliott et al., 1997; van der Wal et al., 
1998; Molinari and Helenius, 1999). In this way ERp57 facilitates disulfide-bond 
isomerization o f class I molecules by transiently forming mixed disulfides with 
them(Farmery et al., 2000; Molinari and Helenius, 1999; High et al., 2000; Ellgaard et al., 
2001; Ellgaard and Helenius, 2001). In agreement with this, Elliott and Zapun have 
observed that the disulfide isomerase activity of ERp57 is greatly enhanced in the 
presence o f CNX or CRT, as they are brought into close proximity by their respective 
interaction with the lectin, their relative local concentration is increased(Elliott et al., 
1997; Zapun et al., 1998). There are two disulfide bonds formed in the class I HC, the 
first one in the a3 domain and the second one in the a2  domain. The importance of 
correctly formed disulfide bonds is demonstrated by mutation analysis in either o f these 
bonds, which leads to misfolding o f class I in the ER and results in reduced cell surface 
expression(Miyazaki et al., 1986; Warburton et al., 1994).
Nevertheless, the importance o f ERp57 in class I HC oxidation has been called into 
question by the finding that class I HC of B cells lacking ERp57, derived from ERp57'/_ 
mice generated by a targeted ERp57 knockout, displays a normal redox status, indicating 
that ERp57 may not play a unique role in HC oxidation(Garbi et al., 2006). In addition to 
this surprising finding, they demonstrated that, in ERp57-deficient cells, although the 
interaction of tapasin with TAP is not affected, the association of class I molecules to the 
TAP complex is reduced by about 90-95%; very few class I molecules are present in the 
loading complex; and the surface class I expression and stability are reduced. They 
concluded that ERp57 is central for recruitment o f MHC class I molecules into the 
loading complex and it is an essential component required for stable assembly of the
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peptide-loading complex. The molecular mechanism for ERp57-mediated binding of 
class I molecules by tapasin and recruitment into the PLC is not yet understood.
Apart from the controversial role ERp57 plays in HC oxidation, Powis et al have showed 
that ERp57 can act to reduce partially folded MHC class I molecules that are produced 
due to lack o f high-affinity peptides. Reduction o f class I molecules leads to unfolding 
and targeting for degradation, which is important for quality control in the ER. They 
suggest that ERp57 is likely to play a dual role in MHC class assembly, being directly 
involved in the formation and/or breakage o f disulfide bonds in class I HCs(Antoniou et 
al., 2002).
1.2.1.4 Calnexin
Calnexin (CNX) is a 65 kDa type I membrane protein and has an ER localization 
sequence at its C-terminus(Ou et al., 1993). Like its luminal homologue CRT, CNX also 
possesses a proline rich central P domain, which has been shown to bind to ERp57(Leach 
et al., 2002; Frickel et al., 2002). This central P domain has also been identified to be the 
lectin site o f calnexin capable o f binding oligosaccharide(Vassilakos et al., 1998).
CNX is regarded as a general chaperone that assists in the folding of newly synthesized 
glycoproteins in the ER, which contributes to ER quality control. MHC class I is one of 
CNX substrates. It has been demonstrated that CNX interacts with MHC class I HC upon 
its co-translational insertion in the ER membrane to facilitate the folding o f HC and 
stabilize it from aggregation as well as promote its assembly with |32m(David et al., 
1993; Degen and Williams, 1991; Degen et al., 1992; Hochstenbach et al., 1992). In 
mouse cells, CNX associates with both free class I HCs and class I~p2m dimmers(Degen 
et al., 1992). In human cells, however, it predominantly associates with free class I 
HCs(Ortmann et al., 1994; Sugita and Brenner, 1994; Nossner and Parham, 1995). This 
maybe due to one fact that human MHC class I molecules possess a single glycosylation 
site at position 86(Parham et al., 1977); while in addition to position 86, mouse HCs are
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also glycosylated at A snl76 for Kb and Asnl76/Asn256 for Db (Evans et al., 1982; Maloy 
and Coligan, 1982; Nathenson et al., 1981; Helenius and Aebi, 2001). Support for this 
hypothesis comes from studies o f mutant human HC with a second glycan introduced 
which revealed an assembly process similar to mouse HC with respect to lectin 
association(Zhang and Salter, 1998).
The requirement for CNX to associate with class I HC is not very clear since the 
assembly, transport, and the cell surface expression o f MHC class I molecules is 
unaffected in CNX deficient cells(Sadasivan et al., 1995; Scott and Dawson, 1995; Prasad 
et al., 1998). It seems likely that there is redundancy in the ER and that other chaperones 
can perform the same function as CNX in its absence. Immunoglobulin binding protein 
(BiP) is a possible candidate as BiP has been shown to associate with free human class I 
HC alleles in $2m'' cells (but not with mouse alleles)(Paulsson et al., 2001; Nossner and 
Parham, 1995). Nevertheless, it is still believed that the interaction between CNX and HC 
could serve to increase the efficiency of HC folding and may protect nascent chains from 
immediate degradation(David et al., 1993; Degen and Williams, 1991; Degen et al., 1992; 
Nossner and Parham, 1995; Hochstenbach et al., 1992).
1.2.1.5 Calreticulin
CRT is a ubiquitous protein, found in a wide range o f species. It is highly conserved, with 
over 90% amino acid identity existing between human, rabbit, and mouse forms of 
protein. CRT was first isolated by Ostwald and MacLennan in 1974(Ostwald and 
MacLennan, 1974), followed by molecular cloning o f the protein in 1989 by Smith and 
Kock, and Fliegel(Smith and Koch, 1989; Fliegel et al., 1989a). It appears most abundant 
in the endoplasmic reticulum (ER)(Nash et al., 1994; Sonnichsen et al., 1994), but has 
also been detected in other cellular compartments, such as the nucleus(Opas et al., 1991), 
cytoplasm and cell surface(Michalak et al., 1992; Arosa et al., 1999; Wiest et al., 1997; 
Xiao et al., 1999) and it may even be secreted in the bloodstream(Eggleton and 
Llewellyn, 1999).
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1.2.1.5.1 The CR T gene and protein
The CRT gene consists o f 9 exons and 8 introns and spans approx. 3.6 kb or 4.6 kb of 
human or mouse genomic DNA respectively(Waser et al., 1997). The genes of human 
and mouse have been localized to chromosomes 19 and 8 respectively(Rooke et al., 
1997). The nucleotide sequences of the human and mouse genes show greater than 70% 
identity. Surprisingly, only one mRNA species encoding CRT was identified in a variety 
o f different tissues, and there is no evidence for RNA splicing, indicating a high level of 
conservation o f the gene. The promoter o f the human and mouse CRT genes contain 
several putative regulatory sites and is activated by Zn2+ and heat shock(Nguyen et al., 
1996; Conway et al., 1995). Expression o f CRT is also induced by viral infection(Zhu,
1996), by amino acid deprivation(Plakidou-Dymock and McGivan, 1994) and in 
stimulated cytotoxic T-cells(Bums et al., 1992).
CRT protein contains 400 amino acids and has a calculated molecular mass of 46 kDa. 
Anomalous migration in SDS-PAGE, likely due to its highly negative charge (PI=4.7) 
and/or other structural features, results in CRT’s appearance as an appropriate 60kDa 
protein(Fliegel et al., 1989a). Moreover, CRT can exist as a 120 kDa dimer(Rizvi et al., 
2004). As an ER resident protein, CRT has an N-terminal cleavable 17 amino acid signal 
sequence to target the protein to the ER and a C-terminal KDEL ER retrieval signal for 
the retention of CRT in the ER(Fliegel et al., 1989a; Munro and Pelham, 1987). 
Structurally and functionally, CRT can be divided into three domains, N-domain, P 
domain and C-domain(Smith and Koch, 1989; Nakamura et al., 2001b), which is 
supported by the NMR structure o f the central, proline-rich P-domain of CRT revealing 
highly unusual arrangements(Ellgaard et al., 2001) (Fig 1.3).
25
Chaperone 
(folding unit)
Calcium storage 
domain
NH3*B
signal
sequence
rs-si 
#88 n\2Q
ERp57 binding
170 re9ion 285 A 1  8 400 residue #
- KDEl COO
N -dom ain P-domain C-domain
Fig. 1.3 Schematic structure of CRT
Adapted from - The International Journal of Biochemistry and Cell Biology. 2005, 37: 
260-266; P. Gelebart et a l Calreticulin, a Ca2+ -binding chaperon of the endoplasmic 
reticulum
The N-domain of CRT (residues 1-180) is coded by exons 1, 2, 3 and 4, and is the most 
conserved domain among CRTs from different species(Michalak et al., 1992; Krause and 
Michalak, 1997). Based on the X-ray structure of soluble calnexin(Schrag et al., 2001) 
and the NMR structure determined for the P-domain of CRT(Ellgaard et al., 2001), the N- 
domain of CRT is predicted to form a highly folded globular structure (Fig 1.4). This 
domain has three cysteine residues, and the location of these amino acid residues is 
conserved in CRT from high plants to that in humans. Two out of three cysteine residues 
form a disulphide bridge (Cysl20-Cysl46), which may be important for proper folding of 
the N-domain of CRT(Michalak et al., 1992). Furthermore, the N-domain of CRT 
contains 5 histidine residues, which are involved in zinc binding to the protein(Baksh et 
al., 1995). This domain contains a high capacity, low affinity zinc binding site(Khanna et 
al., 1986). The importance of 5 histidine residue at position 153 (His 153) has been 
demonstrated by the finding that mutation of His 153 in CRT’s N domain destroys the 
protein’s chaperone function, and biophysical analysis of the His 153 mutant revealed that
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a conformational change in the CRT mutant may be responsible for the loss o f it’s 
chaperone function(Guo et al., 2003). Additionally, it has been reported that the N 
domain o f CRT can bind the cytoplasmic domains o f integrin a  subunits(Rojiani et al., 
1991), interact with the DNA binding domain o f the glucocorticoid receptor in 
vitro(Bums et al., 1994), and associate weakly with protein disulphide-isomerase 
(PDI)(Corbett et al., 1999; Baksh et al., 1995), which catalyzes the in vitro folding of a 
variety o f proteins by assisting in isomerization o f intra-molecular disulfide 
bridges(Freedman et al., 1994; Noiva and Lennarz, 1992). The interaction o f CRT N- 
domain with proteins is believed to have important physiological functions. For instance, 
interaction o f the CRT N-domain with PDI inhibits PDI chaperone function as measured 
by the ability o f PDI to refold scrambled RNase A(Baksh et al., 1995). Studies revealed 
that these protein-protein interactions are regulated by calcium binding to the C-domain 
o f CRT(Corbett et al., 1999). Finally, the N-domain o f CRT has been shown to inhibit 
proliferation o f endothelial cells and suppresses angiogenesis(Pike et al., 1998).
The P-domain of CRT (residues 181-280) may be encoded by exons 5, 6 and 7(Michalak 
et al., 1992; Krause and Michalak, 1997) and forms an extended-arm structure (Fig 
1.4)(Ellgaard et al., 2001). It is rich in proline(Fliegel et al., 1989a) and contains two sets 
o f three sequences repeats (Repeat A: amino acid sequence PXXIXDPDAXKPEDWDE, 
and repeat B: amino acid sequence GXWXPPXIXNPXYX), which is unique to CRT and 
its homologue calnexin(Watanabe et al., 1994; Bergeron et al., 1994). The sequence of 
the P domain is highly conserved from plants and parasites to mammals. For example, 
there is only one amino acid difference between the p-domain o f human and mouse forms 
o f CRT (see appendix). Functionally, like the N-domain o f CRT, P-domain of CRT is 
also involved in protein-protein interactions. Leach et al reported that the P domain of 
CRT interacts with ERp57 through the tip o f the arm domain(Leach et al., 2002). This is 
supported by the work from Ellgaard and colleagues, who showed the nuclear magnetic 
resonance (NMR) structure for the P-domain of CRT(Ellgaard et al., 2001). Furthermore, 
the P-domain of CRT also interacts strongly with PDI(Baksh et al., 1995) and 
perforin(Andrin et al., 1998; Fraser et al., 1998). These protein-protein interactions may 
lead to modulation o f their functions. For example, in the presence of PDI, CRT does not
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bind Ca2+ with high affinity(Baksh et al., 1995). In general, the P-domain of CRT, 
together with the N-domain o f CRT, has been proposed to form a functional “protein- 
folding module” (Michalak et al., 1992). Moreover, like the P-domain of calnexin, the P 
domain o f CRT has also been identified to be the lectin site o f CRT capable o f binding 
oligosaccharide(Vassilakos et al., 1998). The P-domain also plays a role in Ca2+ storage 
in the lumen of ER. It binds Ca2+ with a high affinity, low capacity(Baksh and Michalak, 
1991).
The C-domain o f CRT (residues 281-400) is encoded by exons 8 and 9(Fliegel et al., 
1989b). This domain is highly acidic (37 of its final 57 residues are aspartic or glutamic 
acid) and terminates with the KDEL ER retrieval signal(Fliegel et al., 1989b; Smith and 
Koch, 1989). The C domain binds Ca2+ with high capacity but low affinity(Fliegel et al., 
1989b) (Fig 1.4), which enables CRT to be one o f the major proteins regulating the 
process o f Ca2+ homeostasis in the ER. However, CRT determines the Ca2+ storage 
capacity, not the free Ca concentration of the ER(Nakamura et al., 2001b). Moreover, 
studies have indicated that Ca binding to this domain o f CRT plays a regulatory role in 
the control of CRT interaction with other proteins or chaperones, such as PDI and 
ERp57(Corbett et al., 1999). CRT associates with these ER proteins in a Ca2+-dependent 
manner to modulate their functions(Corbett et al., 1999; Booth and Koch, 1989; Lodish 
and Kong, 1990; Corbett et al., 2000). For example, CRT interacts with PDI only when 
the Ca2+concentration is below 100 |aM, a Ca2+ concentration found upon emptying o f the 
Ca2+ stores, but the protein complex dissociates upon increased Ca2+ concentration 
(>500|aM). In addition, although the formation of the CRT-ERp57 complex is initiated by 
a Ca2+ independent conformational change in ERp57, it is followed by additional Ca2+ 
dependent conformational changes in the complex(Corbett et al., 1999). Therefore, it 
seems that many functions proposed for CRT could be affected by its effects on the ER
7 -4-Ca storage capacity(Nakamura et al., 2001b; Bastianutto et al., 1995).
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1.2.1.5.2 CRTfunction
Although CRT was first identified as a Ca2+ binding protein(Ostwald and MacLennan, 
1974), later multiple functions have been postulated for CRT, including functions of CRT 
within the ER (chaperone(Molinari et al., 2004) as well as Ca2+ storage, 
signaling(Nakamura et al., 2001b; Amaudeau et al., 2002)) and extra-ER functions (CRT- 
dependent modulation of cell adhesion(Opas et al., 1996; Leung-Hagesteijn et al., 1994; 
Dedhar, 1994)). Moreover, CRT plays a crucial role during early cardiac 
development(Michalak et al., 2004; Nakamura et al., 2001a). In addition to its 
physiological function, CRT has been implicated in a number of pathological processes, 
such as autoimmune diseases(Eggleton and Llewellyn, 1999; Karska et al., 1995) and
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cancer (Kageyama et al., 2004; Hong et al., 2004). In the following chapters, however, 
only the functions of CRT that relate to this study will be discussed.
1.2.1.5.2.1 CRT as an ER chaperone
CRT is an important molecular chaperone for glycoproteins in the ER. Together with 
calnexin and ERp57, CRT constitutes the “CRT/CNX cycle”, which is responsible for the 
folding, oligomeric assembly and quality control o f newly synthesized glycoproteins, and 
helps to retain misfolded or incompletely assembled proteins in the ER, which are then 
targeted to the cytosol for degradation(Ellgaard and Helenius, 2001). In the ER lumen an 
integral membrane enzyme complex known as oligosaccharide transferase catalyses the 
transfer o f Glc3Man9GlcNAc2 to the side chain o f asparagine residues o f newly 
synthesized proteins(Kelleher and Gilmore, 1997). Glucosidase I, an integral membrane 
protein, then removes the terminal al,2-linked  glucose (Fig 1.5), followed by elimination 
o f one o f the two al,3-linked  glucose by Glucosidase II, a soluble luminal protein, to 
produce the GlclMan9GlcNAc2 processing intermediate. This is the specific ligand of 
CRT and CNX(Hammond and Helenius, 1994; Ware et al., 1995). The second a  1,3- 
linked glucose exposed by a dynamic association of glycoprotein with CNX or CRT is 
trimmed by Glucosidase II, which is important in the regulation of glycoprotein- 
chaperone interactions(Trombetta, 2003; Helenius and Aebi, 2004). If the glycoprotein is 
folded correctly, it escapes from the folding cycle. However, If  the released de- 
glucosylated glycoprotein does not acquire its native state, the terminal al,3-linked 
glucose is once again added back to the oligosaccharides to generate monoglucosylated 
glycans by the UDP-glucose: glycoprotein glycosyltransferase which serves as a folding 
sensor recognizing and re-glucosylating non-native glycoproteins(Sousa and Parodi, 
1995). This de-glucosylation/glucosylation cycle may be repeated several times before a 
newly synthesized glycoprotein is properly folded. The misfolded proteins are hydrolyzed 
by ER a-mannosidase I to target them for retrotranslocation through Sec61 channel to be 
degraded by the proteasome(Cabral et al., 2001).
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CRT binding to monoglucosylated carbohydrate is sensitive to changes in Ca2+ 
concentrations, suggesting the changes in the ER luminal Ca2+ concentrations may have 
profound effects on the formation of the chaperon-substrate complexes, which 
subsequently affects its ability to assist in the folding o f glycoproteins(Corbett et al., 
2000; Vassilakos et al., 1998).
The importance of CRT for glycoprotein folding comes from the work by Molinari and 
colleagues, who showed that CRT depletion specifically accelerates the maturation o f 
cellular and viral glyoproteins with a modest decrease in folding efficiency(Molinari et 
al., 2004). Additionally, the chaperone function o f CRT has been demonstrated in 
connection with the folding o f insulin receptor monomers(Bass et al., 1998), and the 
assembly o f nascent T-cell receptor proteins(van Leeuwen and Kearse, 1996b).
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Fig. 1.5: Glucose modification by enzymes in the ER
Adapted from -  Trends in cell biology, 1997, 17:193. Ari Helenius et al. Calnexin, 
calreticulin and the folding o f  glycoproteins
Although it is generally accepted that CRT is an important chaperone, there is debate 
about whether CRT binds only to carbohydrate or if  it also binds directly to polypeptides. 
Two models have been proposed to describe the interactions of CRT with newly 
synthesized proteins. In the lectin-only model, CRT functions as lectin binding to 
glycoproteins exclusively through lectin-oligosaccharide(Peterson et al., 1995). Evidence
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for this model is that CRT-glycoprotein complexes are dissociated by the action of 
glucosidase II, which removes the single glucose residue, and that glucosidase inhibitors, 
such as castanospermine, block CRT-glycoproteins complex formation(Zhang et al., 
1997; Peterson et al., 1995; Hammond and Helenius, 1994). Furthermore, CRT was 
shown to be unable to discriminate between reduced and native forms of 
monoglucosylated RnaseB, and the complex between CRT and RnaseB could only be 
dissociated in vitro by digestion with glucosidase II(Rodan et al., 1996). Finally, the in 
vitro study carried out by Wearsch and colleagues showed that CRT bound as efficiently 
to peptide-loaded MHC class I molecules as it did to folding intermediates, namely free 
class I HC and empty HC-|32in heterdimers(Wearsch et al., 2004). The primary lectin site 
of CRT, demonstrated by Leach and colleagues, resides within the N-domain with a 
weaker secondary site within the P-domain(Leach et al., 2002). In the second model 
known as the dual-binding model, CRT is proposed to bind to unfolded glycoprotein 
through interactions with both carbohydrate and exposed hydrophobic polypeptide 
sequences. Therefore, the dissociation of CRT-gly coprotein complexes occurs through 
the action o f glucosidase II as well as a conformational change in the polypeptide-binding 
site. Support for this model comes from the finding that CRT binds to several non­
glycosylated proteins including ERp57(Corbett et al., 1999) and PDI(Baksh et al., 1995). 
Moreover, CRT has been shown to discriminate native and non-native conformations of 
non-glycosylated proteins in vitro(Svaerke and Houen, 1998; Saito et al., 1999), and 
Jorgensen et al have showed that CRT interacted better with unfolded ovalbumin than 
with native ovalbumin(Jorgensen et al., 2000). Additionally, a study carried out by Leach 
et al showed that CRT suppressed aggregation o f unfolded proteins via a polypeptide 
binding site, which is located within the N-domain of CRT, but requires the P-domain for 
its full chaperone function(Leach et al., 2002). However, it has not yet been possible to 
resolve this debate with the current available experimental substrates and methods.
As mentioned above, CRT and CNX recognize identical glycan moieties(Vassilakos et 
al., 1998), but, the substrate glycoproteins with which the two proteins interact are not 
identical(Danilczyk et al., 2000). What determines whether unfolded glycoproteins bind 
to CRT or CNX? The answer may be dependent on the number and position of N-linked
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oligosaccharide chains(Molinari and Helenius, 2000). Extensive mutagenesis studies of 
the glycosylation sites in influenza hemagglutinin revealed that CRT binds preferentially 
to N-glycans located at the membrane-distal domain o f the molecule, whereas CNX binds 
equally well to the membrane-distal and membrane-proximal N-glycans(Hebert et al., 
1997). It was also suggested the proteins that fold in the ER make use o f proteins in 
different combinations and different orders(Molinari and Helenius, 2000). In some cases 
CRT and CNX bind to the same glycoprotein, but they bind different oligosaccharadides. 
For example, Harris et al showed that o f the three glycosylation sites in the mouse Ld HC, 
removal o f the site in the membrane distal a l  domain (residue 86) ablates CRT binding, 
whereas CNX binding is unaffacted(Hebert et al., 1997; Harris et al., 1998). Alternately 
CRT and CNX may bind to the same glycoprotein at different stages o f maturation 
process(van Leeuwen and Kearse, 1996a). For some substrates, the difference may be 
simply due to the topological environment-that is CRT being soluble, whereas CNX 
being membrane bound. This is supported by evidence that the pattern of bound proteins 
to CNX was similar to that of CRT when the ectodomain o f CNX was expressed as a 
soluble ER protein(Danilczyk et al., 2000). However there are examples where the 
ectodomain o f CNX cannot replace CRT. For example, Gao and colleagues have shown 
that transfecting CRT deficient cells with CRT cDNA but not with soluble calnexin 
cDNA restored cell surface MHC class I expression(Gao et al., 2002). Furthermore, the 
spectrum o f proteins recognized by the membrane-anchored CRT was remarkably similar 
to that observed with CNX(Danilczyk et al., 2000; Wada et al., 1995). Therefore, a 
luminal versus membrane topology also appears to play an important role in determining 
the differential binding specificities o f CRT and CNX.
1.2.1.5.2.2 CRT and MHC class I mediated antigen processing
Structurally, CRT is a member o f the PLC and it interacts with other components of PLC. 
After HC is assembled with p2m, CRT associates with MHC class I though the glycan on 
HC(Sadasivan et al., 1996; Solheim et al., 1997), especially the N-linked glycan in the a l  
HC is required for the interaction of the HC with CRT(Harris et al., 1998; Turnquist et 
al., 2002). The association o f CRT with MHC class I molecule is not dependent on either
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TAP(Harris et al., 1998) or tapasin(Sadasivan et al., 1996; Solheim et al., 1997). For 
instance, Tumquist and co-workers demonstrated that in tapasin deficient cells, CRT still 
can interact with class I(Tumquist et al., 2002). Moreover, class I HC mutants lacking 
tapasin interaction retained normal association with CRT(Paquet and Williams, 2002). 
The interaction of CRT with HC appears to be a prerequisite for the association o f class I 
with TAP via tapasin. For example, Elbein and colleagues have showed that class I 
alleles that associate well with CRT also associate well with TAP(Elbein, 1991). 
Furthermore, the drug castanospermine, which blocks the action of glucosidase I and II, 
has been shown to affect HLA class I association with both CRT and TAP, and the 
authors argued that it is likely that castanospermine inhibits class I-TAP association 
because it inhibits the prior interaction o f CRT with class I~p2m dimers(Elbein, 1991; 
Sadasivan et al., 1996). Further evidence comes from the work by Harris that mutation of 
the residue at position 86 alters the Asn-linked glycosylation site and leads to PLC 
disruption through poor CRT association(Harris et al., 1998; Harris et al., 2001), which is 
in agreement with another study showing that tapasin does not interact with class I in the 
absence o f CRT interaction with class I(Tumquist et al., 2002). In addition, Gao et al 
have found that the incorporation of class I molecules into PLC is lower in CRT deficient 
K42 cells compared with that of CRT competent K41 cells(Gao et al., 2002). Although 
CRT-class I can be present as an independent complex in the ER, the vast majority of 
these molecules are simultaneously assembled with three additional accessory proteins: 
ERp57, tapasin and TAP(Sadasivan et al., 1996; Harris et al., 1998; Solheim et al., 1997). 
CRT also interacts with ERp57. Evidence for this comes from the biochemical and NMR 
studies which revealed that the P domain o f CRT interacts with ERp57 through several 
residues located at the tip of its P-domain(Frickel et al., 2002), which is also 
demonstrated by gel filtration chromatography(Zapun et al., 1998), cross-linking and 
native gel analysis(OHver et al., 1999), and by a solid-phase binding assay(Leach et al., 
2002). Based on the interactions o f CRT with both MHC class I and ERp57, a molecular 
mechanism describing how CRT in concert with ERp57 facilitates the folding of MHC 
class I has been proposed. The flexibility o f the P domain of CRT may provide a 
mechanism whereby CRT can effectively optimize interactions between MHC class I and 
ERp57 to allow the ERp57 to catalyze the formation and rearrangement of two intra-
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chain disulfide bonds in MHC class I HC (a2  and a3  domains)(Bouvier, 2003). On the 
basis o f these data, CRT seems to play a central role in the formation of the MHC class I 
PLC.
Functionally, CRT is critical for the assembly of MHC class I. Studies have found that 
CRT preferentially binds to open conformations of MHC class I(Sadasivan et al., 1996; 
Harris et al., 1998) and is not associated with class I after peptide-induced folding(Harris 
et al., 1998), which suggests that CRT could serve to stabilize and retain the HC-(32m 
heterodimer in the ER until the antigenic peptide is loaded(Harris et al., 1998; Danilczyk 
et al., 2000). Furthermore, in vitro studies o f the effects o f CRT on class I assembly 
showed that, although in the absence of other ER components o f the PLC CRT does not 
enhance the extent of MHC class I assembly with peptides, CRT does promote the 
folding o f HLA class I molecules(Culina et al., 2004) and inhibit the aggregation of 
peptide loaded or receptive class I and class I HCs(Wearsch et al., 2004; Mancino et al.,
2002). Additionally, the importance of CRT for the quality o f MHC class I molecules 
was highlighted by cells (K42) from CRT deficient mice, which have impaired peptide 
loading onto class I molecules (the efficiency o f peptide loading was reduced by 50- 
80%), resulting in the accelerated export o f peptide-receptive class I molecule from the 
ER with low cell surface class I expression and low stability of cell surface-expressed 
class I molecules. Conformation dependent antibodies showed that a greater proportion of 
MHC class molecules in the ER remain in the peptide receptive state in K42 (CRT-/-) 
than in K4 1(CRT+/+). Most importantly, 3 of 4 tested epitopes failed to be presented by 
a calreticulin deficient cell line, implying its critical role in antigen processing for T cell 
recognition(Gao et al., 2002). Although evidence is accumulating that CRT is critical for 
efficient MHC class I assembly, the precise role of CRT and the mechanism underlying 
the essential role in class I assembly remains elusive.
1.2.1.5.2.3 CRT and cell adhesion, cell spreading
CRT has been reported to modulate cell adhesion by intracellular and extracellular 
mechanisms in several locations, both inside and outside the cell(Michalak et al., 1999;
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Johnson et al., 2001). Accordingly, changes in levels o f CRT expression affect cell shape, 
motility, and the cytoskeleton. For example, overexpression o f CRT in L fibroblasts 
increases cell-substratum attachment and establishes epithelial-like cell-cell junctions. 
Thus, cells look more spread and have more cell projections(Opas et al., 1996) (Fig 1.6), 
whereas transient down-regulation o f CRT reduces attachment o f cells to extracellular 
substrate, which causes cells to be round and smoother than the control cells (Opas et al., 
1996; Leung-Hagesteijn et al., 1994). In addition, embryonic stem (ES) cells lacking 
CRT have impaired cell adhesion(Leung-Hagesteijn et al., 1994). What mechanisms does 
CRT regulate cell adhesiveness?
CRT might modulate cell adhesion from within the cell through an interaction with 
integrin tails. The integrins are important mediators of cell adhesion to extracellular 
ligands. They belong to a family of heterodimeric, transmembrane glycoproteins that are 
formed by the noncovalent association of a  and p subunits(Hynes, 1992; Ruoslahti and 
Pierschbacher, 1987). On the cell exterior, domains of the a  and p subunits form a ligand 
binding site through which integrins can mediate cell binding to substrates including 
extracellular matrix molecules (cell-substratum adhesions) and other cell surface proteins 
(cell-cell adhesion). Once adhered to a substratum, cells recognizing their cytoskeleton 
convert their shape from sphere to flattened, extended forms. Interior to the plasma 
membrane, the cytoplasmic domains o f integrin subunits can interact with intracellular 
proteins, such as CRT, calcineurin or calmodulin. It has been suggested that CRT 
interacts with the KXGFFKR m otif in the cytoplasmic domain of the integrin a  chain 
through mainly its N-domain(Michalak et al., 1992). Further studies have demonstrated 
that CRT deficient ES cells have impaired integrin-mediated adhesion, although integrin 
expression is unaltered; and expression of recombinant CRT in double CRT knockout ES 
cells by CRT cDNA transfection rescued integrin-mediated adhesion(Coppolino et al.,
1997). But opinion is still divided as to whether CRT dependent integrin mediated cell 
adhesion is through CRT direct binding to cytoplasmic tails o f the integrin or through 
signaling from within the ER. There is no solid evidence to prove the presence o f CRT in 
the cytosol despite the ability o f CRT to bind to integrin tails in vitro(Arvan et al., 1991).
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Furthermore, targeting o f CRT to the cytoplasm either by microinjection or by expression 
of leaderless CRT has no effect on cell adhesion (Michalak, M.1996, Careticulin. R. G. 
Landers, Georgetown. 207 pp). Up to now, the exact mechanism by which CRT 
modulates integrin function is not very clear.
Alternatively, CRT may influence cell adhesion indirectly from the ER by modulation of 
gene expression o f adhesion-associated molecules, such as vinculin, a cytoskeletal 
protein essential for cell substratum and cell-cell attachments. Support for this opinion 
comes from the work done by Opas and colleagues that showed both vinculin protein and 
mRNA levels are increased in L fibroblasts over-expressing CRT and are down-regulated 
in cells expressing reduced levels o f CRT. By contrast, expression of other adhesion- 
related proteins, such as actin ,talin, a5  and pi intergrins, ppl25 focal adhesion kinase, or 
a-catenin, is unaltered(Opas et al., 1996). However, the mechanism of CRT effect on 
vinculin gene activity is currently unknown.
Finally, CRT might affect cell adhesion from the cell surface. CRT has been identified on 
the surface o f a wide variety o f cell types, such as human leukocytes(Wiest et al., 1997; 
Arosa et al., 1999), endothelial cells(Malhotra, 1993) and B16 mouse melanoma 
cells(Davis et al., 1999). Cell surface CRT was also reported to complex with 
integrins(Eaton et al., 2000). Furthermore, antibodies against CRT can prevent spreading 
o f B16 cells(Davis et al., 1999). How CRT escapes ER retention and is translocated to the 
cell surface remains to be answered.
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Fig. 1.6 CRT affecting cell adhesion and spreading
(A) Calreticulin underexpressers. (B) Calreticulin overexpressers. (C) Control mock 
transfectants.
Adapted from -  The Journal o f Cell Biology, Volume 135, Number 6, Part 2, December 
1996 1913-1923. Michal Opas, Calreticulin Modulates Cell Adhesiveness via Regulation 
o f Vinculin Expression
1.2.1.5.2.4 CRT as a chaperone of peptides
It has been proposed that the peptides exist in association with heat shock proteins (Hsps) 
both in the cytosol and in the ER, and these Hsps are the peptide-binding proteins that 
transport peptides(Srivastava et al., 1994). One study has shown that free peptides 
introduced into the cytosol are presented quite inefficiently by class I molecules as 
compared with peptides chaperoned by Hsps, such as Hsp70 or Hsp90, and the 
presentation is both peptide-dependent and -specific(Binder et al., 2001). Furthermore, it 
has been established that ER resident chaperone proteins, such as GRP94, BIP and PDI, 
display peptide-binding activity(Wearsch and Nicchitta, 1997; Spee and Neefjes, 1997; 
Noiva et al., 1991; Lammert et al., 1997b).
Because o f the established role of CRT in the genesis of class I/peptide complexes and 
the propensity o f ER chaperones to display peptide-binding activity, CRT has been 
investigated for its role in chaperoning pepides. CRT has been shown to bind to antigenic 
peptides transported into the ER by TAP in cells(Spee and Neefjes, 1997) and several 
nonglycosylated peptides in vitro(Basu and Srivastava, 1999; Saito et al., 1999; 
Jorgensen et al., 2000). Furthermore, in vitro incubation of such CRT-antigenic peptide
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complexes with APCs allows cross-presentation o f the peptide to CTLs, and the 
immunogenicity of the CRT-peptide complexes is attributed to the peptide chaperoned by 
CRT molecule(Basu and Srivastava, 1999; Nair et al., 1999). Additionally, a study by 
Binder and colleagues showed that CRT associated with peptide in the ER acted as a
nonspecific adjuvant present in the cells since they found that peptides chaperoned by
CRT or other Hsps are the necessary and sufficient source o f antigen transferred to APCs 
for priming CTL responses(Binder and Srivastava, 2005). Finally, CRT purified from 
tumour cells has been shown to elicit tumour specific CTL responses in vivo, which has 
been attributed to the ability of CRT to bind a variety o f tumour specific peptide antigens 
within the cells, and cross present these peptides via class I molecules o f APC(Basu and 
Srivastava, 1999; Nair et al., 1999).
The function o f CRT as a peptide chaperone in antigen presentation has also been
demonstrated at the DNA level. Cheng and colleagues explored the linkage o f CRT to the 
DNA of a model tumor antigen, human papilloma virus type-16 E7, for the development 
of a DNA vaccine. They found that the use o f CRT chimerically linked to E7 DNA 
elicited strong E7-specific CTL immune responses and generated a significant CTL- 
dependent protective effect against E7-expressing tumors(Cheng et al., 2001).
The mechanism by which CRT-peptide complex elicits immunity is however not well 
understood. One o f the possible mechanisms for the chaperone effect o f CRT is directly 
enhancing MHC class I presentation by binding of CRT to peptides to protect them from 
degradation by ER peptidases, a function demonstrated by other ER peptide chaperons 
such as gp96, gpl70, ERp72, ERp57(Menoret et al., 1999; Ishii et al., 1999; Paz et al., 
1999; Lammert et al., 1997a; Lammert et al., 1997b; Basu and Srivastava, 1999; Reits et 
al., 2003). Another possible mechanism is through a process called ‘cross- 
presentation’(Srivastava, 2002; Singh-Jasuja et al., 2000; Tamura et al., 1997). It is 
proposed that APC uptake of CRT chaperoned peptides is through receptors such as 
CD91(Binder et al., 2000; Basu et al., 2001), LOXl(Delneste et al., 2002), and then re­
presented by class I molecules representing one mechanism of cross-priming. This is a
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pathway by which peptides go from the endosome to the cytosol, and then to the ER and 
the secretory pathway, as immunogenicity of CRT-peptide complexes has been shown to 
be dependent on the presence o f a functional proteasome complex and a functional TAP. 
The importance o f receptor CD91 in taking up CRT/peptide complexes was demonstrated 
by Basu et al who showed that both a 2  macroglobulin, a known ligand for CD91, and 
anti-CD91 antibodies can inhibit re-presentation of peptides chaperoned by CRT(Basu et 
al., 2001).
The chaperones and folding enzymes described individually above, are members of the 
PLC, which consists o f one TAP1/TAP2 dimer, four tapasin molecules, four MHC class I 
molecules, four ERp57 molecules and four CRT molecules(Sadasivan et al., 1996; 
Ortmann et al., 1994). PLC is believed to be the result o f cooperative interactions among 
the components o f the class I assembly machinery. Tapasin is the keystone of the 
PLC(Momburg and Tan, 2002). It bridges class I molecules to TAP(Tan et al., 2002). 
Furthermore, tapasin and ERp57 form a stable disulfide-linked dimer within the 
PLC(Peaper et al., 2005; Dick et al., 2002; Lindquist et al., 1998), which is independent 
o f CRT and calnexin(Peaper et al., 2005). Disruption of this disulfide bond by mutation 
of cysteine 95 in tapasin results in incompletely oxidised MHC class I molecules, which 
exit the ER in an unstable conformation(Dick et al., 2002). Additionally, ERp57 interacts 
with the tip o f the CRT P domain(Leach et al., 2002; Ellgaard et al., 2001). Both ERp57 
and CRT non-covalently associate weakly with class I(01iver et al., 1997; van der Wal et 
al., 1998; Kang and Cresswell, 2002). Previously, It was suggested that ERp57 was 
recruited into the PLC by its association with CRT or CNX. However, Gao and 
colleagues studied the formation of PLC in CRT deficient cells, and found that abundant 
ERp57 coprecipitated with TAP, even in cases there was no detectable canexin inside the 
PLC. They, therefore, suggested that the incorporation o f ERp57 into the loading 
complex is not a consequence of its association with CRT or calnexin(Gao et al., 2002). 
Additionally, Peaper et al have showed that all the tapasin in p2m or MHC class I 
deficient cells was disulfide-linked to ERp57, implying that ERp57 interaction with PLC 
is independent o f the recruitment o f class I molecules(Peaper et al., 2005). Now it is
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believed that ERp57, together with TAP and tapasin, forms the core, unchanging 
component of PLC, and that CRT as well as the MHC class I-fLhn dimers cycle through 
the loading complex during peptide loading(Cresswell et al., 2005).
The exact functional role o f each component of PLC is difficult to identify given that the 
interactions between the molecules are highly co-operative. In addition, ER has a 
powerful and redundant system to assist protein folding. I f  access to one chaperone is 
prevented, a different one can take over. Nonetheless, one approach towards 
understanding the nature of interactions among components of PLC and their functions 
involves studying the phenotype o f class I complexes assembled from mutant class I 
molecules with altered binding to other components o f PLC. For example, a non­
conservative point mutation at position 134 of the HLA-A2 HC (A2T134K) renders the 
A2 molecule unable to bind tapasin, TAP and CRT. As a result, A2T134K/|32m 
complexes are rapidly exported to the cell surface in an unstable, peptide-receptive 
form(Peace-Brewer et al., 1996; Lewis et al., 1996; Lewis and Elliott, 1998). Another 
example is the mutation o f asparagine at position 86 (N86). Mutagensis of N86 o f HLA- 
B27 prevented incorporation of the HC/p2m dimer into the PLC, so there is no 
association o f HC with tapasin, TAP or CRT. Although class I surface expression was 
comparable to the wild type B27, a great proportion of class I complexes were thought to 
be empty. Presumably the mutation of N86 prevented class I HC from glycosylation, 
which in turn disrupted the interaction o f HC with CRT as studies have shown that the 
N86 is critical for the interaction o f HC with CRT(Harris et al., 2001). Taken together, 
these data have shown that there is a correlation between the ability of class I molecules 
to interact with PLC and the efficiency of optimal peptide loading(Hill et al., 1993).
The relative physiological importance o f the different components of PLC for antigen 
presentation in vivo can be assessed by using knock-out mice for each component. All 
components o f PLC have been deleted in mice, and the strongest effect on the expression 
of class I/peptide molecules is obtained from mice deficient in |32m. Cell surface HC 
expression is below the detection limit by fluorescent-assisted sorting(Williams et al.,
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1989; Zijlstra et al., 1990). The next component in the order of importance for class I 
expression is TAP1/TAP2 complex. Cells from TAPI deficient mice show a 90-fold 
reduction in surface class I expression(Van Kaer et al., 1992). Tapasin is also important 
for the surface class I expression, about 10-fold reduction in surface class I expression 
was observed in lymphocytes lacking tapasin expression(Garbi et al., 2000; Grandea, III 
et al., 2000). Lastly, MHC class I expression is less critically dependent on CRT and 
ERp57, with threefold to fourfold reduction of surface class I for CRT deficient 
fibroblasts(Gao et al., 2002) and twofold decrease in class I expression in lymphocytes 
from ERp57'A mice(Garbi et al., 2006). Until now, although the function of TAP in 
transporting peptides across the ER membrane has been established, the contribution of 
other components in the PLC to peptide loading is less well understood and still remains 
a topic o f considerable interest.
Finally, it needs to be pointed out that, although peptide-binding onto class I molecules 
within the PLC in the ER contributes the large majority o f class I/peptide complexes at 
the cell surface, many human leukocyte antigen-B (HLA-B) alleles, such as HLA-B13, 
B44 and B60, do not use the PLC for peptide acquaintance(Lewis et al., 1996), implying 
that peptides find their own MHC class I molecules outside the PLC. This has been 
suggested to have important evolutionary significance as many viruses, such as herpes 
simplex virus and adenovirus, have evolved remarkable mechanisms to inhibit MHC 
class I expression by interfering with the function o f PLC(Lybarger et al., 2005). For 
example, The E3/19K protein o f adenovirus was shown to impair the association o f class 
I molecules to the PLC(Bennett et al., 1999). Thus, it has been proposed that class I 
molecules and alleles that are less dependent on the PLC for expression arose in response 
to the selective pressure exerted by microbial pathogens that subvert class I antigen 
presentation(Peh et al., 1998).
1.2.1.6 ER  am inopeptidases associated with antigen processing
Due to the structure of the class I peptide binding groove, peptides suitable for 
presentation generally must have a length of 8-11 amino acid residues in
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length(Rammensee et al., 1995). But evidence suggests that cytoplasmic proteolysis by 
proteasomes generates only the correct carboxy terminus of antigenic peptides suitable 
for presentation by class I molecules, and most of these peptide precursors have an 
extended N-terminus(Kloetzel, 2001; Cascio et al., 2001). Moreover, TAP has been 
shown unable to transport peptides containing a proline residue at position 2 (X-P- 
Xn)(van Endert et al., 1995), but up to 20% of MHC class I molecules actually present X- 
P-Xn peptides (Rammensee, 1997. MHC Ligands and peptide Motifs 1-457 (Landes 
Bioscience, Austin, Texas)). To resolve this paradox, it was proposed that X-P-Xn 
peptides could be transported as N-terminally extended intermediates, which can be 
trimmed further in the ER to yield the final peptides presented by class I molecules.
ER aminopeptidase associated with antigen processing (ERAAP in mice; human ERAAP 
ortholog was named ERAP-1 to designate it as the first member of an ER 
aminopeptidases family)(Serwold et al., 2001; Serwold et al., 2002; York et al., 2002; 
Saric et al., 2002; Tanioka et al., 2003) and ERAP-2 (the second ER aminopeptidase 
discovered in human)(Tanioka et al., 2003; Saveanu et al., 2005; Fruci et al., 2001) were 
identified as aminopeptidases in the ER to customize peptides for MHC class I 
molecules. ERAP-2 is approximately 50% identical to the amino acid sequence of 
ERAAP/ERAP-1 and exists in human. Mouse ortholog of ERAP-2 has not been found in 
the sequence database. Both ERAP-1 and ERAP-2 are up-regulated by interferon-y (IFN- 
y), which also stimulates the induction of other components of the antigen-processing 
pathway, such as class I molecules, TAP, and three proteasome |3-subunits(Gaczynska et 
al., 1993; Gaczynska et al., 1994; Gaczynska et al., 1996). Furthermore, ERAP-1 and 
ERAP-2 colocolize with several ER markers such as calnexin and Bip(Serwold et al., 
2002; Saric et al., 2002; Saveanu et al., 2005). Consistent with their localization in the 
ER, these enzymes are EndoH sensitive. Functionally, both ERAP-1 and ERAP-2 could 
remove N-terminal residues from the peptide precursors(Tanioka et al., 2003).
Human ER is equipped with both ERAP-1 and ERAP-2, which might act in a concerted 
fashion to provide a complete array of trimming activity in the human ER to make sure 
that N-extended versions of antigenic peptides are trimmed until they acquire the optimal
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length to be loaded onto class I molecules(Saveanu et al., 2005). ERAP-1 prefers longer 
peptide substrates than 8 or 9 amino acids, and trims longer substrates to 8 or 9 residue 
products, which suggests that ERAP-1 trims peptides to ideal substrates for MHC class I 
molecules(Saric et al., 2002; York et al., 2002). Moreover, ERAP-1 preferentially 
removes large hydrophobic residues such as Leu and is unable to trim peptides with a 
proline residue at position 2(Serwold et al., 2001), which, as mentioned before, is used as 
a preferred anchor residue for various MHC class I molecules. In contrast, ERAP-2 has a 
strong preference for the basic residues Arg and Leu(Saveanu et al., 2005; Tanioka et al., 
2003; Hattori et al., 2000). In an elegant study, Saveanu and colleagues have showed that 
several N-terminal amino acids, which cannot be removed by ERAP-1, were trimmed 
efficiently by ERAP2. Additionally, they found that ERAP-1 and ERAP-2 can form 
homodimers and heterodimers(Saveanu et al., 2005).
Although there is no evidence that ERAP-1 and ERAP-2 form part of the PLC, there is 
plenty of evidence that they contribute to the generation of suitable class I ligands and 
seem to be an integral part of the antigen-processing pathway. For instance, reducing 
ERAAP/ERAP-1 expression through RNA interference or gene knockout prevents the 
trimming of peptides for MHC class I molecules and greatly reduces the expression of 
MHC class I on the cell surface. In addition, a greater proportion of MHC class I 
molecules in ERAAP deficient cells are loaded with suboptimal paptide, which suggests 
that ERAAP is essential for the generation of the normal repertoire of processed 
peptides(Serwold et al., 2002; Hammer et al., 2006). Conversely, over-expression of 
ERAP1 can enhance processing in the ER of an N-terminal extended ovalbumin-derived 
precussor and presentation of mature epitopes(Saric et al., 2002). In addition to 
generating optimal peptides for class I molecules, ERAAP can also over-process 
peptides. Consequently, wheareas some epitopes are poorly presented in the absence of 
ERAAP, some are presented better(York et al., 2002; Hammer et al., 2006).
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1.2.2 Production and provision of peptides for MHC class I
The origin o f many peptides for display by MHC class I molecules is from defective 
ribosome products (DRiPs), which are newly synthesized polypeptides degraded 
cotranslationally or very swiftly after translation, possibly as the result o f protein 
misfolding, misassembly, or mistranslation/transcription such as cryptic translation 
products(Reits et al., 2000; Schubert et al., 2000; Yewdell et al., 1996). Cryptic 
translation refers to polypeptides encoded by introns, intron/exon junctions, 5 and 3 
untranslated regions, and alternative translational reading frames(Shastri et al., 2002). 
This pool o f DRiPs is considerable, ranging from 20 to more than 70% of cellular 
translation products, depending on the cell type(Princiotta et al., 2003). Support for the 
theory that antigenic peptides are derived from the newly synthesized proteins came from 
studies using a tetracycline-regulated LCMV nucleoprotein (NP) that allows rapid 
cessation o f protein synthesis(Khan et al., 2001). Antigen presentation stopped 48 hours 
after terminating NP synthesis, suggesting the antigenic epitopes were derived from 
newly synthesized NP. This ongoing degradation of newly synthesized proteins has the 
important function providing a continuous supply o f peptides that are loaded onto MHC 
class I molecules to be presented on the cell surface(Yewdell and Bennink, 2001; Turner 
and Varshavsky, 2000). In cells infected by viruses, the detection of DRiPs-derived 
peptides may allow T cells to deal with them rapidly, without having to wait for 
degradation o f mature protein. In healthy cells, the peptides are derived from normal 
cellular proteins, and the immune system is rendered tolerant to these peptides during 
development except in autoimmune diseases. Furthermore, complexes of self-peptide and 
MHC class I molecule are necessary to establish the repertoire o f TCR. Another source of 
peptides for display by MHC class I molecules is from proteins at the end of their useful 
life, which are also processed to produce peptides for MHC class I, but how this is 
monitored is unclear, possibly some form of unfolding acts as an initiator.
The final peptides required for loading onto class I molecules are produced in several 
steps that occur both in the cytoplasm and in the ER. The first step involves the 
recognition o f a protein (self or foreign) by intracellular degradation machinery and the
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transfer of multiple ubiquitin moieties to the substrate protein(Hershko and Ciechanover,
1998). Complete polyubiquitination o f a substrate protein is necessary for recognition by 
proteasome, which is a dominant protease complex and plays the major role in normal 
turnover of proteins in the cytosol(Kloetzel and Ossendorp, 2004; Forster and Hill, 2003). 
In the absence of proteasome, MHC class I molecules remain in the ER, starved for 
peptides due to the reduced protein degradation(Rock et al., 1994; Hughes et al., 1996). 
However, in vivo experiments suggest that the proteasome is the only candidate to 
generate the correct C-terminus of MHC class I ligands(Craiu et al., 1997; Mo et al., 
1999; Yewdell et al., 2003), and the majority o f the peptides generated by proteasomes 
are N terminal extended peptide precursors longer than 15 amino acids(Cascio et al., 
2001; Paz et al., 1999; Serwold et al., 2001; Goldberg et al., 2002; Reits et al., 2004). 
Such NH 2-extended peptides appear to be more resistant to degradation o f cytosolic 
peptidases than mature epitopes(Goldberg et al., 2002; Mo et al., 1999) and they may also 
be preferentially transported by TAP(Lauvau et al., 1999; Serwold et al., 2001).
NH 2-extended peptide precursors have to be further trimmed to mature epitopes for the 
loading o f class I molecules, which can occur in the cytosol and/or in the ER. In the 
cytosol, a few cytosolic aminopeptidases have been shown to be implicated in the 
generation o f peptides for MHC class I by trimming the extended N-terminus. Tripeptidyl 
peptidase II (TPP II) has been demonstrated to play a role in antigen processing by 
removing 2-3 N-terminal residues at a time from long peptides, unless it finds a N- 
terminal proline(Geier et al., 1999; Kloetzel and Ossendorp, 2004; Rock et al., 2004). It 
prefers substrates longer than 15 amino acids in length(Reits et al., 2004), which 
represent most of the proteasomal products in vivo. The importance o f TPP II in the class 
I pathway was demonstrated by Reits et al who showed that by short interfering RNA of 
TPP II resulted in a marked downregulation of class I expression at the cell surface(Reits 
et al., 2004). Most short proteasome and TPPII products (8-16 amino acids) are degraded 
by thimet oligopeptidase (TOP)(Ray et al., 2004) or by aminopeptidases such as leucine 
aminopeptidase (LAP)(Saric et al., 2004; Beninga et al., 1998) and puromycin-sensitive 
aminopeptidase (PSA)(Stoltze et al., 2000). However, Levy and colleagues have 
demonstrated that not all class I ligands have to undergo trimming in the cytosol(Chapatte
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et al., 2004). Studies have also indicated that proteasomes and the peptidases can also 
destroy some potential MHC class I-binding peptides by cleavage(01iveira et al., 2001; 
Saric et al., 2004). In fact, more than 99% of the cytosolic peptides are destroyed within 1 
min after their generation by a large number o f cytosolic peptidases before they encounter 
TAP(Reits et al., 2003). Interestingly, some studies have suggested that the peptide 
precursors are bound to and protected by chaperones such as tailless complex 
polypeptide-1 (TCP-1) ring complex (TRiC) or chaperonin-containing TCP-1 (CCT) 
prior to TAP transport(Kunisawa and Shastri, 2003). Shastri et al examined the TRiC 
immunoprecipitates and found the presence of several distinct N-terminally extended 
peptides. Furthermore, when the expression of TRiC was knocked down by RNA 
interference, the same set o f peptides were lost in the cell extracts. Additionally, cells in 
which TRiC was knocked down expressed a lower level o f MHC class I molecules on the 
surface(Kunisawa and Shastri, 2003; Dunn et al., 2001). However, Reits and colleagues 
have studied the behavior of peptides in living cells and concluded that the majority of 
peptides are free rather than associated with larger protein chaperones, or if  they do 
associate with chaperones, they probably do so in a highly transient manner(Reits et al.,
2003).
1.2.3 Peptide loading and optimization
Peptide loading onto MHC class I molecules is a prerequisite for both the stability and the 
function o f class I in presenting intracellular antigens to CTLs(Neeljes et al., 1993; 
Townsend et al., 1989). Optimal peptides for MHC class I heterodimers are normally 8-9 
amino acids in length with specific anchor residues(Falk et al., 1991; Falk et al., 1990; 
Matsumura et al., 1992; Bouvier and Wiley, 1994). Optimization of the peptide repertoire 
presented by MHC class I molecules relates to the preferential selection o f peptides with 
slow off-rate and undergoes time-dependent. Loading o f MHC class I with highly stable 
peptides requires a fully competent loading complex where TAP, tapasin, CRT, ERp57 
and class I molecules all interact with one another(Tan et al., 2002). Accordingly, 
disruption o f any interactions between different the component results in compromised 
peptide loading. For example, Dick et al showed that peptide loading of HLA-B44 was
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less optimal when the formation of the tapasin-ERp57 disulfide bond was inhibited(Dick 
et al., 2002). Moreover, Lewis and colleagues found that class I-TAP interaction is 
obligatory for the presentation of optimal peptides since a mutant HLA-A2 molecule 
where threonine at position 134 in the a 2  domain is changed to lysine (T134K) is rapidly 
released to the cell surface, but is unstable due to its inability to interact with TAP(Lewis 
et al., 1996).
It has been proposed that peptide loading and optimization occur in two steps, the first 
being the loading of low-affinity peptides for stabilization of the MHC class I 
heterodimer, followed by replacement of low-affinity by high-affinity peptides, which 
induces conformation change of MHC class I molecules and dissociation of class I from 
loading complex(Lehner and Cresswell, 2004; Paulsson et al., 2001). Support for such 
two-step peptide optimization view comes from a study by Marguet et al who used GFP- 
tagged MHC class I to show that peptide-loaded class I can also be retained in the ER for 
optimizing the peptide cargo(Marguet et al., 1999). Lewis and colleagues also provided 
evidence that MHC class I assembly is a two-stage process. They demonstrated that in 
TAP deficient cells, the majority o f T134K molecules do not exit the ER in comparison 
to the majority o f T134K molecules exit in a peptide-receptive state in TAP competent 
cells. They suggested that supply o f TAP-derived peptide is essential to allow T134K 
molecules to escape degradation and to exit the ER, which suggests that the mutation in 
T134K acts to prevent class I molecules from optimizing the peptide ligand, rather than 
preventing peptide binding per se(Lewis et al., 1996; Lewis and Elliott, 1998). Finally, it 
was also suggested that there might be an important quality control check-point between 
these two steps, which ensures both the retention of suboptimally loaded class I 
molecules and the release of those with longer half-life to the cell surface(Elliott and 
Williams, 2005).
Peptide optimization is tapasin-dependent. Tapasin, acting in co-ordination with other 
members o f the PLC, has been shown to retain empty class I molecules in the 
ER(Grandea, III et al., 2000), mediate preferential selection of peptides with slow off-
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rate, and promote the optimal peptide loading of MHC class I molecules(Grandea, III and 
Van Kaer, 2001; Garbi et al., 2000). In the presence of tapasin, there is a kinetic, 
quantitative, and qualitative improvement in the peptide repertoire of MHC class I 
molecules(Williams et al., 2002a; Howarth et al., 2004). Studies using peptide-sensitive 
antibodies have demonstrated different peptide repertoire profiles across tapasin-positive 
and tapasin-negative cell lines(Tan et al., 2002; Purcell et al., 2000). Additionally, 
peptide-elution studies o f MHC class I molecules in the presence or absence o f tapasin 
have found a reduction in the recovery o f peptides from tapasin negative cell lines(Garbi 
et al., 2000; Zarling et al., 2003). Furthermore, peptide optimization occurs preferentially 
at the TAP interface. It was reported that in the presence of soluble tapasin (C-terminal 
deletion), which can bind to class I but cannot bind TAP, surface expression of HLA-B44 
and HLA-B27 were restored but with optimization peptide profiles that were intermediate 
between no tapasin and full length tapasin(Williams et al., 2002b). Finally, it has been 
suggested that the dependency of peptide optimization on tapasin is allele specific. For 
example, Williams et al have shown that in the absence of tapasin, HLA-B2705 could 
load peptides and also improve peptide cargo over time, but only a very small number of 
HLA-B4402 class I complexes assembled with most retained in the ER and subsequently 
degraded due to the inability to optimize the peptide cargo(Williams et al., 2002b).
Tapasin has also been suggested to contribute to peptide optimization by retrieving of 
suboptimally loaded MHC class I molecules from the Golgi network to the ER by its 
association with COPI(Paulsson et al., 2002). Previously, it has been generally assumed 
that only MHC class I molecules loaded with peptides exit the ER. However, studies by 
Baas et al found that some peptide-receptive class I molecules or perhaps more correctly 
class I complexes bound to suboptimal peptides may exit the ER and travel along the 
secretory pathway. These suboptimally loaded class I molecules could potentially recycle 
between the Golgi and the ER(Hsu et al., 1991). COPI-coated vesicles ferry cargo 
molecules from the Golgi to the ER and are recruited by carboxy-terminal double lysine 
motif containing proteins(Letoumeur et al., 1994; Schekman and Orci, 1996; Rothman 
and Wieland, 1996). Tapasin is a transmembranne protein with a double lysine motif in 
its carboxyl-terminal cytoplasmic tail(Li et al., 1997; Ortmann et al., 1997). Wang et al
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have demonstrated that tapasin-associated, peptide-receptive class I molecules were 
found throughout the early secretory pathway and proposed that tapasin-associated 
unstable MHC class I molecules that fail to load optimal peptide and escape the ER are 
allowed a second chance by recycling between the ER and the Golgi complex until 
optimal peptide is loaded(Paulsson et al., 2002).
In addition to tapasin, a second component that complements the function o f tapasin for 
MHC class I peptide optimization within the PLC has been proposed. This second 
component would relate to the recycling of MHC class I molecules loaded with 
suboptimal peptides, and may involve the CRT/UDP glucosyl glycoprotein transferase 
(UGGT) binding cycle that may lead to an iterative process o f peptide 
optimization(Wright et al., 2004). Studies have found that while some MHC class I 
complexes loaded with optimal peptides traffic through the secretory pathway to the cell 
surface, it is possible the suboptimal peptides will dissociate from class I soon after 
leaving the PLC, thereby regenerating the flexible HC conformation. Furthermore, as 
described above, tapasin-associated unstable MHC class I molecules that fail to load 
optimal peptide and escape the ER are allowed a second chance to recycle between the 
ER and the Golgi(Paulsson et al., 2002). These unfolded MHC class I molecules might 
confer recognition by UGGT, which has been shown to recognize a localized disruption 
in conformation(Caramelo et al., 2003). One region predicted to be mobile in the absence 
o f peptides resides at one end of the a l  helix around the glycosylation site at 
Asn86(Zacharias and Springer, 2004). Recognition by UGGT would lead to 
glucosylation of the core glycan and restoration of the CRT-binding site. Relevant to this 
idea are the observations that MHC class I molecules in the CRT deficient cells have a 
faster trafficking rate and a reduced steady-state surface expression that could be rescued 
with exogenous peptide(Gao et al., 2002). Additionally, Kearse et al have demonstrated 
that murine class I complexes released from PLC can be blocked by using inhibitors of 
deglucosylation(van Leeuwen and Kearse, 1996a). Taken together, CRT may aid the 
retention o f the suboptimally loaded class I complexes in the ER for peptide 
optimization(Elliott and Williams, 2005). Therefore, it has been suggested that tapasin is
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the key chaperone that selecting the peptides with a long off-rate for binding of class I 
molecules with contribution from CRT.
Optimization of peptide loading onto class I complexes may be linked to their retention 
time in the ER. Lewis et al have tested this idea by incubating cells expressing T134K 
molecules in the presence of the drug brefeldin A (BFA), which promotes the retention of 
newly synthesized class I in the ER. They found that the fraction of stable T134K 
molecules increased dramatically(Lewis and Elliott, 1998), and they proposed that ER 
retention alone may facilitate the assembly of class I molecules with optimal peptides. 
Consistent with this model, the importance of tapasin for peptide optimization as 
described above may be due to its ability in retaining the empty class I molecules in the 
ER until they acquire the optimal peptide(Grandea, III et al., 2000).
The exact molecular mechanism for optimizing the peptide cargo displayed on class I 
molecules is not yet fully understood. It could be achieved by peptide exchange, as 
described above(Sijts and Pamer, 1997). This process may require the assistance of a 
cofactor similar to the role o f HLA-DM, which edits the peptides bound to MHC class II 
according to their binding stability(Karlsson, 2005). Tapasin, like DM, appears to retain 
and stabilize class I molecules in a peptide-receptive stage and has been suggested to 
have the model of action similar to the quality control model proposed for DM(Brocke et 
al., 2002). Further studies are needed to ascertain the role o f tapasin or other cofactors in 
facilitating peptide loading and selecting optimally binding peptides.
1.2.4 Export of MHC class I to the cell surface
Upon peptide loading and optimization, peptide/MHC complexes dissociate from the 
TAP complex, exit the ER, and then transport to the plasma membrane via Golgi 
apparatus(Ortmann et al., 1994; Suh et al., 1994). However, the mechanism for the export 
o f class I molecules from ER is not very clear. It has been assumed that class I molecules 
exit ER in vesicles in bulk flow, which proposes that retention and retrieval signals keep
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ER resident proteins in the ER while cargo proteins (membrane and secretory proteins) 
progress by default to the Golgi system(Wieland et al., 1987). However, the transport rate 
o f peptide loaded MHC class I complex from ER to Golgi remains unchanged after 
dissociation from TAP. Furthermore, peptide loaded MHC class I molecules accumulate 
at ER exit sites from which TAP molecules are topologically excluded. On the basis of 
these observations, a second model, in contrast to the bulk flow model, has been proposed 
that cargo proteins contain signal sequences that mediate selective incorporation into 
COPII-coated vesicles(Kuehn and Schekman, 1997; Spiliotis et al., 2000). MHC class I 
molecules, however, do not possess any of the known ER export sequences. Thus, recent 
models favor a cargo receptor-mediated transport of class I molecules out o f the ER. This 
model suggests that B cell-associated protein (Bap) 31, and perhaps Bap29, ER 
molecules identified as putative cargo receptors, are recruited to the peptide-loading 
complex in which they interact directly with MHC class I and possibly with tapasin. This 
association promotes the targeting and possibly the clustering of class I at ER exit sites. 
At the time of packaging into coat protein complex II (COPII)-coated vesicles in the 
ER(Rothman and Wieland, 1996; Schekman and Orci, 1996) or upon arrival at the Golgi, 
stably assembled class I molecules are released from Bap31 and transport to the cell 
surface(Paquet et al., 2004). In this way, MHC class I molecules with high affinity for 
transport receptors are positively selected for efficient export from ER(Spiliotis et al., 
2000). Support for this model also comes from the study showing that, in the absence of 
Bap29/31, there is a loss co-localization of MHC class I with mSec31 (p i37), a 
component o f mammalian COPII coats, which associates with a delay in class I traffic 
from ER to Golgi(Paquet et al., 2004).
Upon reaching the cell surface, MHC class I molecules are susceptible to internalization. 
By tagging the HLA-A2 HC with GFP, Gromme and colleagues have demonstrated that a 
small fraction of these class I molecules were found in endo/lysosomal compartments, 
and these HLA-A2-GFP molecules were not directly derived from the biosynthetic 
pathway because they were resistant to BFA treatment. They suggested that these class I 
molecules were routed from the cell surface into the endocytic pathway where they can 
be reloaded with peptides generated in the endocytic compartments from exogenous
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antigens(Gromme et al., 1999). This has been regarded as one of the mechanisms for 
cross-presentation(Rock and Shen, 2005). Evidence for recycling MHC class I molecules 
also comes from other studies, which showed that surface MHC class I molecules can be 
internalized into endosomal vesicles where peptide exchange occurred(Dasgupta et al., 
1988; Chiu et al., 1999).
In the above three sections, I have discussed the production and provision of class I 
peptides, peptides loading onto class I molecules and their optimization and export of 
peptide-loaded MHC class I molecules to the cell surface. Despite the highly efficient 
generation of peptides by proteasomes, only a small fraction of these peptides presented 
by class I molecules are displayed on the cell surface for recognition by CD8 T cells. The 
efficiency of the MHC class I antigen presentation pathway is low, but exactly how many 
protein molecules have to be degraded to produce a single MHC/peptide complex on the 
cell surface? By using a monoclonal TCR-like antibody, 25-D1.16, which is specific for 
ovalbumin-derived epitope SIINFEKL/H-2Kb complex, Princiotta and colleagues have 
calculated that between 440 and 3000 protein molecules are degraded to generate each 
surface Kb/SIINFEKL complex, an average efficiency of 0.05%(Princiotta et al., 2003).
1.2.5 CD8+ T cell activation and effector function
Following the export from the ER, peptide-loaded class I molecules traffic to the cell 
surface for inspection by CD8+ T cells. CD8+ T cells use T cell receptors (TCRs) to 
recognize antigen/MHC complexes. TCRs are cell surface heterodimers consisting of 
either disulfide-linked a -  and p- or y- and 6-chains. Most T cells express a(3 TCRs. 
Compared with cx|3 TCRs, much less is known about y6 TCRs, which will not be 
discussed here. The a p  TCR is associated physically with a series of polypeptides, 
collectively called CD3, which comprises 4 invariant polypeptides, called y, 6, s and 
An alternatively spliced form of called r\, has also been identified. The CD3 
association is required for the expression of the TCR complex at the cell surface and 
signal transduction following antigen recognition by the TCR heterodimer, a p  TCRs bind
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generally with very low affinity to peptide-MHC (pMHC) complexes, and the half -life 
of the binding of the TCR to pMHC is seconds at 37°C(Davis et al., 1998; van der Merwe 
and Davis, 2003). Activation of CD8 T cells can be induced by recognition of as few as 
10-100 MHC/peptide complexes displayed at the cell surface(Yewdell et al., 2003; 
Sykulev et al., 1996; Christinck et al., 1991; Brower et al., 1994). But exactly how many 
interactions between TCRs and pMHCs are necessary for activation of CD8 T cells may 
depend on the type of the T cell and its activation state. For instance, naive T cells are 
less sensitive to antigen stimulation than CTLs; murine hybrids (derived from the fusion 
of a normal T cell with a T-cell tumour cell) are known to be easily triggered(Stoll et al., 
2002; Hugues et al., 2004).
Recognition of ligands (pMHCs) by CD8+ T cells induces a conformational change in 
TCR-CD3s complex, which exposes a C-terminal proline-rich sequence in its 
cytoplasmic tail that requires the adapter molecule for down-stream signalling to initiate 
early T cell activation(Krogsgaard et al., 2003). These signals activate specific 
transcription factors, which then translocate to the nucleus to activate genes including 
‘immediate early genes’ for cell division and cytokine secretion, such as IL-2 and IFN- 
y(Huppa et al., 2003).
Activated CTLs can kill target cells by two different mechanisms. One mechanism is via 
granule exocytosis. CTLs contain granules within their cytoplasm. These granules 
contain a number of proteins. Two important proteins are perforin and granzymes, which 
are a collection of serine proteases. After binding to its target cell, CTL direct its granules 
towards the membrane adjoining the target cell. Then, the granule contents are discharged 
into a cleft between CTL and target cell. Perforin is able to form pores in the target cell 
membrane, through which Granzymes are thought to enter the target cell to cleave 
proteins. In this way the target cells is lysed. Another mechanism that activated CTL uses 
to kill target cell involves the Fas pathway. Fas is a death molecule which can directly 
signal apoptosis. Fas can be expressed on many cell types. The ligand for Fas (Fas-L) is 
expressed on mature CD4+ and CD8+ T cells after activation. Binding of TCR to its 
specific pMHC causes expression of Fas ligand (Fas-L) on CTL. Fas on the target cell
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will be cross-linked by the Fas-L on the CTL. Then, apoptosis and death of the target cell 
will be triggered. Therefore, by displaying the short peptides on the cell surface for 
recognition by CTLs, cells carrying foreign or mutated proteins can be eradicated(Shastri 
et al., 2002).
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1.2.6 Objective of the project
CRT has been regarded to be a multi-compartmental and multifunctional protein. That 
one protein can perform so many functions is intriguing and further investigation is 
required in order to fully understand the CRT functions. In particular, we still do not 
understand what exact functional role CRT plays in MHC class I assembly and antigen 
presentation, although there is definitely impaired surface class I expression in a 
calreticulin deficient cell line. The aim of this project is to try to investigate the following 
outstanding issues:
(1) What’s the functional role o f CRT in MHC class I antigen presentation?
(2) As a general chaperone for the folding and assembly of newly synthesized 
glycoproteins, does the absence of CRT affect the expression and/or function o f the other 
components o f PLC?
(3) How does CRT contribute to MHC class I antigen presentation?
(4) How does the function of CRT relate to its structure?
To study the conventional MHC class I pathway, the protein antigen o f interest has to be 
expressed inside cells. In chapter 3 a novel method was described to deliver protein 
antigen directly into the cell cytosol. Mouse fibroblasts, RMA and its TAP-2 deficient 
counterpart cell line-RMA-S were used to demonstrate that both adherent and suspension 
cells were permeabilized with streptolysin O (SLO) and chicken ovalbumin (OVA) was 
successfully introduced into the cytoplasm. Evidence was presented that in TAP 
competent RMA and mouse fibroblast cells OVA was properly processed and OVA- 
derived peptide OVA258-265 (or SIINFEKL) was successfully presented via MHC class I 
molecule (Kb) to SIINFEKL- Kb specific T cell hybridoma-B3Z, while TAP-2 deficient 
RMA-S cells failed to stimulate B3Z.
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To investigate the functional role CRT plays in MHC class I antigen presentation, in 
chapter 4 the SLO antigen delivery system was used to introduce OVA into the 
cytoplasm of both CRT deficient mouse fibroblasts (K42) and CRT competent cells (K41 
(CRT+/+), and K42 cells transfected with full length human CRT. It was showed that 
CRT deficient cells exhibited a TAP deficient phenotype in terms of class I assembly, 
without loss of TAP expression or functionality; expression o f calnexin, tapasin was 
unchanged while up-regulation of ERp57 was observed in CRT deficient cells; a higher 
concentration of antigen in the cytosol was required for specific T cell stimulation in 
CRT deficient cells than in CRT competent cells. The results indicated that CRT has a 
functional role in the maintenance o f the low peptide concentration threshold required in 
the ER for efficient antigen presentation to T cells.
To learn more about how CRT contributes to MHC class I antigen presentation and how 
the function of CRT relates to its structure, in chapter 5 full length CRT or one o f three 
structurally and functionally distinct domains, N-domain, the central P-domain, and the 
C-domain, were introduced into both CRT deficient cells (K42) and CRT competent cells 
(K41) to examine the role of CRT and its truncated forms in the formation of the PLC 
and MHC class I antigen presentation. It was found that while full length CRT restored 
MHC class I surface expression on K42 (CRT-/-) cells to the levels seen in the wild-type 
K41 (CRT+/+) cells, the expression of P-, NP-, PC-domains of CRT down-regulated 
MHC class I expression in K42 (CRT-/-) cells. In contrast, K41 (CRT+/+) cells 
transfected with truncated CRT exhibited a normal class I surface expression, indicating 
that disruption to MHC class I assembly only happened in the absence o f CRT. 
Assessment was also made on the effect o f truncated CRT expression on cellular 
functions, such as peptide loading, TAP function, and expression of other members of 
PLC. The data indicated that in cells without CRT calnexin may compensate for the loss 
of CRT function. In CRT deficient cells, expression of truncated forms o f CRT might 
block the redundant function of calnexin, leading to further reduced cell surface MHC 
class I expression.
57
Chapter 2 Materials and Methods
2.1 Cells and antibodies
Table 2.1: Cells used in this study
Cell line Description Defect Source
K41 Mouse embryo 
fibroblasts(Nakamura et al., 
2001b), expressing H-2Kb 
and H-2Db
Dr M Michalak
K42 Mouse embryo fibroblasts 
(Nakamura et al., 2001b), 
expressing H-2Kb and H-2Db
CRT deficient Dr M Michalak
EG7-OVA A transfected clone o f  T 
lymphocyte, producing 
chicken ovalbumin(Moore et 
al., 1988), expressing H-2Kb
Alain Townsend
RMA Derived from a Rauscher 
leukaemia virus-induced cell 
lymphoma(Karre et al., 
1986), expressing H -2K b and 
H-2Db
Alain Townsend
RMA-S Derived from a Rauscher 
leukaemia virus-induced cell 
lymphoma(Karre et al., 
1986), expressing H -2Kb and 
H-2Db
TAP-2 mutant cell 
that express low 
levels o f  class I 
molecules H-2Kb 
and H-2Db 
(Ljunggren and 
Karre, 1985; Attaya 
et al., 1992)
Alain Townsend
RlE/TL8x Mouse B cell line, expressing 
H-2Kb
P2m deficient The American Type Culture 
Collection (ATCC, USA)
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B3Z T cell hybridoma specific for 
H-2Kb-SIINFEKL complex. 
This hybridoma has a copy of 
(3-galactosidase gene under 
the 11-2 promotor, which is 
activated following T cell 
receptor
engagement(Karttunen et al., 
1992)
Dr N. Shastri
M ycl-9E10 A hybridoma cell line 
producing anti human c-myc 
antibody
ATCC
25-D1.16 A hybridoma cell line 
producing monoclonal 
antibody specifically against 
H-2Kb/SIINFEKL 
complex(Porgador et al., 
1997)
Dr Germain
Y3 A hybridoma cell line 
producing monoclonal 
antibody reactive with mouse 
MHC class I H-2Kb
ATCC
The above cell lines were grown in RPMI 1640 supplemented with 10% FCS and L- 
Glutamine (Gibco BRL). Transfected K41, k42 cells were cultured in the same medium 
with 6mg/ml G418 (SIGMA).
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Table 2.2: Antibodies for FACS
Antibody Target Concentration,
Dilution
Source, type Conjugation
Y3
Mouse class I: 
H-2Kb
Unknown protein G 
purified hybridoma 
supernatant, 1/200
Hybridoma 
supernatant, o f Y -3 
cell line,
Mouse, monoclonal
None
25-D1.16
H-2Kb/SIINFEKL
complex
Unknown protein G 
purified hybridoma 
supernatant, 1/200
Hybridoma
supernatant,
Mouse,monoclonal
None
Anti-mouse 
PE (Sigma)
Mouse IgG Unknown, 1/200 Sheep, polyclonal PE
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Table 2.3: Antibodies for Western Blot
A ntibody Target C oncentration,
Dilution
Source, type Conjugation
Anti-myc Myc-tagged
recombinant
proteins
Unknown protein G 
purified hybridoma 
supernatant,
1/3,000
Hybridoma
supernatant, o f  myc- 
9E10 cell line, Mouse, 
monoclonal 
(Clone: 9 E 10)
None
Anti-CRT 
serum
Human, mouse 
Calreticulin
Unknown, 1/3,000 Rabbit, polyclonal None
Anti CRT 
(Stressgen)
Human
Calreticulin
0.9 mg/ml, 1/2,000 Mouse, monoclonal None
Anti-calnexin
serum
Mouse calnexin Unknown, 1/2,000 Rabbit, polyclonal None
Anti-TAP2
serum
Mouse TAP2 Unknown, 1/500 Rabbit, polyclonal, 
provided by Professor 
Ping Wang
None
Anti-tapasin
serum
Mouse tapasin Unknown, 1/10,000 Rabbit, polyclonal 
provided by Professor 
Ping Wang
None
Anti-ERp57
(abeam)
Mouse ERp57 Unknown, 1/3,000 Rabbit, polyclonal None
Anti-HC  
serum (T18)
Free mouse D l 
and Kb HC
Unknown, 1/2,000 Rabbit, polyclonal, 
provided by Dr Tim  
Elliott
None
Anti mouse -  
HRP (Sigma)
Mouse IgG Unknown, 1/10,000 Goat, polyclonal HRP
RG96
(Sigma)
Rabbit IgG Unknown, 1/7,000 Mouse, monoclonal 
(Clone: RG-96)
HRP
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2.2 Protein G Purification of Antibodies
The ImmunoPure Immobilized protein G (PIERCE, Lot number: FE71154) column was 
washed with 5 bed volumes of 20 mM Sodium Phosphate Buffer, pH 7.0. The hybridoma 
supernatant (containing Y3 or anti-myc antibody) was centrifuged or filtered to remove 
any particulates, and then applied onto the column. The column was washed with 5 bed 
volumes of 20 mM Phosphate Buffer, pH 7.0. The bound antibody was eluted with 1-3 
bed volumes of 0.1 M Glycine into the collection tubes prepared by adding 0.1 ml of 1M 
Tris per ml of each fraction to be collected. Fractions were pooled and dialyzed against 3 
changes of PBS, at least 100 times the sample volume. Aliquots were stored at -20°C. 
The column was regenerated with 2% Ethanol and stored at 2-8°C.
2.3 Peptides and proteins
SIINFEKL (ovalbumin peptide 257-284), flu matrix protein peptide GILGFVFTL, and 
fluorescein (FITC) tagged RRYQNSTEL as TAP transport substrate were purchased 
from Eurogentic, Belgium and received as lyophilised powder and re-suspended in water 
to a stock concentration o f 5mg/ml. For routine use these were then diluted 1/10000 (final 
concentration 0.5pg/ml). BSA and chicken ovalbumin were purchased from Sigma.
2.4 Molecular cloning
2.4.1 DNA modifying enzymes
The following DNA modifying enzymes were used according to manufacturer’s 
instructions.
Restriction endonucleases (Promega UK): Generally l-2p,g DNA, 1-2 units of enzyme, 
5pl lOx reaction buffer, 0.5pl BSA, Sterile water to a total of 50pL Incubate at 37°C (or 
optimal enzyme temperature) for 1 hour.
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T4 DNA Ligase (Promega UK): Generally plasmid and insert were mixed at a molar 
ratio of 1:3 and incubated overnight at 16°C with 2 units of enzyme and 1.2/d lOx 
reaction buffer in a total volume of 12 pi.
2.4.2 Polymerase Chain Reaction (PCR)
Reagents for PCR were mixed in a total volume of 50pl as laid out in the table below. 
Taq DNA Polymerase (Invitrogen) was used. PCR was carried out for 30 cycles on a 
GeneAmp PCR System 9700 (PE Applied Biosystems):
1) Denaturation (initial) 94°C 5 min.
2) Denaturation (cycle) 94°C 45 secs.
3) Annealment (cycle) 55°C 45 secs.
4) Polymerisation (cycle) 72°C 60 secs.
5) Polymerisation (final) 72°C 10 min.
Table 2.4 - Reagents for s tan d ard  PCR
Reagent Stock Concentration Volume (pi) Final concentration
PCR buffer (Tris-Cl (pH 
8.4), KC1)
10X (200mM, 500mM) 5 lx  (20mM, 50mM)
MgCl2 50mM 1.5 1.5mM
dNTP (Invitrogen) Each at 5mM 2 0.2mM
Primer 1 12.5pM 1 0.25pM
Primer 2 12.5pM 1 0.25pM
DNA polymerase 5U/pl 0.2 1 unit
H20 39.3
The genes of P domain, PC domain, NP domain and full length human CRT were 
amplified using different combination of the following primers (synthesized from Sigma ) 
with Tag DNA Polymerase (Invitrogen):
Forward-F 5'-(PstI)CTG CAG-gag cct gcc gtc tac ttc aag-3'
Reverse-F 5'- (Notl)GC GGC CGC-ggc ctg gcc ggg gac ate ttc—3'
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Reverse-NP 5'-(Not I)GC GGC CGC-ata ggc ata gat act ggg atc-3' 
Forward-P 5'-(PstI)CTG CAG -gat tgg gac ttc ctg cca ccc-3'
P domain: Forward-P, Reverse -N P  330 bp 
PC domain: Forward-P, Reverse-F 645 bp 
NP domain: Forward-F, Reverse-NP 922 bp 
CRT: Forward-F, Reverse-F 1237 bp
2.4.3 TA TOPO cloning
PCR products were run on a 1% agarose gel and purified using QIAquick Gel Extraction 
Kit (QIAGEN) before use in the TOPO TA Cloning (Invitrogen) reaction as below:
Gel Purified PCR product 4 pi 
Salt Solution 1 pi
TOPO TA vector 1 pi
These were mixed gently and incubated for 5 min at room temperature.
2.4.4 Transformation of chemically competent E. coli
Competent cells were thawed slowly on ice (~30 min) and gently resuspended. lOOpl of 
cells was dispensed into a pre-cooled eppendorf and ~10ng supercoiled plasmid DNA or 
2 pi of T4 ligation product or product from the TOPO TA cloning reaction was added. 
Cells were incubated with the DNA on ice for 30 min before heat shocking for 30 
seconds at 42°C on a heat block (Grant QB2T). Cells were then put back on ice, topped 
up with 0.5 ml of prewarmed SOC (37°C), and shaken vigorously for 1 hour at 37°C to 
allow the bacteria to recover. 100 -  250pl of transformed bacteria were then spread on 
LB agar containing the appropriate antibiotic for selection. Agar plates were incubated 
overnight at 37°C. 2-5ml LB broth with 50pg/ml ampicilliin was inoculated with a single 
colony from the plate and incubated in a 37°C shaker overnight. Bacterial broth was then 
used to miniprep the plasmid. Once analysed a successfully cloned plasmid was amplified 
by Qiagen Maxiprep. The plasmid product was quantified by spectrophotometry and sent
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to the Wolfson Institute of Biomedical Research (WIBR) at University College London 
for sequencing.
2.4.5 Bacterial Growth
Sterilisation of Broth and agar was carried out by autoclaving at 120°C for 90 min.
Luria Broth -  16 LB capsules (BiolOl) were added to 1 litre of Millipore water and 
sterilised. (Final formulation -  lOg Tryptone, 5g Yeast Extract, 0.5g NaCl, 1 litre H20 )
LB Agar -  lOg/litre of Select Agar (Gibco BRL) was added to LB Broth before 
sterilisation. Agar was allowed to cool and was remelted by microwaving. It was then 
placed in a 45°C Water bath to cool slowly before adding the appropriate antibiotic and 
15ml poured into 10cm Agar plates (Sterlin, UK).
SOB - 20g Tryptone, 5g Yeast Extract B, 0.5g NaCl, 5g M gS041H20  (BiolOl 
formulation) in 1 litre Millipore water.
SOC - filter sterilised glucose added to autoclaved SOB to a final concentration of 20mM 
Stock ampicillin -  500pl Aliquots of 50mg/ml ampicillin (Sigma) were kept at -20°C. 
Stock ampicillin was diluted 1/1000 into Luria Broth and LB Agar as required.
2.4.6 DNA extraction and purification
DNA plasmids were extracted from E. coli strains DH5a using mini/maxiprep kits 
(Qiagen, UK) according to the manufacturers instructions.
DNA fragments were purified from restriction endonucleases and other molecular 
biology tools using a PCR purification kit (Qiagen, UK).
DNA fragments were purified from agarose gels using Qiaquick Gel Purification kit 
(Qiagen, UK)
DNA/RNA concentration and purity were assessed by measuring the light absorption at 
260 and 280 nm using a spectrophotometer (Hitachi U1800). Concentration is calculated 
using the formulae:
DNA concentration = A260 x 50 pg/ml x dilution factor
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RNA concentration = A260 x 40 ng/ml x dilution factor 
Purity is assessed by calculating A260: A ^ .  For DNA in low salt buffer pH 7.5 - 8 this 
ratio should be about 1.8. For RNA the ratio at neutral pH should be between 1.9 and 2.3.
2.4.7 Agarose Gel separation of DNA/RNA
50x TAE: 2M Tris-Acetate, 0.5M EDTA pH 8.3
Ethidium Bromide stock solution: lg  EtBr in 100ml Millipore water. (Stored in the dark 
at room temperature)
Working TAE Buffer: 1/50 dilution of 50x TAE
1% Agarose Gel: lg  Agarose (Sigma), 100ml TAE Buffer. Heated by microwave and 
allowed to cool to 65°C before pouring.
2pl of 6x Loading Buffer (Promega UK) was added to 10/d of DNA/RNA sample. 
DNA/RNA samples were then run alongside a 1Kb Ladder (New England) in TAE buffer 
through 1% Agarose Gels at 100V for 20-40min. Gels were stained in 200ml TAE buffer 
with 10p,l Ethidium Bromide Stock solution and visualised using an Alphalmager system 
(Alpha Innotech, UK).
2.5 Establishment of stable gene expression cell lines
2.5.1 Determining G418 sensitivity
Since transfected cells are to be selected using G418 (A 1720, Sigma) it is necessary to 
determine the drug sensitivity of the cell line to be transfected.
K42 and K41 Cells were plated at around 25% confluence on a 6-well plate. Medium at 
various concentrations of G418 from 2-8mg/ml was added to the cells. Fresh G418 
containing medium was added to the cells every 2-3 days or as necessary. Cells were 
grown for up to ten days, or until there were no surviving cells.
The lowest concentration of G418 (6mg/ml) at which no cells survived after 10 days of 
culture was subsequently used to select transfected cells.
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2.5.2 Cell Transfection
All plasmids were linearized at convenient restriction sites after stop codon using Sea I 
restriction enzyme before transfection. 2x 105 cells were seeded per well of a six-well or 
35 mm tissue culture plate in 2 ml normal growth medium and incubated at 37°C in a 
C 0 2 incubator until the cells were 70-80% confluent. The following solutions were 
prepared in 12 x 75 mm sterile tubes. Solution A: For each transfection, 2 pg plasmid 
DNA was diluted in 375 pi serum-free OPTI-MEM I (GiBco BRL, Lot number: 
1175599). Solution B: For each transfection, 12 pi LIPOFECTAMINE Reagent (Life 
Technologies) was diluted in 375 pi serum-free OPTI-MEM I. The two solutions were 
combined, mixed gently, and incubated at room temperature for 15-45 min. Cells were 
washed once with 2 ml serum-free OPTI-MEM I. For each transfection, 750/<l of serum- 
free OPTI-MEM I was added to each tube containing the lipid-DNA complexes (no 
antibacterial agents). The diluted complex solution was mixed gently and overlaid onto 
the washed cells. The cells were incubated for 5 h at 37°C in a 5% C 0 2 incubator. 1.5 ml 
OPTI-MEM I with 20% FBS was added without removing the transfection mixture. 
Medium was replaced at 18-24 h following start of transfection.
2.5.3 Generating stable cell lines
16 hours post transfection, the medium was exchanged for medium supplemented with 6 
mg/ml of G418 and this was used for the next 14 days. This is the time for the G418 to 
act on the nontransfected cells, which then detach and are washed away during the 
medium exchange. Once all cells have died in the well of the negative control 
(nontransfected), cloning was carried out.
Cells were trypsinized, spun down, resuspended in the medium containing 6 mg/ml 
G418, and plated onto 10cm dishes. Cells were grown for two weeks. Once the big 
colonies were visible by eye when viewing from the bottom of the dish, 10 colonies were 
picked off with an inoculation loop and transferred to separate wells of a 24 well plate 
containing normal medium with 6 mg/ml of G418. Cells were transferred and grown in 
T25 flasks. Expression of recombinant CRT was determined by western blotting using
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the antibody pair: first antibody, anti-myc; second antibody, anti-mouse HRP, or anti- 
CRT (against human CRT, Stressgen) was used to double check the expression of 
recombinant CRT.
2.6 Western Blotting
2x SDS loading Buffer: (Tris-Cl pH 6.8, 4% w/v SDS, 0.2% w/v bromophenol blue 
(Sigma) and 20 % v/v glycerol)
Lysis Buffer: 1% Triton X-100 in PBS
Run Buffer: 0.025M Tris, 0.192M Glycine, 0.1% SDS (Flowgen)
Transfer Buffer: 0.02M Tris, 0.15M Glycine, 20% Methanol (Flowgen)
PBST: PBS, 0.05% Tween (Sigma)
Enhanced Chemiluminescence fluid (Pierce): 1ml Super signal Dura West luminal 
enhancer solution, 1ml stable peroxide buffer.
106 cells were centrifuged at 300g for 5 minutes, the supernatant discarded and the pellets 
frozen at -20°C. After thawing, cells were resuspended in lysis buffer to a final
7 8 1concentration of 10 - 10 cells ml' and incubated on ice for 10 minutes. Cells were then 
centrifuged at 13,000 rpm for 15 minutes at 4°C in a micro centrifuge (Eppendorf 
centrifuge 5415R) and the supernatant added to an equal volume of 2x SDS loading 
buffer and heated to 94°C for 5 minutes. lOpl samples were added to the wells o f 12-14% 
SDS protein separating gels made using the Flowgen Protogel system (Flowgen) and run 
in an Xcell SureLock mini Cell and Blot module (Invitrogen) according to the 
manufacturer’s instructions for 1 hour at 200V or until samples had travelled sufficiently. 
A High Molecular Weight Rainbow Marker was run alongside the samples to allow 
analysis o f the size of the detected protein. The gel was then blotted on to Hybond C 
Extra membrane (Amersham) in the same module at 20V for 2 hours. The membrane was 
carefully removed and blocked in 10 ml o f PBS 2% Marvel (Premier International Foods, 
UK) on a plate rocker (Stuart Gyro Rocker STR-9). The membrane was washed 3 times 
in PBS and transferred to 10 ml o f PBST 2% Marvel milk containing the primary
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antibody. After 1 hour of rocking in primary antibody the membrane was washed 3 times 
in PBS for 1 minute and transferred to PBST 2% Marvel containing the secondary HRP 
conjugated antibody and rocked for 1 hour. The membrane was washed twice in PBST 
and twice in PBS. The membrane was dabbed dry with a paper towel and 2ml of 
enhanced chemiluminescence fluid was added evenly to the membrane. After 5 minutes 
the fluid was pipetted off and the membrane dabbed dry. The membrane was then 
wrapped in parafilm and attached to one side of an exposure box with tape. Photographic 
film (Kodak Biomax) was exposed to the membrane for 10 seconds to half an hour.
2.7 Cell staining and FA CS analysis
FACS analysis was carried out on a Becton Dickinson FACScan running CellQuest™ 
software. Cells were gated according to size, as measured by forward scatter and side 
scatter. Typically 20,000 -  50,000 events were collected for each condition.
For cell staining: cells were re-suspended to a concentration of 106 cells m l1 in cold 
FACS buffer and 100/d aliquots were added to wells in a round bottomed 96-well plate 
(Merck, Germany). The plate was centrifuged at 300g for 5 minutes, the supernatant 
flicked off gently and the plate vortexed to loosen the cells. The cells were then 
resuspended in 50/d of FACS buffer containing the appropriate antibodies at their 
optimal dilution (determined by antibody titration). Cells were incubated with antibody in 
the dark at 4°C for 30-60 min. The cells were then washed 2 times in FACS buffer by 
vortex, resuspension and centrifugation. Where necessary the cells were then resuspended 
in 50/d of FACS buffer containing secondary antibody and incubated as above and then 
washed twice in FACS buffer. Cells were washed one final time in FACS buffer, 
resuspended in 100/d of FIX buffer and transferred to LP2 tubes (A1 Lab supplies, UK) 
for FACS analysis.
2.8 Empty MHC class I molecules come out in the cold
Equal numbers of K41, K42, K42-P, K42-PC, K42-NP, K42-CRT, RMA and RMA-S 
were cultured at 26°C with 5% C 0 2 for 24 h. As a control, the same number of these cells
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were also cultured at 37°C with 5% C 0 2 for 24h. Cells were washed, and surface MHC 
class I was stained with mAb Y3 (recognizes H-2Kb). Anti-mouse IgG-PE was used as 
secondary antibody. Cells were then analysed by flow cytometry.
2.9 Titration of vaccinia virus
Target cells (0.5X106) were infected with different amounts (2 j j .1, 5pl, lOpl, and 25 pi) of 
recombinant vaccinia viruses expressing either a minigene encoding SIINFEKL with 
leader sequence to the ER or matrix protein of Flu as a control in 200pl PBS solution 
supplemented with 0.1% (w/v) bovine serum albumin at 37°C for 1 hour. The infection 
mixture was then transferred to a T25 flask. 2.5 ml of normal growth medium was added 
to each flask, and the cells incubated overnight at 37°C in a 5% CO2 incubator. Cells 
were then washed, stained with mAb Y3 and 25-D1.16, a mAb with TCR-like 
specificities that recognizes the mouse MHC class I molecule H-2Kb and SIINFEKL 
peptide complex. Anti-mouse IgG-PE was used as secondary antibody. Cells were then 
analyzed by flow cytometry.
2.10 Streptolysin O activation
lml of PBS supplemented with 0.05% (w/v) BSA was added to a vial containing 
25,000U of streptolysin O (SLO) (S5265-25KU, Sigma). The solution was resuspended 
and then transferred to a “Universal” tube. 4ml of PBS supplemented with 0.05% (w/v) 
BSA was added to the “Universal” and mixed. 20ml of PBS was added to the “Universal” 
to make the final concentration of SLO lOOOU/ml. SLO was activated by addition of 
dithiothreitol (Invitrogen) to a final concentration of 5mM. After incubating at 37°C for 2 
hours, SLO was placed on ice and tested for its activity by performing a permeabilization 
experiment described below. If activity was satisfactory, it was aliquoted and stored at -  
20°C until use.
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2.11 Titration of streptolysin-O
Cells (lx lO 6) were washed twice with warm RPMI 1640 (no serum), resuspended in 
200/d of RPMI 1640, and placed in the wells of a 24-well plate. Different amount of SLO 
were added to each well and the plate agitated immediately after each addition. 
Fluorescein (FITC) tagged RRYQNSTEL peptides were added to each well at a 
concentration of lOpM. Plates were incubated at 37°C with 5% C 0 2 for 10 min, and 
agitated twice during this period. 500/d of warm RPMI 1640 media with 10% FCS was 
added to each well, and the plate was replaced at 37°C for further 30 min. Cells were 
washed once with ice-cold growth media and resuspended in 700/d of ice-cold growth 
media. lOpl lmg/ml propidium iodide (P4170, Sigma) in PBS was added and the cells 
incubated on ice for 5-10min. The cells were then centrifuged and resuspended in 700/d 
of ice-cold growth media and analysed by 2 colour flow cytometry: colourless cells = non 
permeabilised; green only cells = permeabilised and resealed; red or red and green cells = 
dead.
2.12 T cell (B3Z) activation assay with target cells pulsed with 
exogenous peptides
B3Z T cell hybrids express lacZ upon binding of the T cell receptor (TCR) to SIINFEKL/ 
Kb complex. The amount o f lacZ enzyme was quantified by the hydrolysis of CPRG 
(chlorophenol red (3-galactoside; Calbiochem), which produces chlorophenol red 
absorption at 595 nm. Target cells were pulsed with lpg/m l SIINFEKL peptide or with 
flu matrix protein peptide GILGFVFTL as a control for 3 hours at 37°C, then centrifuged 
at 300g for five minutes and the supernatant discarded. The cells were then washed 3 
times with 200pl PBS by vortex, resuspension and centrifugation. The T cell hybrids 
(B3Z) were added into each well (105 cells) and co-cultured overnight at 37°C in a CO2 
incubator. Next day, individual cultures were centrifuged at 300g for five minutes and the 
supernatant discarded. The cells were then washed once with 200pl of PBS by vortex, 
resuspension and centrifugation and then lysed by addition o f 100 pi Z buffer (100 mM 
2-mercaptoethanol, 9 mM MgCl2, 0.125% NP-40 in PBS) containing 0.12 mM CPRG. 
After 4 hours incubation at 37°C, 50pl stop buffer (300 mM glycine and 15 mM EDTA
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in water) was added to each well and the absorption of each well was read using a 96- 
well plate reader. Absorption wavelength used was 570 nm with 630 nm as the reference 
wavelength.
2.13 Antigen presentation assay with TCR-like antibody 25- 
D1.16
Target cells (0.5X106) were infected with 25pl recombinant vaccinia virus expressing 
either a minigene encoding SIINFEKL with leader sequence to the ER or matrix protein 
of flu as control in 200pl of PBS solution supplemented with 0.1% (w/v) bovine serum 
albumin at 37°C for 1 hour. The infected cells were transferred to a T25 flask containing
2.5 ml normal growth medium and incubated at 37°C in a 5% CO2 incubator overnight. 
The cells were then washed and stained by 25-D1.16 to detect Kb/SIINFEKL complex 
presented on the cell surface. Anti-mouse IgG-PE was used as second antibody. Cells 
were then analyzed by flow cytometry.
2.14 Antigen presentation assay with B3Z.
Cells (lx lO 6) were washed twice with warm RPMI 1640, resuspend in 200/d of RPMI 
1640 (no serum), and added into the wells of a 24-well plate. The cells were 
permeablized by adding streptolysin-0 (SLO) at an appropriate concentration (10 U/106 
cells for K41, K42 and K42-CRT; 45 U/ 106 cells for RMA and RMA-S). The plate was 
agitated immediately after each addition. Different concentrations of ovalbumin or BSA 
as control were added to each well. The plate was incubated in a 37°C incubator with 5% 
CO2 for 10 min and agitated twice during this period. 500/d  of warm RPMI 1640 media 
with 10% FCS was added and cells incubated for further 30 min. The cells were then 
washed twice with normal growth media and resuspended in growth media at lxlO6 /ml. 
100/d o f the above cell suspensions were placed in a well of a 96-well plate. EG7 was 
used as the experiment control. 100/d o f lx l0 6/ml B3Z cells were added and co-cultured 
with target cells overnight at 37°C with 5% C 0 2. Individual cultures were then 
centrifuged at 300g for five minutes and the supernatant was discarded. The cells were
72
then washed 1 time with 200 //I o f PBS, lysed by addition of 100 /d  Z buffer (100 mM 2- 
mercaptoethanol, 9 mM MgCh, 0.125% NP-40 (BDH) in PBS) containing 0.12 mM 
CPRG (chlorophenolred-p-D-galactopyranoside; Calbiochem). After 4 hours incubation 
at 37°C, 50/d o f stop buffer (300 mM glycine and 15 mM EDTA in water) was added to 
each well and absorption of each well was read using a 96-well plate reader. Absorption 
wavelength used was 570 nm with 630 nm as the reference wavelength(Karttunen et al., 
1992).
2.15 Peptide transport assay
Cells (3xl06) were washed twice with RPMI 1640 media (no serum) and permeabilized 
for 10 min at 37°C with streptolysin-O (10 units per million cells for K41 and K42 cells; 
45 units per million cells for RMA and RMA-S cells). Cells were then washed once with 
15ml of buffer (0.005M MgCl2 in PBS) and resuspended in 200/d of warm translocation 
buffer (78 mM KC1, 4 mM MgCl2, 8.4 mM CaCl2, 10 mM EGTA, ImM dithiothreitol, 10 
mM ATP, 0.1%BSA, 50 mM HEPES, PH7.0). Fluorescein (FITC) tagged RRYQNSTEL 
peptide described previously(Boname et al., 2004; Neefjes et al., 1993) was added to the 
cells to a final concentration of lOpM. The cells were incubated at 37°C for 10 minutes, 
then 1ml of ice-cold lysis buffer (l% NP-40 in PBS) was added and incubated on ice for a 
further 15 min. Insoluble proteins were removed by centrifugation at 16,000g for 15 min 
and glycosylated peptides were bound to 50/d concanavalin A sepharose beads 
(50%(v/v)) by incubating overnight at 4°C with vigorous agitation. The beads were 
washed three times with 0.1% NP-40 in PBS and bound peptides were eluted with 500/d 
of 200mmol/L methyl-a-D-mannopyranoside in PBS in the dark at room temperature for 
60 min with vigorous agitation. The intensity of fluorescence of supernatant was 
quantified using a fluorescence spectrometer (PERKIN-ELMER, LS-3) with excitation 
and emission wavelengths at 484 nm and 535 nm, respectively. The reading was 
calculated as ratio of fluorescence of transported peptide to the total fluorescent peptide 
added.
73
2.16 Real-time PCR for ERp57
RNA was extracted from cells using TRIzol Reagent (Gibco BRL, Gaithersburg, MD) 
according to the manufacturers' instructions. The integrity of the RNA was confirmed by 
gel electrophoresis. Reverse transcription was preformed using 5 pg of total RNA, oligo 
(dT) 1218, and Superscript II RT (Invitrogen) in a total volume of 20 pi according to the 
procedure provided by manufacturer. After the reaction, the enzyme was denatured at 70 
°C for 15 min. The cDNA was diluted at 1:5 in water. 2 pi of diluted cDNA was used for 
real time PCR.
Primers for ERp57:
Sense: 5'-GCC TAG GAC TGC TGA TGG AA-3'
Antisense: 5'-CG ATC TCC TTC ACC AGA GAC TCA-3'
GAPDH (used as a control):
Sense; 5'-GAAGGTGAAGGTCGGAGT-3'
Antisense: 5'-GAAGATGGTGATGGGATTTC-3'(Di Como et al., 2002).
PCR reactions were carried out in a volume of 25 pi containing 2 pi of cDNA template,
1.5 pi (10 mM) of each primer, and 12.5 pi SYBR Green PCR master mix (AB Applied 
Biosystems UK). The products were detected with the ABI 7700 Real-Time PCR 
Detection System (Bio-Rad) and the cycle values (Ct) were determined as a measure of 
the cycle number at which a statistically significant increase in fluorescence intensity was 
first detected and normalized to the value for the control gene GAPDH to yield the 
relative abundance.
2.17 Immunofluorescence con focal microscopy
K42 and K41 cells transfected with control vector pEF/myc/ER-GFP were trypsinised 
and replaced on glass cover slides at a density of 0.5-1 xlO4 cells/well. Cells were allowed 
to spread out on the glass slide overnight. The next day, cells were fixed with 4%
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formaldehyde for 10 minutes and washed three times in PBS. They were then mounted on 
slides and cover slips sealed with nail polish before analysis on the confocal microscope.
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Chapter 3 Investigation of endogenous antigen processing by 
delivery of an intact protein in cells
3.1 Introduction
The classic MHC class I antigen processing and presentation pathway uses antigens 
derived from proteins that are present within the cell. Short peptides are generated by the 
proteasome and transported via the transporter associated with antigen processing (TAP) 
into the lumen of endoplasmic reticulum (ER) where peptides can bind to nascent MHC 
class I molecules(Townsend and Bodmer, 1989). Once MHC class I molecules are 
properly loaded with antigenic peptide they traffic to the cell surface to interact with T 
cells(York and Rock, 1996). This pathway plays a crucial role in the generation of 
cytotoxic T cells (CTL) reactive to cells infected by intracellular pathogens such as 
viruses and to tumour cells(Brodsky and Guagliardi, 1991). In order to investigate MHC 
class I antigen processing and presentation, or generation of specific CTL responses 
against a particular protein, it is therefore necessary to deliver the exogenous antigen into 
the cytosol so that the protein can be processed inside cells generating epitopes for 
presentation to T cells.
Several methods have previously been used to deliver antigens into the cytoplasm of 
cells, including virus infection and plasmid transfection. In both situations the desired 
antigen protein is expressed inside cells by introducing the encoding gene. However, this 
relies on introducing the DNA construct rather than protein antigen itself and requires 
tedious cloning and transfection, or time-consuming procedures for virus production. 
Furthermore, inconsistent transfection or infection rates for individual experiments make 
it difficult to quantitatively analyze the efficiency of antigen processing using these 
methods. Delivery of an accurate amount of protein antigen into the cytosol would be 
desirable to investigate the efficiency of antigen processing and presentation in a defined 
system.
There are several methods available for the delivery of protein into the cytosol for the
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investigation of protein function, but none of them has gained wide application due to 
the limitations of each individual method. Microinjection of protein into the cells is an 
obvious possible method(Narayanan et al., 2003; Abarzua et al., 1995), but the 
requirement for specialized equipment and sophisticated procedures means that it is only 
suitable for very small numbers of cells. Electroporation can be used with a variety of 
cell types, even some cell lines that are resistant to other delivery methods, but the 
overall efficiency is often quite low and the electroporation process can be damaging to 
the cells, frequently killing the majority of the cells used (Fenton et al., 1998). Several 
proteins and small peptides have the ability to transduce or travel through biological 
membranes, such as the HIV-1 TAT protein and the herpes simplex virus 1 (HSV-1) 
DNA-binding protein VP22 (Schwarze et al., 2000). A drawback is that the transduction 
domain must be covalently attached to the protein being delivered, either by creating a 
DNA construct or by chemical cross-linking. The cationic liposome strategy has also 
been applied successfully to protein delivery (Zelphati et al., 2001), but properties of an 
individual protein, such as its charge and hydrophobicity, will influence the efficiency of 
delivery dramatically. Streptolysin O (SLO) is a family of bacterial exotoxins, which can 
form pores in the plasma membrance of mammalian cells. Permeablisation appears to be 
reversible since cells can repair lesions caused by SLO (Bhakdi et al., 1996; Giles et al.,
1998). This pore-forming reagent has been used successfully for delivery o f anti-sense 
oligonucleotides into cells (Holasova et al., 2005) and for permitting cellular uptake of 
molecules for investigation of other cellular processes. Peptides have been delivered by 
this method for the investigation of TAP peptide transport function (Jun et al., 2000), and 
whole proteins for investigations o f protein function(Fawcett et al., 1998; Walev et al., 
2001).
In this chapter, a method using SLO to introduce protein antigen directly into the cells 
for the investigation of endogenous antigen processing and presentation is described. 
Cells were treated with SLO and the permeabilized cells then incubated with the desired 
protein antigen for delivery into the cells. MHC class I antigen processing and 
presentation of the delivered antigen in these cells was then investigated. The feasibility 
o f this method was demonstrated with a widely used OVA antigen presentation system.
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Intact ovalbumin (OVA) was successfully delivered into the cytosol of a mouse 
fibroblast; antigen was properly processed and the dominant epitope SIINFEKL was 
generated and presented to B3Z, a unique CD8+ T cell hybridoma restricted to OVA/H- 
2Kb (Sanderson and Shastri, 1994). By contrast, delivery of OVA protein into RMA-S, a 
cell line with deficiency of MHC class I antigen processing due to a TAP defect, failed 
to present the SIINFEKL epitope to B3Z. The results demonstrate an efficient and cost- 
effective method for delivery of intact protein antigen into cytoplasm for the study of 
MHC class I antigen processing and presentation. This method permits the efficiency of 
antigen processing in a defined system to be analysed quantitatively.
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3.2 Results
3.2.1 Delivery of intact proteins into the cytosol by streptolysin O
Before investigating endogenous antigen processing by delivery of intact protein, 
different concentrations of streptolysin O were tested for their ability to permeabalise 
cells. Under suitable conditions, the cells will be permeablised to allow external protein 
to enter the cell and allow the cell to repair the lesion caused by streptolysin O treatment 
so that the cells can be used for further study. To optimise the conditions, a double 
staining FACS analysis to monitor the efficiency of protein delivery and viability of the 
cells was adopted. A peptide labelled with FITC was used as an indicator of 
permeabalisation. Cells loaded with the fluorescein (FITC) tagged RRYQNSTEL would 
show green fluorescence. After incubation of permeablized cells with labelled peptide, 
propidium iodide (PI) was used to stain dead cells.
In both mouse fibroblasts and RMA cells, four populations of cells could be seen after 
treatment with SLO and incubation with FITC tagged peptide (Fig. 3.1): (1) ‘unlabelled’ 
- non-permeabilized cells; (2) green only - viable permeabilised cells loaded with 
peptide; (3) red only - dead cells without peptide loading and (4) red and green - peptide 
loaded but dead cells. The percentages of these four cell populations varied with 
increased concentrations of SLO. In the absence of SLO, the bulk of cells exhibited no or 
very little green or red fluorescence (Fig. 3.1 a,b). With increased dosage of SLO, the 
proportion of permeabilized cells went up (green cells) at the cost of increased levels of 
cell death, demonstrated by the PI staining. In RMA cells, when SLO was applied at 30 
units per million cells, approximately 32% of the original cell population would remain 
nonpermeabilized, approximately 14% would be dead, and about 54% would be 
permeabilized and loaded with FITC labeled peptides. However, when SLO 
concentration was increased to 60 units per million cells, the nonpermeabilized cell 
population was slightly reduced to 5%, whereas the percentage of cells in the dead cell
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Fig. 3.1 Flow cytometry analysis of cell permeabilization with different 
concentrations of Streptolysin O
RMA cells (left panel) and Mouse fibroblasts (right panel) were permeabilized using 
different concentrations o f SLO. Cells were incubated with lOfxM FITC tagged 
RRYQNSTEL and subsequently with 20/ug/ml PI. After extensive washing, flow cytometry 
analysis was performed for the presence o f FITC and/or Pi-labelled cells. Data are 
representative o f three independent experiments.
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population went up to 35%, reducing the percentage of live cells loaded with peptide to 
61%.
For the mouse fibroblasts used here, 10 units of SLO per million cells was sufficient to 
obtain a population of 50% of the cells which are live and loaded with FITC labelled 
peptides in the cytosol (Fig. 3.1). However, for RMA cells a higher concentration of 
SLO was required to achieve the same efficiency of peptide loading. 45 units of SLO per 
million cells are used to permeabilize RMA or RMA-S cells to achieve the desired 65% 
live and permeabalised population (Fig. 3.1 e).
3.2.2 Intact protein delivered by SLO undergoes proper endogenous 
antigen processing and a dominant epitope was successfully 
presented to specific T cells.
Once proteins are delivered into the cytosol of cells, they are processed via a 
conventional MHC class I antigen-processing pathway (Harding and Geuze, 1993). 
Cytosolic proteins are cleaved by the proteasome, and peptides are transported into the 
endoplasmic reticulum (ER) through a peptide transporter, TAR In the ER lumen, 
epitopes can bind to newly synthesized MHC class I molecules and then traffic to the 
cell surface to be inspected by cytotoxic T cells (CTL). To find out whether proteins 
delivered into cytosol by SLO could go through the normal MHC class I antigen- 
processing pathway, a widely used OVA antigen presentation system (Goldberg et al., 
2002) was adopted. This system tests whether intact OVA protein can be properly 
processed so that the dominant epitope SIINFEKL derived from OVA is presented by 
mouse MHC class I H-2Kb on the cell surface to B3Z, Kb /SIINFEKL restricted T 
hybridoma cells. Mouse fibroblast K41 cells were treated with 10 units of SLO per 
million cells as described in materials and methods. Then Ovalbmin was incubated with 
permeablised cells to allow antigen to enter the cell. The ability of the OVA derived 
epitope SIINFEKL to complex with H-2Kb for stimulation of B3Z cells was measured by 
LacZ activity (Sanderson and Shastri, 1994) following overnight incubation of K41 
fibroblasts loaded with OVA with B3Z T cells. As shown in Fig. 3.2, K41 mouse
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fibroblasts loaded with OVA by SLO permeabalisation were indeed able to present 
SIINFEKL epitope derived from cytosolic OVA to B3Z. No activation of B3Z was 
observed for SLO permeabilized mouse fibroblasts pulsed with a non-relevant control 
protein BSA (open square), demonstrating that the response of B3Z to the target cells 
was specific to the OVA derived peptide. The level of B3Z stimulation was close to that 
stimulated by EG7, an EL4 cell line which endogenously expresses chicken OVA 
(Moore et al., 1988).
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Fig. 3.2 OVA epitope specific T cells can be stimulated by fibroblasts loaded with 
OVA after treatment with SLO
Mouse fibroblasts permeabilized with SLO were loaded with ovalbumin (OVA) protein or 
with BSA as a control. Protein loaded cells were co-cultured with the lacZ-inducible, 
SIINFEKL/K?-specific B3Z T cell hybridoma at different effector/target (E:T) ratios 
overnight. The EG7 cell line expressing endogenous OVA was used as a positive control. 
The B3Z activation level was evaluated by /3-Gal activity following overnight incubation 
as described in the materials and methods. Individual experiments were carried out in 
triplicate and were repeated at least three times for each cell line.
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3.2.3 An endogenous antigen processing defect can be demonstrated 
in TAP deficient cells loaded with intact protein using SLO
Antigenic peptides generated in the cytosol through the proteasome pathway must, 
through TAP, enter the ER lumen where peptides are assembled with newly synthesized 
MHC class I molecules. In the absence of TAP, the peptides generated in the cytosol are 
unable to be accessed by class I molecules in the ER resulting in a failure of antigen 
presentation (Kelly et al., 1992; Spies et al., 1992). To find out whether the SLO system 
can be used to detect endogenous antigen processing defects, OVA was delivered into 
the TAP-2 locus mutant cell line RMA-S using SLO permeabalisation (Attaya et al., 
1992). Due to the known defect for transporting peptides from the cytosol to the ER in 
this cell line, few peptide loaded MHC class I molecules appear on cell surface, therefore 
RMA-S cells loaded with OVA using SLO would not be expected to stimulate B3Z cells.
As illustrated in Fig.3.3, when OVA was delivered into the RMA TAP competent 
parental cell line of RMA, OVA protein was successfully processed and the dominant
• Hepitope SINNFEKL was presented in association with H-2K on the surface of the cell, as 
evidenced by efficient stimulation of B3Z. By contrast, in TAP-2 mutant RMA-S cells, 
there was no activation of B3Z due to the incompetence of translocation of peptides from 
cytosol to the lumen of ER in these cells. In a control experiment, SLO treated RMA cells 
pulsed with the irrelevant protein BSA did not stimulate B3Z, demonstrating that the 
response of B3Z to target cells was specific to OVA peptide.
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Fig. 3.3 Demonstration of TAP-dependent presentation of OVA derived epitope to T 
cells by cells loaded with OVA using SLO treatment
Both TAP deficient RMA-S and TAP competent RMA cells were permeabilized using SLO 
and loaded with ovalbumin (OVA) or with BSA as a negative control. Cells loaded with 
proteins were co-cultured with B3Z in different effector/target (E:T) ratios. The EG7 cell 
line expressing endogenous OVA was used as a positive control. The B3Z activation level 
was evaluated by /3-Gal activity following overnight incubation. Experiments were 
carried out in triplicate and the data shown is a representative experiment o f three 
independent experiments.
84
3.3 Discussion
To study MHC class I antigen processing and presentation, the antigen o f interest must 
be delivered into the cytosol of cells. Different protocols have been described for this 
purpose, including microinjection and electroporation of whole protein, and recombinant 
vaccinia transduction and transfection of cDNA constructs. Electroporation is a widely 
used in vitro technique that allows direct access of large molecules to the cell cytosol 
(Song and Harding, 1996). However, electroporation induces cell death in up to 45% of 
cells by both necrosis and apoptosis due to the damage caused to cell membranes, DNA 
and chromatin by the electrical charge (Pinero et al., 1997). Microinjection has been used 
to investigate the role of the ubiquitin-proteasome pathway in generating peptides for 
presentation on MHC class I molecules (Michalek et al., 1993), but sophisticated 
equipment and the individual cell based operation restrict the wider application of this 
method. Transfection of target cells with a plasmid containing a gene of interest, such as 
Lipofectin or Lipofectamine (Pulaski et al., 1996), requires the construction of 
intermediate vector expressing desired gene, and the transfected cells need time to 
express the protein before they can be used for the further study. Furthermore, the 
transfection efficiency varies between experiments, which makes it difficult to analyze 
the efficiency of endogenous antigen processing.
Vaccinia infection probably is mostly used system for investigation of MHC class I 
pathway for a particular protein and can infect a larger fraction o f recipient cells 
(Townsend and Bodmer, 1989). However, vaccinia expression requires construction of 
vector expressing protein, a time consuming procedure to screen recombined clones and 
the facility to make recombinant vaccinia viruses. Furthermore, there are several other 
disadvantages to use the system. (1) the inhibitory effect of vaccinia on epitope 
presentation to class I-restricted CTL observed during the late phase of vaccinia 
infection. The possibility is that vaccinia, like other pox viruses, may express one or 
more serine protease inhibitors that could accumulate in the cytoplasm of infected cells 
and inhibit host proteases involved in the degradation of antigens recognized by CTL. In
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addition the inhibition of host class I molecules during vaccinia infection may contribute 
to the reduced efficiency of antigen presentation (Townsend and Bodmer, 1989). (2) the 
dominate epitope derived from vaccina virus itself might corrupt proper epitope 
processing from the desired protein; (3) non-specific stimulation of T cells. Berwin B et 
al reported that vaccinia viruses induce necrotic cell death, which yields the release of 
cellular immunogenic component-GRP94/96 into extra cellular space, which can elicit 
the activation of OVA-specific hybridomas (Berwin et al., 2001). In our initial 
experiments, vaccinia viruses expressing OVA were also used to infect mouse fibroblasts 
to stimulate B3Z T cells for the purpose of investigation of the efficiency of 
endogenously antigen processed in a defined fibroblast system. However, as shown in 
Fig. 3.4, vaccinia expressing either irrelevant protein or vaccinia alone, as well as 
vaccinia expressing OVA were found to be able to stimulate hybridoma B3Z efficiently. 
So the vaccinia expression system could not be used in our OVA-B3Z model system.
Compared with the above traditional methods, delivery of OVA into the cell cytosol by 
SLO is efficient, specific, fast and cost-effective. It can achieve a viable cell population 
with model protein inside the cytoplasm of 50 to 65% of total cells depending on 
different cell types (Fig. 3.1). Additionally, it is suitable for both adherent and suspended 
cells. This novel method allows specific stimulation of T cells since target cells pulsed 
with the irrelevant protein BSA did not activate B3Z, demonstrating that the response of 
B3Z to target cells is specific to the OVA derived peptide (Fig. 3.2 and Fig. 3.3). The 
inability o f TAP-2 mutant RMA-S cells to activate B3Z demonstrates the failure of 
endogenous antigen presentation pathway in these cells due to their inability to 
translocate peptides from cytosol to the lumen of ER (Fig. 3.3). The new technique of 
delivery of OVA into the cell cytosol by SLO presented here, is quick, 40 minutes is 
sufficient for the permeabilization target cells and incubation with protein OVA before 
the co-culture of target cells with effecter cells. Conversely, after transfection or vaccinia 
infection, a 24 hour cell incubation is needed to allow transfected or infected cells to 
express the introduced protein. Furthermore, the permeabilization reagent SLO is much 
cheaper compared to transfection reagents. But the most desirable advantage o f using 
this system is that the efficiency of endogenous antigen processing can be quantitatively
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analysed. The protein antigen can be added to SLO permeablized cells in a concentration 
controlled manner. The intensity of T cell stimulation is proportional to protein antigen 
delivered into cell (Fig.3.5). Therefore, the efficiency of endogenous antigen processing 
for a particular protein can be assessed in a defined cell system.
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Fig. 3.4 Non-specific stimulation of B3Z by target cells infected with vaccinia virus
Mouse fibroblasts (K41) and (32 m deficient R1E cells were infected by vaccinia virus 
expressing model protein OVA or with vaccinia virus expressing flu matrix protein (MP) 
as a negative control. Cells were washed, counted, and cocultured with the lacZ- 
inducible, SIINFEKL/K0-specific B3Z T cell hybridoma in different effector/target (E:T) 
ratios. The B3Z activation level after overnight incubation was evaluated as described in 
materials and methods. The experiments were carried out in triplicate each time and 
repeated at least three times for each cell line.
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Fig. 3.5 Intensity of T cell stimulation is proportional to protein antigen delivered 
into cell
Cells were permeabilized using Streptolysin O and different concentrations of Ovalbumin 
were added to the permeablilized cells. Cells loaded with Ovalbumin were co-cultured 
overnight with the T cell hybrid (B3Z). T cell activation was measured by colour 
development in an ELISA as described in the materials and methods. Each experiment 
was carried out in triplicate for each cell line and repeated at least three times. Data was 
combined for the plot and error bars show s.d. from the mean.
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Chapter 4 Calreticulin maintains the low peptide 
concentration threshold required in the ER for efficient 
antigen presentation
4.1 Introduction
Calreticulin (CRT) is an abundant endoplasmic reticulum (ER) resident protein that has a 
large number of cellular functions in a variety of biological systems. Among these, two of 
its most important functions are intracellular calcium homeostasis and acting as a 
chaperone in the folding of newly synthesized glycoproteins(Krause and Michalak, 
1997). CRT associates with glycoproteins when they are freshly synthesized and retains 
them in the ER until they are properly folded. This process of ER retention is an 
important mechanism in quality control for the production of correctly folded 
glycoproteins (Hammond and Helenius, 1995; Hebert et al., 1996). CRT has been 
demonstrated to be involved in class I antigen processing and presentation; it plays an 
important role in the formation o f the peptide-receptive MHC class I complex(Sadasivan 
et al., 1996) and subsequently in efficient peptide loading(Gao et al., 2002).
Assembly of MHC class I molecules in the ER and their presentation to CD8 T-cells and 
NK cells is a highly coordinated process involving several critical steps including: the 
supply of peptides, the generation of peptide receptive class I molecules, the loading of 
peptide onto class I molecules and ER exit of loaded class I to the cell surface. Peptides 
are generally derived from newly synthesized polypeptides located in the cytosol where 
they are cleaved by the proteasome (Cascio et al., 2001; Kloetzel, 2001) and other 
proteases (Reits et al., 2004; Saric et al., 2004; Stoltze et al., 2000). The position of 
cleavage generally produces peptides which are extended at the N-terminus but have the 
correct C-terminus (Cascio et al., 2001). Perhaps assisted by cytoplasmic chaperones 
(Kunisawa and Shastri, 2003; Dunn et al., 2001), these peptides are transported by TAP 
into the ER (Powis et al., 1991; Kelly et al., 1992; Androlewicz et al., 1993; Lankat- 
Buttgereit and Tampe, 1999; Abele and Tampe, 2004) and the extra N-terminal residues
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are removed by an aminopeptidase in the ER (ERAAP) (Serwold et al., 2002; Serwold et 
al., 2001; Saric et al., 2002; York et al., 2002). In the ER, peptides are loaded onto the 
class I complex through the collaborative work of molecules of the PLC(Cresswell et al.,
1999). CRT is closely associated with MHC class I-|32M dimers via its lectin-like 
binding site and acts as an important member of PLC (Sadasivan et al., 1996). In the 
absence of CRT, MHC class I molecules are still able to traffic to the cell surface, but the 
majority of class I molecules are either empty or loaded with sub-optimal peptides, 
showing that CRT is indispensable for efficient class I assembly and antigen presentation. 
CRT deficient cell line also fails to present the majority of epitopes tested to specific T 
cells (Gao et al., 2002). In some respects, the phenotype appears similar to the T134K HC 
mutant, in which MHC class I molecules exit the ER rapidly as an 'empty' heterodimer. In 
contrast, empty wild-type MHC class I molecules are normally retained in the ER and 
degraded. The association of the T134K mutant class I molecules with TAP and CRT is 
disrupted (Peace-Brewer et al., 1996; Lewis et al., 1996) and this could explain the 
similarity in the phenotype of the T134K mutant and CRT deficient cells.
As well as being a member of the PLC, CRT has also been shown to bind to peptides 
transported into the ER by the transporter associated with antigen processing (Spee and 
Neefjes, 1997). A number of experiments have shown that binding of CRT to peptide 
may contribute to generating specific immune responses. For instance, immune responses 
have been generated against tumours by immunising with CRT extracted from them. The 
immunogenicity is attributed to peptides associated with the extracted CRT and not to the 
CRT molecule itself (Basu and Srivastava, 1999). It has also been shown that CRT 
molecules can be complexed in vitro to unglycosylated peptides and used to elicit 
peptide-specific CD8(+) T cell response by exogenous administration (Basu and 
Srivastava, 1999). Furthermore, a conjugate of CRT and tumour antigen DNA produced 
protective immunity against the tumour accompanied with a significant increase in 
tumour antigen specific CD8(+) T cell precursors (Hsieh et al., 2004; Cheng et al., 2001). 
Additionally, CRT and other members of the HSP family when associated with peptides 
can provide a necessary and sufficient source of antigen for cross-priming of CD8 T cells 
(Binder and Srivastava, 2005).
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To further understand how CRT is involved in proper peptide loading onto the class I 
complex and how it contributes to efficient anti-tumour responses by its adjuvant effect, 
the involvement of CRT in TAP function, recruitment of (32M to associate with class I 
HC, and its direct or indirect affect on peptide loading and in the expression and folding 
of other members of the PLC was investigated.
4.2 Results
4.2.1 TAP deficient phenotype exhibited in CRT knock-out cell line
Previously it has been demonstrated that in a cell line lacking CRT, there is a reduction in 
MHC class I surface expression compared to a wild type cell line. The reduction is 
mainly due to the fact that class I is devoid of peptide or loaded with sub-optimal peptide 
in the ER (Gao et al., 2002). Here evidence is provided that CRT deficient cells have a 
TAP deficient-like phenotype manifested as unstable class I surface expression, which 
can be rescued by incubation at lower temperature.
In RMA-S, a murine cell line with a TAP2 defect, class I molecules are formed in the ER 
but there is a shortage of peptides to load onto them. Empty class I molecules reach the 
surface of RMA-S cells, but are thermolabile and are degraded at physiological 
temperature(Ljunggren et al., 1990; De Silva et al., 1999). Although physiological 
temperature might be optimal for protein function, it might be too high for efficient 
protein folding and assembly. Consequently, an increase in folding efficiency is often 
found when cells are grown at reduced temperatures(Hurtley and Helenius, 1989). To 
assess the stability of class I molecules in the absence of CRT, CRT deficient K42 cells, 
and their wild type counterparts were incubated at either 26 °C or 37 °C overnight and 
cell surface class I expression was determined by FACS analysis with anti-class I 
antibody. As demonstrated in Fig.4.1, when CRT deficient cells K42 were incubated 
overnight at 37 °C, class I surface expression was reduced about five to seven fold 
compared to that in wild type K41 cells. However, when K42 cells were incubated 
overnight at 26 °C, the surface expression of class I of cells was restored to the same level
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as in wild type cells (Fig. 4.2). In contrast, there was no difference in class I surface 
expression between cells cultured at 26 °C and 37 °C in the wild type fibroblasts cell line 
K41 since the majority of class I in this cell line are properly loaded with peptides (Fig. 
4.2). Furthermore, when human CRT (that differs by only a dozen amino acids from its 
mouse counterpart) was transfected into K42 cells (Fig. 4,3) it restored surface class I 
expression on K42 to the level of wild type K41 cells (Fig. 4.1). In this case, there was no 
difference in class I expression between cells incubated at 37 °C and 26 °C (Fig. 4.2). 
Therefore, the phenotype of K42 cells is similar to that observed in RMA-S, a TAP 
deficient cell. When RMA-S was cultured at normal physiological temperature (37 °C), 
there was little class I expressed on the surface of the cell due to quick degradation of 
empty class I molecules. But when the cells were incubated at 26 °C cell surface 
expression of class I molecules was restored to normal levels (Fig. 4.2).
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Fig. 4.1 Expression of CRT in K42 cells restored surface MHC class I expression
The surface expression o f iC in K42, CRTK42 transfectant (K42-CRT) and K41 was 
analysed by FACS staining with the anti-Ff antibody Y3 and rabbit anti-mouse IgG 
labeled with PE. The shaded peak indicates the staining with secondary PE- 
conjugated anti-mouse IgG alone.
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Fig. 4.2 Calreticulin (CRT) deficient cell line exhibits a TAP-deficient phenotype
K42, CRT K42 transfectant (K42-CRT), and CRT competent K41 cells were incubated at 
either 37° C (thin line) or 26 °C (thick line). MHC class I expression o f each cell lines was 
analysed by FACS staining with the anti-fC antibody Y3 and rabbit anti-mouse IgG 
labeled with PE. The shaded peak indicates the staining with secondary PE-conjugated 
anti-mouse IgG alone. RMA-S, an established TAP deficient cell line, and RMA, the 
parent cell line o f RMA-S with normal TAP function were treated as in (a) and served as 
a control. All experiments were repeated at least three times. One representative 
experiment is shown here.
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Fig. 4.3 Expression of full length CRT in K42 cells
CRT deficient cell line K42 was transfected with human CRT cloned into a vector with 
both ER leader sequence and retention signal to create K42-CRT. K41 is a CRT 
competent ‘wild type ’ cell line. HCT cells served as a positive control. The expression of 
CRT in K42-CRT was confirmed by western blot with anti-CRT antibody.
4 .2 .2  T ran sloca tion  o f  p e p t id e s  into  th e  ER is  e f f ic ien t  in CRT 
d e f ic ien t  c e l l s  and is  a c c o m p a n ie d  by norm al le v e l s  o f  TAP  
e x p r e s s io n
Since CRT is an important chaperone, involved in quality control of protein synthesis and 
folding and given the fact that the phenotype appears somewhat similar to TAP 
deficiency, it was important to determine whether there was either a direct or indirect 
effect on the function of TAP in the CRT deficient cell line. TAP was quantitatively 
analysed at the protein level by western blot. For protein detection, cells from both the 
CRT deficient line and their competent counterparts were carefully counted, diluted in a 
series of two fold dilutions and analysed by western blot using anti-TAP antibody. Level 
of tapasin expression was used as a loading control since it has been shown previously 
not to be affected by CRT deficiency (Gao et al., 2002). By western blot there was the 
same amount of TAP detected in CRT deficient cells compared with CRT wild type cells 
(Fig. 4.4a). The amount of TAP produced in CRT deficient cells appears to be normal
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but this does not prove that its function in the translocation of peptide is unaffected. To 
clarify this, the efficiency of peptide translocation in CRT deficient cells with was 
compared that in CRT competent cells. Fluorescent peptide was incubated with 
Streptlysin O permeablised cells, and peptides transported into the ER by TAP were 
purified by ConA beads which only bind to properly glycosylated protein. Peptides 
transported into the ER, glycosylated and purified by ConA beads were quantitatively 
analysed by a fluoresescence spectrometer. Fig.4.4b shows that an equal amount of 
RRYQNSTEL peptide with fluorescent label FITC, were transported into the 
endoplasmic reticulum in CRT deficient cells as in CRT restored cells. This suggests that 
CRT deficient cells can still efficiently transport peptide into the ER and is consistent 
with the normal level of TAP in these cells. As a control, TAP-2 mutant RMA-S cells 
were demonstrated to fail to transport the FITC labelled RRYQNSTEL across the ER 
membrane, while TAP competent RMA cells were capable to do so.
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Fig. 4.4 TAP expression and peptide transportation efficiency in CRT deficient cell 
line K42 compared to that in CRT competent cell line K41
a: Cells were counted and lysed with 0.5% NP-40 in PBS. Two fold diluted lysates were 
run on 12%SDS-PAGE and the proteins were transferred onto cellulose membrane, 
which was then probed with anti-tapasin and anti-TAP2 rabbit serum, 
b: cells permeablised with streptolysin O and then incubated for ten min in translocation 
buffer containing FITC labeled RRYQNSTEL to test their capacity to transport peptides 
into the ER. Transported peptides having undergone N-linked glycosylation in ER were 
recovered by precipitation with Con A-sepharose from lysed cells. The fluorescent 
intensity of recovered FITC labelled RRYQNSTEL was quantified using a fluorescence 
spectrometer as described in the material and methods. Data are presented as the 
percentage of the total peptides that were transported and recovered from lysates and 
shown as means ±SD of three independent experiments.
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4.2.3 Delivery of peptide into the ER restored normal MHC class I 
surface expression in CRT deficient cells
Since the presence of sub-optimally loaded and/or empty class I molecules in the CRT 
deficient cell line was not due to the failure of peptide supply by TAP, it is possible that 
there might be a defect in peptide loading itself. To test this, SIINFEKL, a dominant 
murine H-2Kb binding peptide from ovalbumin, was delivered into the ER directly using 
vaccinia virus expressing SIINFEKL with an ER leader sequence. H-2Kb:SIINFEKL 
complexes in the cell surface can be detected by flow cytometry after staining with 
monoclonal antibody 25-D1.16, which is specific for SIINFEKL associated with H- 
2Kb(Porgador et al., 1997), or by T-cell hybridoma assay. These two assays have 
different advantages. The flow cytometry assay provides a more quantitative measure of 
antigen presentation as the antibody binds directly in proportion to the density of 
peptide/MHC complexes on the cell surface, whereas the T-cell assay is much more 
sensitive. Unfortunately the T-cell activation assay could not be used to evaluate H- 
2Kb:SIINFEKL complexes after infection of target cells by vaccinia virus because 
vaccinia expressing either irrelevant proteins or vaccinia alone were also able to stimulate 
the B3Z hybridoma (Fig 3.4). Vaccinia viruses can induce necrotic cell death, which 
causes the release of the cellular component-GRP94/96 into the extra cellular space and 
elicits B3Z activation(Berwin et al., 2001). Therefore, the expression of SIINFEKL 
loaded Kb was analysed using the mAb 25-D1.16.
First vaccinia titration assays were done on normal mouse fibroblasts. In Fig.4.5, by 
staining with mAb 25-D1.16 and analysing by FACS, it is shown that, when different 
amounts of SIINFEKL were delivered into normal murine fibroblast cells the number of 
cells expressing Kb/SIINFEKL is proportional to the multiplicity of infection (MOI) of 
vaccinia used. While staining with mAb Y3, an antibody recognising conformation- 
dependent H-2Kb bound to any peptide, showed that little change was observed in total Kb 
expression between cells infected by different amount of vaccinia virus. 25-D1.16 staining 
can be used to measure the fraction of Kb molecules loaded with SIINFEKL at the cell 
surface. The result of vaccinia virus titration assay revealed that when more vaccinia virus
97
was used to infect cells, a higher percentage of cells was infected to express SIINFEKL 
peptides, but the less viable cells were left expressing SIINFEKL peptides because 
vaccinia virus caused cell death(Berwin et al., 2001). Therefore, 25pl of the same batch of 
vaccinia virus was used to infect the same number of cells and evaluate the ability of 
different cell lines to load the SIINFEKL peptide onto class I H-2Kb molecules and 
express them at the cell surface. The data shown in Fig.4.6 demonstrated that the surface 
expression of class I molecules on CRT deficient K42 could be restored to the same level 
as that in CRT competent cell lines by delivering SIINFEKL peptide directly into ER. 
This suggests that the loading of peptide onto class I molecules is normal in CRT deficient 
cells as long as enough peptide is delivered into the ER.
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Fig. 4.5 Titration of vaccinia virus
Murine K41 fibroblast cells were infected with different amount o f vaccinia virus 
expressing the ER leader sequence followed by SIINFEKL. Expression of total murine 
MHC class I Kf and of A*/SIINFEKL on the surface of cells was analysed by FACS using 
the monoclonal antibodies Y3 (left panel) and 25-D1.16 (right panel). The shaded peak 
indicates the staining with secondary PE-conjugated anti-mouse IgG alone.
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Fig. 4.6 MHC class I surface expression was restored when SIINFEKL was directly 
delivered into the ER
K41, K42 and K42-CRT were infected with 25 /al of vaccinia expressing ER targeted 
SIINFEKEL, and surface expression K/°/SIINFEKL was analyzed by flow cytometry using 
25-D1.16 antibody. Histograms show cells infected with vaccinia virus expressing 
SIINFEKL (thick line), cells infected with control vaccinia virus expressing a non- 
relevant protein (thin line). The shaded peak indicates the staining with secondary PE- 
conjugated anti-mouse IgG alone.
4.2 .4  C ova len t a s s o c ia t io n  o f 02M  to  c l a s s  I h e a v y  ch a in  d o e s  not
r e s c u e  th e  red u ced  c l a s s  I e x p r e s s io n  in CRT d e f ic ien t  c e l l s
It is widely accepted that when class I HC is newly synthesized it associates with 
calnexin (Nossner and Parham, 1995; David et a l ,  1993) to maintain a p2M receptive 
state. p2M is then recruited to associate with class I HC and this is accompanied by the 
replacement of calnexin with CRT (Sadasivan et al., 1996). Although there is no direct 
evidence to show how CRT is involved in the replacement of calnexin and in bringing 
beta-2-microglobulin into proximity with HC, given the order of protein interactions it is 
possible that CRT may be responsible either for promoting the assembly of class I HC 
with |32M or for the recruitment o f |32M.
To investigate a possible defect in the recruitment of p2M to class I HC in the CRT 
deficient cell line, a fusion protein of |32M was covalently linked to HLA-A2 (A2B2) was 
transfected into K41 and K42 cells by B Flutter. This fusion protein should fold into a
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class I molecule without requiring p2M recruitment and has been shown to efficiently 
expressed on the surface of the cell and presented antigen to specific CTL (B Flutter et al: 
unpublished data). The A2B2 construct was transfected into both K41 and K42 cell lines, 
and stable cell lines were established by zeocin selection and sub-cloning. The expression 
of A2B2 in both cell lines was confirmed by western blot (Fig. 4.7). Surface expression 
of A2B2 was demonstrated in these cell lines with the conformation-dependent antibody 
W6/32, suggesting that linked chain was folded properly in both cell lines and was able to 
traffic normally to the surface of the cell. Surface expression of the A2B2 in the CRT- 
deficient cell line was significantly lower than that on the CRT competent cell line (Fig. 
4.8). The observed difference in linked chain expression was similar to the difference in 
murine class I surface expression between CRT-deficient and competent cells. Since pre­
assembled A2B2 does not overcome the calreticulin deficiency in K42 cells, the 
recruitment of P2M to class I is unlikely to be the reason for the class I assembly defect 
in the absence of CRT.
K41 K42
A2B2 + - +
 A2B2
Fig. 4.7 Expression of linked chain HLA-A2- p2M  (A2B2) in both K42 and K41 
cells.
Expression o f fusion protein A2B2 was confirmed by western blot using the antibody 
BBM1, specific for human f2M. This figure was produced by Dr Barry Flutter.
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Fig. 4.8 Class I HC pre-linked to beta-2-microglobulin failed to restore norm al class 
I expression in CRT deficient cells.
Cells were stained with W6.32 antibody against human class I and analysed by flow  
cytometry. K42 cells transfected with A2B2 expressed lower levels o f human class I 
compared to that ofK41 (CRT+/+) cells. This figure was produced by Dr Barry Flutter.
4 .2 .5  A h igher th re sh o ld  o f p e p t id e  c o n c en tr a t io n  is  required  for  
eff ic ien t  a n t ig en  p r e se n ta t io n  in th e  a b s e n c e  o f  CRT
Since peptide loading onto MHC class I molecules in ER was not impaired and TAP 
function was normal in calretciulin deficient cells, it was thought that CRT might play a 
role in the maintenance of the low threshold of peptide required in the ER for efficient 
presentation to T cells. This might occur through the enrichment of the peptide in the ER 
or by promoting efficient assembly of the PLC. To test this idea, the activation of a 
specific T cell by antigen presenting cells loaded with controlled concentrations of whole 
protein antigen was investigated. To achieve a controlled protein loading into the cell, the 
new method developed in chapter 3 using streptolysin O to temporarily permeablise the 
cells was used. Ovalbumin (OVA) antigen was added to the permeabilised cells and 
loaded into the cytosol of the cell. OVA was processed inside the cell and the peptides 
degraded from OVA transported into the ER. In the ER, the dominant peptide
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SIINFEKL was further assembled with Kb and presented on the surface of the cell. The 
levels of specific SIINFEKL:MHC-I complexes generated after exposing cells to 
ovalbumin (that requires processing) are much lower than the levels achieved with higher 
concentrations of exogenous peptides either incubated with the cells or delivered to the 
ER by vaccinia virus. Therefore, endogenous protein processing experiments were 
evaluated using the T-cell assay, as the T-cell assay is much more sensitive than staining 
with 25-D1.16 antibody and flow cytometry.
As shown in Fig. 4.9, CRT deficient cells stimulated B3Z cells less effectively than wild 
type cells. Maximal response of T cells stimulated by CRT deficient cells pulsed with 
optimal amount of OVA was lowered significantly compared to wild type cells. 
Detectable stimulation required about a 3-fold higher ovalbumin concentration in CRT 
deficient cells than wild type cells, suggesting that the concentration of ovalbumin 
required for efficient antigen presentation is lowered in the presence of CRT. 
Furthermore the increased threshold o f OVA antigen required for antigen presentation in 
CRT deficient cells could be corrected by transfecting CRT back into the deficient cells 
(K42-CRT). Noticeably, in CRT transfected cells, the stimulation of B3Z was stronger 
than in wild type cells. Since transfected cells express a high level of CRT, this further 
supports the notion that CRT may promote efficient antigen processing. In control 
experiments, both streptolysin O treated cells pulsed with non-relavent protein BSA and 
untreated cells incubated with OVA failed to stimulate B3Z, demonstrating that the 
response of B3Z to the target cells treated with streptolysin O and pulsed with OVA is 
specific (Fig. 4.9).
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Fig. 4.9 CRT maintains a low threshold of peptides required in the ER for efficient 
antigen presentation to T cells
Cells of K41, K42, CRT K42 transfectant (K42-CRT) were permeabilized using 
Streptolysin O and different concentrations of Ovalbumin with BSA as a control were 
added to the permeablilized cells. Cells loaded with Ovalbumin were then co-cultured 
overnight with the T cell hybrid (B3Z). T cell activation was measured by colour 
development in an ELISA as described in the materials and methods. EG7 was used here 
as experimental control. Each experiment was carried out in triplicate for each cell line 
and repeated at least three times. Data was combined for the plot and error bars show 
s.d. from the mean.
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4.2.6 Up-regulation of ERp57, but normal level of tapasin and calnexin 
expression in CRT deficient cells
There are two likely explanations for the higher threshold of antigen required for efficient 
antigen stimulation in the absence o f CRT. One is that CRT is capable of enrichment of 
peptides in ER for efficient loading onto class I molecules, which is supported by the 
documented peptide binding capacity of CRT (Binder and Srivastava, 2005; Basu and 
Srivastava, 1999). Alternatively, CRT may contribute to efficient peptide loading 
indirectly, either by chaperoning the proper folding of other members of the PLC or by 
somehow promoting their function in peptide loading. A precedent for this kind of 
phenomenon is seen in tapasin deficient cells in which the absence of tapasin affects the 
expression and function of TAP (Garbi et al., 2003). The fact that the CRT deficient cell 
line is still able to process endogenous antigen also led us to consider whether, in the 
absence of CRT, a redundant protein in the ER might be able to partly compensate for the 
functions of CRT. The most likely candidate for this would be one of proteins involved in 
MHC class I assembly.
To find out if any other member of the PLC is affected by the absence of CRT, individual 
components of the PLC were quantitatively analysed by western blot. Cells were counted, 
lysed in 1% NP40, serially diluted in PBS and analysed by western blot with antibodies 
to calnexin, tapasin, HC and ERp57. Accurate cell counting between samples was again 
confirmed by equal calnexin expression. In contrast to other components of the PLC, the 
expression of ERp57 in K42 cells was increased at least two fold compared to that in both 
CRT transfected K42 and competent wild type cells (Fig. 4.10). This increased level of 
protein expression is consistent with an upregulated level of mRNA transcription 
confirmed by quantitative real time PCR (Fig. 4.11). As with calnexin and TAP, there 
was no significant difference in the expression of tapasin between CRT deficient and 
competent cells (Fig. 4.10). However, under carefully controlled conditions it was shown 
that there were more class I HCs accumulated in CRT deficient cells than that in either 
CRT wild type cells or CRT deficient cells transfected with CRT (Fig. 4.10). This is not 
consistent with previous observations (Gao et al., 2002). However, the level of total HC 
in CRT deficient cell lines detected by western blot is very sensitive to minor differences
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in experimental procedure. For example, the length of time cells are digested by trypsin 
and even the amount of time the cells are kept in suspension before lysis could affect 
protein level (unpublished observation). In this report all assay conditions were made as 
consistent as possible.
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Fig. 4.10 Up-regulation of ERp57 but normal expression of tapasin, TAP and 
calnexin in CRT deficient cells
Two-fold dilutions were made on cell lysates o f  K41, K42 and K42-CRT, and samples 
were separated on 12% SDS-PAGE. Individual proteins were detected by western blot 
using the antiserum to calnexin (CNX), tapasin (TPN), HC and ERp57.
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Fig. 4.11 Transcription o f ERp57 was up-regulated in CRT deficient 
K42 cells
mRNA was isolated from K41, K42 and K42-CRT, and real time PCR was carried out 
using ERp57 specific primers. The results are shown as mRNA expression normalized 
against the expression level in K41 cells.
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4.3 Discussion
CRT is a member of PLC(Cresswell et al., 1999) and there is impaired class I surface 
expression in a CRT deficient cell line (Gao et al., 2002), indicating its critical role in 
class I antigen processing and presentation. On the other hand, CRT associates with 
peptides in vivo to trigger a strong T cell response (Nair et al., 1999) and the response 
initiated is protective against the tumor that the peptide is derived from (Basu and 
Srivastava, 1999), suggesting that CRT is important in specific T cell responses. 
However, exactly how CRT is involved in MHC class I antigen processing and 
presentation and how it contributes to anti-tumor responses remains a mystery. Using an 
OVA protein based antigen processing assay it has been shown here that significantly 
higher antigen concentration is required for efficient presentation of the dominant epitope 
SIINFEKL to specific T cells in CRT deficient cells compared to that in normal cells 
(Fig. 4.9). Therefore, CRT reduces the ER peptide concentration needed for efficient 
MHC class I antigen presentation to T cells. The impaired endogenous antigen 
presentation in CRT knockout cells was also mentioned in the previous work done by 
Gao et al(Gao et al., 2002). They tested the ability of CRT deficient cells (K42) to present 
the Kb-restricted OVA-derived epitope SIINFEKL following infection with vaccinia 
virus expressing cytosolic OVA and showed that at all doses of virus used to infect cells, 
between 2- to 3-fold more SIINFEKL: Kb complexes, detected by mAb 25-D.16, were 
found on the surface of CRT competent cells than CRT deficient cells(Gao et al., 2002). 
The function of CRT in lowering the peptide concentration threshold required in the ER 
for class I antigen presentation has physiological importance, especially in virus-infected 
cells. Studies have demonstrated that viruses have evolved remarkable mechanisms to 
inhibit MHC class I expression by interfering with the function of the MHC class I 
assembly machinery to evade the immune response. An efficient way to inhibit class I 
expression is to cut off the source of peptides(Lybarger et al., 2005). For example, herpes 
simplex virus-infected cells express the viral evasion protein ICP47, which binds to the 
TAP peptide transporter and blocks peptide translocation into the ER(Ahn et al., 1996). 
By doing so, herpes simplex virus down regulates the surface class I expression to avoid
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recognition by CTLs. By reducing the peptide threshold in the ER, CRT is likely to be 
important so that virus-infected cells could present virally derived antigenic peptides 
efficiently to CTLs when they are limited in the lumen of ER.
In this chapter, the possible mechanisms by which CRT reduces the ER peptide 
concentration needed for efficient MHC class I antigen presentation to T cells were 
investigated. It was shown that CRT deficient cells exhibited a TAP deficient phenotype 
in terms of class I assembly. Normal surface expression of MHC class I molecules in 
CRT deficient cells could be restored by incubation of cells at 26 °C. At this low 
temperature, empty or sub-optimal peptide loaded class I were more stable than that at 37 
°C. Based on the previous experimental observation that correlates the thermostability of 
a MHC class I complex with the affinity of its peptide cargo(Williams et al., 2002b), the 
data suggested that the MHC class I molecules in CRT deficient cells were peptide- 
receptive (empty) or suboptimally loaded. This result was consistent with previous work 
showing that the ability of intracellular loading of Kb with peptides in K42 by 
immunoprecipitating a cohort of newly synthesized class I molecules in the presence or 
absence of peptide ligand using either conformation-sensitive mAb (Y3) or an antiserum 
(T18) which only recognizes the (32m free Kb and found that a greater proportion of class 
I molecules in CRT deficient cells were peptide receptive(Gao et al., 2002).
There are three possibilities why empty or suboptimally loaded MHC class I molecules 
appear on the cell surface of K42: shortage of peptide supply, impaired quality control 
and/or peptide-loading defect in the ER.
These possibilities were investigated. Experiments were first carried out to determine 
whether there is shortage of peptides in CRT deficient cells. TAP is responsible for 
transporting peptides from cytosol to the ER. In TAP deficient cells, most class I 
molecules fail to assemble with stably bound peptide duo to the shortage of peptide 
supply and are therefore retained in the ER(Grandea, III et al., 2000; Schoenhals et al., 
1999). These empty class I molecules that accumulate in the ER are eventually 
translocated to the cytoplasm for degradation(Van Kaer et al., 1992; Wiertz et al., 1996).
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Consequently, they are unable to present intracellular antigens on the cell surface(Hosken 
and Bevan, 1990; Spies et al., 1992). However, the peptide translocation assay and 
western blot did not provide any evidence of abnormality in the expression and function 
of TAP in CRT deficient cells (Fig. 4.4), which suggested that peptide supply from 
cytosol to the ER was unchanged in the absence of CRT. Taking all these findings into 
consideration, it is hypothesized that CRT plays a critical role in the enrichment of 
peptides in the ER for loading onto class I molecules, therefore maintaining a low peptide 
concentration threshold for efficient antigen presentation. If  CRT maintains a lower 
peptide concentration threshold for efficient antigen presentation, it is not surprising that 
while some epitopes cannot be presented by CRT deficient cells certain epitopes were 
still able to be properly processed and presented to corresponding T cells (Gao et al., 
2002). These presented epitopes could simply be more abundant or have a sufficiently 
high affinity for class I molecules so that they do not require enrichment by CRT. The 
efficiency of generation of a specific class I/peptide complex from a given antigen differs 
enormously between different antigens. It has been demonstrated that Listeria 
monocytogenes-infected macrophages generate about 10 class I/peptide complexes per 
100 lesteriolysin O proteins degraded, and three class I/peptide complexes per 100 p60 
proteins degraded(Villanueva et al., 1994). It is possible therefore that a higher efficiency 
in the number of class I/peptide complexes per degraded antigenic protein may result in a 
lesser dependency on CRT for enriching peptide concentration in the ER. Furthermore, 
the result that CRT maintains a lower peptide concentration threshold for efficient 
antigen presentation also provides a possible logical explanation as to why CRT could be 
used with peptides to invoke efficient anti-tumor immunity.
The involvement of CRT in the formation of peptide-receptive class I complex is well 
documented. When class I molecules are newly synthesised they associate with calnexin 
(Nossner and Parham, 1995; Degen and Williams, 1991; David et al., 1993), which in 
humans binds only to free HC(Rajagopalan and Brenner, 1994). Subsequently when HC 
binds P2M, CRT replaces calnexin. Mouse HCs can bind simultaneously to both calnexin 
and CRT whether expressed in human or mouse cells, reflecting extra glycosylation sites 
on mouse HC (in addition to position 86, mouse HCs are also glycosylated at Asnl76 for
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Kb and Asnl76/Asn256 for Db (Evans et al., 1982; Maloy and Coligan, 1982; Nathenson 
et al., 1981; Helenius and Aebi, 2001). In mouse cells calnexin binds preferentially to 
free HC in contrast with the association of CRT with MHC class I molecules which 
requires HC assembly with |32m (Nossner and Parham, 1995).Considering that CRT is 
not associated with HCs in a |32M deficient cell line (Sadasivan et al., 1996) and calnexin 
was found not to co-exist with properly folded class I molecules in human cells 
(Rajagopalan and Brenner, 1994), it has been suggested that CRT and |32M might 
replace calnexin to produce a peptide-receptive class I heterodimer. CRT might be 
required for (32M recruitment, and reduced surface class I expression in CRT deficient 
cell lines might be related to the failure in p2M recruitment. However, a pre-tethered 
class I (32M-HC dimer was unable to rescue impaired class I expression in CRT deficient 
cells, clearly demonstrating that CRT is not essential for the recruitment of (32M to 
associate with HC (Fig. 4.8).
Using semiquantitative western blot, the steady-state protein expression level of HCs in 
CRT deficient cells was found to be higher than that in CRT competent cells (Fig. 4.10). 
Although experimental conditions could affect the level of total HCs in CRT deficient 
cell lines detected by western blot, in this study all assay conditions were kept as 
consistent as possible and the amount of protein loaded was strictly controlled. MHC 
class I HC is a glycoprotein with two highly conserved disulfide bonds (a2  and cx3 
domains) (Oliver et al., 1999). It associates early during biosynthesis with calnexin(David 
et al., 1993; Degen and Williams, 1991; Degen et al., 1992) and with ERp57(Lindquist et 
al., 1998; Lindquist et al., 2001) to facilitate the folding of HC and stabilize it from 
aggregation as well as promote its assembly with |32m. ERp57 has been proposed to 
function as a ‘co-chaperone’ of CNX to modulate disulfide-bond isomerization of class I 
molecules and promote class I HC folding(Farmery et al., 2000; Molinari and Helenius, 
1999; High et al., 2000; Ellgaard and Helenius, 2001). It is possible, therefore, that the 
higher level of ERp57 in CRT deficient cells increases the folding efficiency of class I 
HC, which results in the accumulated class I HCs in cells. Additionally, Gao and 
colleagues have demonstrated that the total amount of Kb assembled with (32m was
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similar in CRT deficient K42 and CRT competent cells, and the peptide-receptive class I 
molecules released to the cell surface of K42 had the same affinity for the peptide ligand 
as they did in K41(Gao et al., 2002). Taken together, these results indicated that the 
empty or suboptimally loaded MHC class I molecules on the cell surface of CRT 
deficient cells were not related to the formation of peptide receptive class I heterodimer 
or its affinity for the peptide ligand.
CRT is an important molecular chaperone for glycoproteins in the ER. CRT together with 
calnexin and ERp57, constitute the “CRT/CNX cycle”, which is responsible for the 
folding, oligomeric assembly and quality control of newly synthesized glycoproteins, and 
helps to retain in the ER misfolded or incompletely assembled proteins, which are then 
targeted to the cytosol for degradation(Peterson et al., 1995; Wada et al., 1995). This 
quality control system works at a general level that is applied to nearly all proteins. 
Therefore, CRT is expected to take part in proper folding of members of PLC, such as 
calnexin, tapasin, TAP and ERp57. To assess the effect of loss of CRT on the presence 
and amount of these ER-localized chaperones and folding enzymes, semiquantitative 
western blot was used to study the steady-state protein expression level of these proteins. 
In these experiments, the amount of TAP (Fig. 4.4a), tapasin or calnexin expressed was 
not affected by the absence of CRT (Fig. 4.10). Although it is not possible to test the 
functionality of all these proteins translocation of peptides by TAP was normal in the 
absence of CRT (Fig. 4.4). Interestingly, there was about a 2-4 fold increase in the level 
of ERp57 in CRT deficient cells shown by western blot (Fig. 4.10) and confirmed by real 
time PCR (Fig. 4.11). It is well documented that CRT interacts with ERp57 to contribute 
to class I folding, for example, CRT forms one to one complexes with ERp57 to modulate 
MHC class I folding (Oliver et al., 1997). The tip of the arm-like P-domain o f CRT 
interacts with ERp57 allowing it to interact optimally with cysteines in the class I HC and 
catalyse the formation of two intra-chain disulfide bonds in MHC class I HC (a2 and a3 
domains) (Oliver et al., 1999). Stable association of MHC class I-heterodimers with CRT 
appears to be a prerequisite for their association with TAP via tapasin (Sadasivan et al., 
1996), and although some tapasin can bind to class I molecules in the absence of CRT, 
the majority of tapasin is unable to associate with class I molecules (Sadasivan et al.,
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1996). Since CRT, not calnexin, shows predominant association with the TAP complex, 
CRT could aid the stabilization and/or the ER retention of (32m-assembled H chains 
awaiting peptide(Harris et al., 1998). Indeed, since CRT binds to newly formed HC-|32M 
heterodimers, ERp57 and the TAP complex, it has been suggested that the binding of 
CRT to class I is likely to induce specific effects on the folding of polypeptide chain, 
which may help in mediating the association of class I with tapasin/TAP and ERp57 
complex(Sadasivan et al., 1996). CRT may act as an initial bridge between peptide free 
class I molecules and the PLC.
It is worth mentioning that Helenius and colleagues concluded that there was no 
significant increased ERp57 expression in CRT deficient mouse embryonic fibroblasts 
based on western blotting results(Molinari et al., 2004). However, the western blots 
shown in their study appeared to have an increase in the expression of ERp57 to at least 
the same level as BiP highlighted by the authors. Furthermore, enhanced ERp57 
expression might explain the observation that hemagglutinin was fully oxidized and six 
intramolecuelar disulfide bonds were formed more efficiently in CRT deficient cells than 
that in normal cells(Molinari et al., 2004). Addtionally, proteomic analysis of C. Elegans 
also indicated that there was a dramatic increase in expression of ERp57 in CRT deficient 
worms compared to that in wild type counterparts(Lee et al., 2006). ERp57 interacts with 
CRT and calnexin to assist in folding of N-glycosylated substrates(01iver et al., 1997; 
Zapun et al., 1998). Perhaps the association of ERp57 with CRT is important for the 
maturation of class I molecules, but whether the elevation o f ERp57 is a compensative 
measure for the defect in CRT deficient cells is not clear at this time. Both CRT and 
ERp57 have been demonstrated to maintain the integrity of the PLC. For example, in the 
absence of CRT, less MHC class I molecules were present in the PLC(Gao et al., 2002). 
Similarly, Garbi and colleagues have found that very few class I molecules were present 
in the loading complex of ERp57 deficient cells(Garbi et al., 2006). ERp57 is involved at 
different steps of the MHC class I pathway, first during biosynthesis and later as a 
component of the PLC. Less class I molecules in the loading complex of ERp57 deficient 
cells may be due to its effect on class I folding prior to the formation of PLC. They 
further quantified the total cellular pool o f MHC class I molecules and found that the
112
absence of ERp57 resulted in a decrease of 50-90% in total steady-state class I molecules. 
However, the reduction in the total cellular pool of MHC class I molecules did not 
correlate with the cell surface class I expression, indicating ERp57 functions to some 
extent within the loading complex. Taken together, both CRT and ERp57 seem to play an 
important role in stabilizing the PLC. It is therefore possible that the elevation o f ERp57 
is a compensative measure for the defect in CRT deficient cells. Alternatively, unfolded 
protein response may be activated due to aberrant proteins accumulated in the ER in the 
absence of CRT(Kaufman, 2002; Harding et al., 2002), which leads to the coordinated 
synthesis of ER-resident chaperones and enzymes(Mori, 2000), such as BiP(Molinari et 
al., 2004) and ERp57 (this study). Unfolded protein response could further point to the 
importance of CRT chaperone function in the maturation of newly synthesized proteins. 
This result also suggests that CRT and ERp57 may play closely related roles in the 
quality control of protein maturation, in this case MHC class I assembly. Finally, ERp57 
might be dedicated to the reduction o f exposed disulfide bonds in the class I molecules 
due to the incompletely folded or misfolded MHC class I in the absence of CRT. In this 
way, ERp57 may initiate retrotranslocation and degradation of misfolded class I 
molecules(Antoniou et al., 2002).
The results in this chapter show that the mechanism by which CRT lowers the peptide 
concentration threshold did not involve peptide supply, the expression of class I HC and 
its assembly with |32m, or the chaperone levels in the PLC. The other most likely 
possibility was impaired peptide loading in CRT deficient cells. To test this possibility, 
mouse class I Kb binding peptide SIINFEKL was directly delivered into the ER lumen. 
The cell surface SIINFFEKL:Kb complexes were then assessed by mAb 25-D1.16. 
Surprisingly, the results showed that ER targeted delivery of SIINFEKL rescued the 
surface class I expression on CRT deficient cells to the level seen on CRT competent 
cells (Fig 4.6). Thus, it is reasonable to conclude that CRT deficient cells do not have a 
global defect in intracellular peptide loading of SIINFEKL peptide after infection by 
vaccinia virus.
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Although peptide loading onto class I molecules within the PLC in the ER contributes to 
the large majority of class I/peptide complexes at the cell surface, some class I molecules, 
such as human leukocyte antigen-B (HLA-B) alleles, HLA-B13, B44 and B60, do not 
seem to use the PLC complex at all for peptide loading(Neisig et al., 1996). Wang et al 
have suggested that the newly synthesized MHC class I molecules can bind their specific 
peptide immediately after synthesis without the help of PLC as peptide loading onto class 
I molecules can occur in the presence or absence of MHC class I-TAP interactions when 
large amount of class I binding peptides are present in the ER(Paulsson and Wang, 2004). 
Further evidence for this comes from a study showing only a two fold decrease in surface 
class I expression even although there is very little recruitment of class I molecules into 
the PLC in ERp57 deficient cells(Garbi et al., 2006). Furthermore, Williams studied the 
optimization of HLA-B2705 in tapasin deficient .220 and tapasin-restored .220 cells and 
found there may be a route of peptide optimization without the need of TAP interaction. 
Additionally, utilizing the ER competition for TAP association between recombinant rat 
MHC class I allele RT1-Aa and endogenous class I allele RT1-AU in the rat C58 thymoma 
cell line, Powis and colleagues also demonstrated that the loading and optimization of 
peptide can occur without TAP association(Ford et al., 2004). Taken together, these 
findings imply that peptides can find their own MHC class I molecules outside the PLC 
with relatively efficient peptide loading onto MHC class I molecules.
It has been suggested that the dependency of class I molecules on tapasin or TAP/tapasin 
docking sites for peptide binding is inversely correlated with the size of respective 
peptide pool capable of binding to class I molecules(Suh et al., 1996; Neisig et al., 1998; 
Peh et al., 1998). Further evidence exists that the failure of the loading complex to load 
peptides onto MHC class I molecules can be overcome by increasing peptide 
concentration in the ER(Lybarger et al., 2001). It is also a formal possibility that an 
increased concentration of peptide in the ER expressed by vaccinia viruses could 
compensate for the defect in peptide loading. This was supported by work from several 
independent studies. For example, in tapasin deficient .220 cells, class I is not associated 
with TAP. TAP dependent peptide loading is defective in these cells leading to reduced 
surface class I expression. This defect can be rescued by direct delivery of peptide into
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the ER by vaccinia virus. Likewise, a non-conservative point mutation at position 134 of 
the HLA-A2 HC (A2T134K) renders A2 molecules unable to bind tapasin, TAP and 
CRT. As a result, A2T134K/p2m complexes are rapidly exported to the cell surface in an 
unstable, peptide-receptive form. The defect of T134K in endogenous antigen 
presentation can also be overcome by direct delivery of peptide to the ER using an ER 
signal sequence(Peace-Brewer et al., 1996; Lewis et al., 1996; Lewis and Elliott, 1998). 
Although cell surface class I expression on K42 was restored when class I binding 
peptide was delivered to the ER in a TAP-independent manner, the possibility that the 
peptide optimisation process is impaired and class I molecules are unable to enrich high 
affinity peptides for loading in CRT deficient cells still cannot excluded.
Wang et al have proposed the following scenario for MHC class I maturation. Shortly 
after the newly synthesized HC binds to |32m, a peptide will occupy the peptide binding 
groove(Neefjes et al., 1993). Peptide loading can occur in the presence or absence of 
class I-TAP interaction(Paulsson and Wang, 2004). If the peptide is of high affinity, the 
trimeric complex will be transported to the cell surface(Spiliotis et al., 2000). On the 
other hand, if the class I receives low-affinity peptide, further action of ER chaperones is 
required. If the suboptimally loaded class I molecules are able to interact with tapasin, 
they will not exit the ER as unstable complexes but instead incorporated into PLC to 
optimize the peptide cargo by exchanging low affinity peptide for high-affinity 
peptide(Ortmann et al., 1997; Cresswell et al., 1999). Loading of high-affinity peptide 
dissociates the class I molecules from the PLC and then exits the ER, and traffics to the 
cell surface(Pentcheva and Edidin, 2001). If the suboptimally loaded class I molecules 
are unable to interact with tapasin, they will exit the ER followed by either immediate 
degradation or short-term expression at the cell surface, then followed by endocytosis and 
degradation(Paulsson et al., 2001).
On the basis of above analysis, I favour the following hypothesis. When high-affinity 
SIINFEKL peptide was targeted to the ER of CRT deficient cells and over-expressed by 
the vaccinia virus systems used, the newly formed HC-|3m heterodimers will bind the 
SIINFEKL peptide even in the absence of MHC class I-TAP interaction. TAP association
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with class I molecules is not essential for loading peptides as peptides targeted to the ER 
associate with class I molecules in TAP-deficient cells(Henderson et al., 1992; Wei and 
Cresswell, 1992; Anderson et al., 1991). However, under normal cellular conditions when 
peptides are generally present in quantities that are low, loading of MHC class I with 
stable peptides requires a fully competent loading complex where TAP, tapasin, CRT, 
ERp57 and class I molecules all interact with one another(Tan et al., 2002). In CRT 
deficient cells, class I does not interact well with tapasin and TAP in the absence of CRT 
interactions with class I(Turnquist et al., 2002), leading to lower incorporation of class I 
molecules into the mature loading complex in CRT deficient K42(Gao et al., 2002). The 
empty or suboptimally loaded class I molecules that are unable to interact with tapasin 
are exported in an unstable state and fall apart en route to the cell surface or at the cell 
surface, resulting in the reduced cell surface levels of MHC class I on CRT deficient 
cells. On the base of this analysis, CRT would facilitate the class I association with PLC 
either by recruiting MHC class I into the loading complex or by stabilizing the interaction 
between class I and tapasin-TAP complex. By doing so, CRT maintains the low peptide 
concentration threshold required in the ER for efficient antigen presentation.
CRT is important in the assembly of MHC class I molecules by promoting correct folding 
(Culina et al., 2004) and by inhibiting aggregation of newly synthesised class I 
molecules(Mancino et al., 2002). CRT possibly also plays a more important role in 
regulating the release of class I from the PLC and exit to the cell surface, and this 
mechanism may be important for proper control of peptide loading (Williams et al., 
2002a). CRT, like calnexin, only associates with monoglucosylated class I molecules and 
it has been suggested that this interaction could control the release of class I molecules 
from the PLC. When class I molecules are properly folded, the terminal glucose is 
removed by glucosidase-II and this disrupts the interaction between class I and CRT and 
could lead to the dissociation of CRT-class I-TAP complexes (van Leeuwen and Kearse, 
1996a). Glucosidase II and UDP-glucose glycoprotein glucosyltransferase, two ER 
proteins might distinguish whether MHC class I is loaded with peptide or empty, while 
CRT modulates the interaction of class I and the PLC (Sadasivan et al., 1996). If  class I 
molecules are not properly folded or not loaded with peptide they will be sensed by UDP-
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Glucose glycoprotein glucosyltransferase (GT) and the terminal glucose is then added 
back onto unloaded class I molecules by GT. In this way, the association of class I 
molecule with CRT is restored, and unloaded or suboptimally loaded class I returned to 
the PLC to further optimize its peptide cargo(Wright et al., 2004). This hypothesis is also 
supported by the observation of fast trafficking and incomplete peptide loading of class I 
molecules in both CRT deficient cells(Gao et al., 2002) and the T134K mutant in which 
the association of class I molecules with CRT is disrupted (Lewis et al., 1996; Peace- 
Brewer et al., 1996). Lewis et al have suggested that the optimization of peptide loading 
onto class I complexes may be linked to their retention time in the ER. They tested this 
idea by incubating the cells expressing T134K molecules in the presence of the drug 
brefeldin A (BFA), which promotes the retention of newly synthesized class I in the ER. 
They found that the fraction of stable T134K molecules increased dramatically and they 
proposed that ER retention alone may facilitate the assembly of class I molecules with 
optimal peptides(Lewis and Elliott, 1998). CRT may therefore aid the retention of the 
empty or suboptimally loaded class I complexes in the ER for peptide 
optimization(Elliott and Williams, 2005). In this way CRT lowers the ER peptide 
concentration needed for antigen presentation.
One further property of CRT is its ability to bind to peptides transported into the ER by 
TAP (Spee and Neefjes, 1997). This binding can be enhanced under the condition of cell 
stress (Rizvi et al., 2004). Peptides of free form probably do not exist in the ER as they 
are degraded very quickly by ER peptidases unless they are protected, most likely by 
their association with chaperones, such as CRT(Paz et al., 1999; Spee and N e e f j e s ,  1997; 
Basu and Srivastava, 1999; Reits et al., 2003). As a component o f the PLC, CRT might 
be able to bring peptides into the proximity of class I molecules and facilitate their 
loading. CRT chaperoned peptides would also remain in the ER longer to increase the 
chances o f loading onto MHC class I molecules. In this way CRT may help to increase 
the efficiency of peptide loading and lower the concentration of peptides required for 
proper antigen presentation.
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CRT is an ER resident protein, but has been observed elsewhere, such as on the cell 
surface (Arosa et al., 1999; Wiest et al., 1997). It can not be excluded therefore that CRT, 
like some other members of heat shock protein family, could bind to peptides in the 
cytosol and enrich them for further processing. It would be interesting to deliver 
extended peptides containing a specific epitope to the cytosol to investigate whether there 
is a difference in epitope presentation between CRT deficient cells and wild type cells.
Facilitating peptide loading onto the class I complex and chaperoning peptide might also 
be a mechanism for the adjuvant property of CRT. A study done by Binder and 
colleagues showed that CRT associated with peptide in the ER, acted as a nonspecific 
adjuvant. Peptides chaperoned by CRT or other Hsps were a necessary and sufficient 
source of antigen for transfer to APCs for priming CTL response(Binder and Srivastava, 
2005). Although a direct need for chaperones in peptide delivery to MHC class I 
molecules in the ER has not been uncovered, various peptide-chaperone complexes have 
been tested in tumor vaccines with some success. They are apparently able to deliver 
peptides to class I molecules through a process called cross-presentation(Srivastava, 
2002; Singh-Jasuja et al., 2000; Tamura et al., 1997). In vitro incubation of such CRT- 
antigenic peptide complexes with APCs allows cross-presentation of the peptide to CTLs. 
The immunogenicity of the CRT-peptide complexes is attributed to the peptide 
chaperoned by the CRT molecule(Basu and Srivastava, 1999; Nair et al., 1999).
In the absence of CRT, there were still a substantial amount of class I molecules recruited 
into the PLC. CRT deficient cells were able to present cytosolically-derived peptides at 
the cell surface for recognition by T cells, albeit with reduced efficiency. As discussed 
earlier, however, the interaction of CRT with HC has been demonstrated to be a 
prerequisite for the association of class I with TAP via tapasin. For example, the drug 
castanospermine, which prevents the generation of the specific ligand recognized by CRT 
and CNX, has been shown to inhibit the interaction between MHC class I molecules and 
TAP(Sadasivan et al., 1996). Additionally, Harris et al showed that the mutation of the 
amino acid at position 86 alters the Asn-linked glycosylation site, and leads to PLC
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disruption through poor CRT association(Harris et al., 1998; Harris et al., 2001). This, 
therefore, leads us to consider that there may exist a redundent chaperone with roles like 
CRT in mediating MHC class I mediated antigen presentation in CRT deficient K42 
cells.
In general, the ER contains a powerful and redundant system with chaperones able to 
substitute for each other and cooperate in different ways to assist protein folding and 
assembly. For example, in a cell line that lacked calnexin, the class I HC was able to 
assemble with (32m, associate with TAP/tapasin complex, receive peptide, and exit the 
ER normally(Sadasivan et al., 1995; Scott and Dawson, 1995; Prasad et al., 1998). 
Accordingly, it has been proposed that there is redundancy in the ER and that other 
chaperones can perform the same function as CNX in its absence. Immunoglobulin 
binding protein (BiP) has been suggested to be a possible candidate as BiP has been 
shown to associate with free human class I HC alleles in (32m"7" cells and its expression is 
upregulated in calnexin deficient cells(Paulsson et al., 2001). CRT, which has homology 
in some domains to calnexin and shares lectin-like activity with it(Michalak et al., 1992; 
Peterson et al., 1995), is another candidate for adopting some of the functions performed 
calnexin. Chaperone redundancy may account for the lack o f any observed effect of 
calnexin absence on class I assembly, transport and surface expression in calnexin 
deficient cells. The “backup” mechanisms existing within the ER quality control system 
assures the correct folding and assembly of MHC class I molecules in cells without 
calnexin.
Due to the similarity in glycan binding specificity and overall structure, CRT and 
calnexin have been proposed to have redundant activities. When one was absent, binding 
of substrate glycoproteins to the other increased. A dramatic loss of stringency in the ER 
quality control is only observed when substrate access to both CRT and calnexin is 
prevented(Molinari et al., 2004). The most likely redundant protein carrying out the 
chaperone function of CRT in CRT deficient cells is therefore calnexin. Calnexin has 
been shown to interact with the glycan moities on the class I HC and assists the assembly
119
of class I molecules(David et al., 1993; Degen and Williams, 1991; Degen et al., 1992; 
Hochstenbach et a l, 1992). In addition, CNX has been detected in complexes with 
mouse class I HC-|32m dimers(Degen et al., 1992; Jackson et al., 1994). Furthermore, 
calnexin has been found to be part of PLC in K42 cells(Gao et al., 2002). Accordingly, it 
has been suggested that calnexin and CRT have redundent functions in the assembly and 
expression of MHC class I molecules(Danilczyk et al., 2000; Sadasivan et al., 1995; 
Solheim et al., 1997). Calnexin, like its luminal homologue CRT, possesses a proline rich 
central P domain, which has been shown to bind to ERp57(Leach et al., 2002) and has 
been identified to be the lectin site of CRT capable of binding oligosaccharide(Vassilakos 
et al., 1998). One possible model to account for the phenotype of CRT deficient K42 cells 
is that calnexin, interacting with both class I molecules and ERp57, may act like CRT to 
assist the formation of PLC and modulate the peptide loading. This could explain why 
MHC class I molecules are still incorperated into the PLC of CRT deficient cells, loaded 
with cytosolically-derived peptides, and presented them at the cell surface for recognition 
by T cells(Gao et al., 2002). Nonetheless, it is possible that calnexin is not as competent 
as CRT in assisting the formation of PLC, providing quality control of class I folding and 
recycling, and facilitating peptide loading onto class I through its capacity of peptide 
binding. Accordingly, CRT deficient K42 cells have impaired assembly, suboptimal 
peptide loading, and reduced cell surface expression of class I molecules.
In summary, CRT is an important molecule for maintaining a lower threshold of peptides 
in ER and efficient antigen presentation. Possible mechanisms by which CRT achieves 
this role would be to assist the formation of PLC; to provide quality control of class I 
folding and recycling; and/or to facilitate peptide loading onto class I through its capacity 
of peptide binding, or a combination of these three activities.
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Chapter 5 Investigating the domain functions of CRT in 
MHC class I antigen presentation
5.1 Introduction
Peptide loading onto class I HC-p2microglobulin heterodimers is critical for both the 
structural stability and the function o f MHC class I molecules and is assisted by the 
PLC(Cresswell et al., 1999). Structurally, CRT is an important member o f the PLC and 
seems to play a central role in the formation of the PLC by interacting with other 
component o f the complex. CRT associates with MHC class I after HC is assembled with 
p2m, and the association o f CRT with MHC I is not dependent on either TAP or tapasin, 
but appears to be a prerequisite for the association o f class I with TAP via 
tapasin(Sadasivan et al., 1996; Solheim et al., 1997; Harris et al., 1998; Turnquist et al., 
2002). Disrupting the CRT interaction with class I HC by either mutation o f the residue at 
position 86 to alter the Asn-linked glycosylation site(Harris et al., 1998; Harris et al., 
2001; Turnquist et al., 2002), or using the drug castanospermine to block the action of 
glucosidase I and II to prevent the generation o f the monoglucosyl-glycan recognized by 
CRT has been shown to cause PLC disruption through poor association with class 
I(Sadasivan et al., 1996; Elbein, 1991; Harris et al., 1998; Harris et al., 2001). 
Furthermore, Gao et al. have found that less class I molecules were incorporated into the 
PLC in the absence o f CRT(Gao et al., 2002). In addition to its association with class I 
HC, CRT has been found to interact with ERp57 through the tip o f its P-domain(Frickel 
et al., 2002; Leach et al., 2002). It was suggested that CRT recruits ERp57 providing an 
'‘attachment” site for this enzyme to chaperone (disulfide bond formation) newly 
synthesised glycoproteins. ERp57 chaperone activity is greatly increased when 
complexed with CRT(Zapun et al., 1998).
Functionally, CRT has been suggested to stabilize and retain the HC-p2m heterodimer in 
the ER until the antigenic peptide is loaded(Harris et al., 1998). Studies have shown that 
CRT preferentially binds to open conformations o f MHC class I and does not associate 
with the class I after peptide-induced folding(Harris et al., 1998; Sadasivan et al., 1996).
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Furthermore, CRT deficient cells have reduced cell surface class I expression and fail to 
present the majority o f epitopes tested to specific T cells, which suggests that CRT is 
critical for MHC class I assembly and its subsequent antigen presentation(Gao et al., 
2002). In chapter 4, it was shown that higher concentration o f antigen in the cytosol is 
required for specific T cell stim ulation in CRT deficient cells than in CRT competent 
cells, whereas TAP function and protein expression level was the same. It was proposed 
that CRT functions to maintain the low peptide concentration threshold required in the 
ER for efficient antigen presentation.
To learn more about how CRT contributes to MHC class I antigen presentation and how 
the function o f CRT relates to its structure, full length CRT or one o f three structurally 
and functionally distinct domains, N-domain, the central P-domain. and the C-domain, 
were introduced into both CRT deficient cells (K42) and CRT competent cells (K41) to 
examine the role o f CRT and its truncated forms in the formation of the PLC and MHC 
class I antigen presentation. An assessment was also made on the effect o f such 
expression on cellular functions, such as peptide loading, TAP function, and expression 
o f other members o f PLC, and the possible underlying mechanisms.
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5.2 Results
5.2.1 Generation of stable cell lines expressing CRT and its 
fragments
5.2.1.1 C onstructs design
To further dissect the role o f calreticulin in MHC class I antigen processing, different 
fragments o f human calreticulin w ith functional domains (Fig. 5.1a) were cloned into a 
mammalian cell expression vector along with a full length o f CRT as control. Human 
CRT was chosen because CRT is a highly conserved protein, with the nucleotide 
sequences o f the human and mouse genes showing greater than 70% identity, and 95% 
amino acid identity' existing between human and mouse forms o f protein with only one 
amino acid difference in P-domain between human and mouse type CRT (Appendix). In 
order to maintain CRT fragments in the ER, the genes were cloned into a vector with 
built-in ER leader and retention signals. For the convenience o f detection, a myc 
sequence was attached to the C-terminal o f each fragments before the stop codon. A two- 
step strategy o f cloning was adopted: first, PCR products o f each fragment were cloned 
into a TOPO vector and then they were subcloned into the vector containing both ER 
leader sequence and retrieval signal. The genes encoding full length human CRT and its 
P, PC and NP domains were am plified by PCR using appropriate primers (listed in 
materials and methods) with 5 ’ flanking Pst I and 3’ flanking Not I restriction sites (Fig.
5.1 b). Then the PCR products were separated in an agarose gel and the PCR band was 
gel-extracted and cloned into the polylinker o f the pcDNA3.1 TOPO TA vector (Fig. 
5.2). Next, the Pst I/Not I cDNA fragment, containing cDNA encoding full-length human 
CRT or different fragments o f calreticulin, were excised from TOPO TA vector and 
inserted into the Pst I/Not I restriction sites o f pEF/myc/ER vector to generate 
pEF/myc/ER-P, pEF/myc/ER-PC, pEF/myc/ER-NP and pEF/myc/ER-CRT (Fig. 5.3). 
The sequences o f all constructs were confirmed by sequencing.
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Leading N domain P domain
signal 1-180
residues
180-280
residues
C domain Retention
280-400 Signal 
residues
NP domain
PC domain
P domain
b
600 bp
P PC NP Full 
Fig. 5.1: PCR CRT and its P, PC, NP fragments
a: Schematic representation of full length calreticulin and its NP, PC, P fragments used 
in this study.
b: Genes were successfully amplified from plasmids containing calreticulin cDNA as 
outlined in Table 4.2 by PCR. PCR products were run on 1% Agarose gels and stained 
with ethidium bromide (EtBr) and photographed on a UV transilluminator. P is the P- 
domain fragment and its size is 330 bp. PC is the fragment with P and C domains of 
calreticulin and the size is 645 bp. Similarly, NP represents N and P domains of 
calreticulin and the size is 922 bp. The size of full CRT gene is 1237 bp. The DNA ladder 
is a 100 bp ladder (Invitrogen).
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3 kb 
2Kb  
1.5Kb 
1Kb
0.5 Kb
P PC NP Full
Fig. 5.2: TOPO TA cloning of CRT and its three fragments
Successfully TOPO cloned plasmids were purified and digested with restriction enzymes 
PstI and Notl to release the cloned insert. The released insert of the individual clone 
corresponded to the size expected for the gene of interest. The right hand lane is a 1 Kb 
DNA ladder from New England, Biolab.
P PC NP Full
Fig. 5.3: Cloning of CRT and its three fragments into pEF/myc/ER
The pEF/myc/ER-P, pEF/myc/ER-PC, pEF/myc/ER-NP, pEF/myc/ER-CRT vectors were 
digested with restriction enzymes Pstl/Notl. The expected sizes have been observed for all 
cloned genes. The right lane is a 1 Kb DNA ladder from New England, Biolab.
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5.2.1.2 Expression o f CRT and its fragm ents in both K41 and K42 cells
The Calreticulin-deficient cell line-K42 and its wild type cell line-K41 were transfected 
with individual pEF/myc/ER expression vectors containing cDNAs encoding the full- 
length human CRT or its P, PC and NP domains using a Lipofectamine based transfection 
kit (Invitrogen). To verify that the full-length and P, PC, NP domains of CRT expressed 
with this vector would be directed to the ER, K42 and K41 cells were transfected with 
GFP expression control vector pEF/myc/ER-GFP and the expression pattern of GFP was 
analysed by immunofluorescence confocal microscopy. An ER-distribution fluorescence 
pattern was observed in these cells (Fig. 5.4), suggesting the recombinant CRT and its 
domains would be targeted correctly to the ER of K42 and K41 cells.
To establish stable lines for individual transfectants, G418 was added to the medium of 
cells transfected with vector containing the G418 resistant gene. Since both cell lines 
came from a G418 resistant background, a very high concentration of drug was necessary 
for selecting stable transfected cell line. 6mg/ml G418 was used for selection. The 
expression of myc tagged CRT and its domains in transfected K42 and K41 cells were 
first confirmed by western blot using anti-myc antibody against the c-myc epitope. 
Positive clones expressing CRT and its P, PC and NP domains were obtained with both 
K42 (Fig. 5.5a) and K41 cells (Fig. 5.5b). Results showed that the anti-myc antibody 
reacted with a 60 kDa protein in lysates of full-length CRT transfected k42 and K41 cells 
confirming the expression of full-length CRT. The anti-myc antibody reacted with a 30 
kDa protein in lysates of P domain transfectants and with a 45kDa protein in lysates of 
PC, NP transfectants demonstrating the expression of myc tagged P, PC and NP domains 
of CRT in these cells.
The cell lysates were further analysed by Western blot using an anti-CRT monoclonal 
antibody specific for human CRT. This antibody reacted with a 60 kDa protein in full- 
length CRT transfected cells and a 45 kDa protein in NP domain transfected cells (Fig.
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5.5c) but not P and PC encoding products. This suggests that the monoclonal antibody is 
N-domain specific.
For simplicity, stably transfected K42 and K41 cell lines expressing full length human 
CRT and its P, PC, NP domains will be referred to as K42-CRT, K42-P, K42-PC and 
K42-NP, and K41-CRT, K41-P, K41-PC and K41-NP respectively. To make sure that all 
stable cell lines were genuinely calreticulin positive (K41) or negative (K42), western 
blots for mouse native CRT was also performed on these eight positive colones. K41 cells 
and the four K41 clones expressing recombinant CRT and its domains were confirmed as 
CRT positive, while K42 cells and K42 clones expressing recombinant CRT and its 
domains were confirmed as CRT deficient in Fig. 5.5 d and e.
Phase contrast analysis of K41, K42 and P, PC and NP domain of CRT transfected K42 
cells revealed that the morphological appearance of the wild-type (K41) and calreticulin- 
deficient (K42) cells is indistinguishable and typical of fibroblasts. The cell lines all 
attached firmly to plastic although K42 cells grew a bit slower than K41 cells.
The morphological appearance o f P, PC and NP domain transfected K42 cells is different 
from that o f the wild-type (K41) and calreticulin-deficient (K42) cells. The K42 cells 
expressing CRT fragments but not full length CRT were more rounder than K41, K42 
cells (Fig. 5.6). The reasons for morphological difference require further investigation.
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Fig. 5.4 ER distribution of GFP expressed using pEF/myc/ER/GFP vector
K42 (upper panel) and K41 cells (lower panel) were transfected with expression vectors 
encoding GFP with the same vector (pEF/myc/ER) used for the expression of P, PC, NP, 
andfull length CRT.
Left panel: low magnification of fluorescence microscopy (10X)
Middle panel: high magnification of fluorescence microscopy (100X)
Right panel: confocal microscopy
Intracellular location of recombinant CRT analysed by immunofluorescence microscopy 
revealed a reticular, perinuclear pattern characteristic of ER.
128
P PC NP CRT
-60kDa 
■45 kDa 
-30kDa
-60kDa 
-45 kDa 
-30kDa
-60kDa 
“45 kDa
K41 K42
CNX
CRT
6 0  k D a
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Fig. 5.5 Establishment of cell lines expressing full-length recom binant CRT and its 
fragm ents
The calreticulin deficient cell line K42 and its wild type counterpart K41 cells were 
transfected with human calreticulin and its P, PC, NP domains cloned into a vector with 
both ER leader sequence and retention signal. Cells were lysed in 1% Triton X-100, and 
the lysates were separated by 12.5% SDS-PAGE, transferred to nitrocellulose 
membrane, and probed with anti-myc monoclonal antibody (a and b), anti-calreticulin 
monoclonal antibody from Stressgen (c), and a rabbit anti-calreticulin antibody (d and 
e), which recognizes only native CRT, not recomninant CRT.
Western blot with anti-myc mAb confirms transfection of P, PC, NP and full length CRT 
into K42 (a) and K41 (b) cells. Anticalreticulin antibody (Stressgen) can only recognize 
the NP and full length CRT, not the P and PC fragments (c)
K41 cells and its clones expressed mouse native calreticulin. There was no expression o f  
native calreticulin in K42 cells and its clones as expected (d and e).
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Fig. 5.6 Phase contrast morphological observation of K42 and its transfectants
The morphological appearance of the wild-type (K41) and calreticulin-deficient (K42) 
cells is indistinguishable and typical of fibroblasts. The cell lines all attached firmly to 
plastic.
The morphological appearance of of P, PC and NP domain of CRT transfected K42 cells 
is different from that of the wild-type (K41) and calreticulin-deficient (K42) cells. The 
cells o f CRT fragments K42 transfectants are more round than K41 and K42 cells.
5.2.2 Cell-surface class I expression is reduced by truncated CRT, 
while full-length CRT corrects the class I expression defect in K42 
(CRT-/-) cells
To determine the effect of recombinant CRT and its P, PC, NP fragments on MHC class I 
antigen presentation, cell-surface expression of mouse class I (H-2Kfc) on transfected K42 
(CRT-/-) cells was investigated. H-2Kb expression was detected with Y3, a conformation 
dependent monoclonal antibody (mAb) recognizing H-2K*. The results demonstrated that 
expression of full length human CRT completely restored the surface MHC class I 
expression in CRT deficient K42 cells to the level seen in CRT competent K41 cells, 
whereas, the introduction of P, PC, and NP fragments of CRT into the ER of cells 
without CRT further reduced surface expression of MHC class I (Fig. 5.7, left panel).
These results raised the question whether the individual fragments had a major impact on 
class I synthesis and folding or caused some other damage to the CRT deficient cells, 
which lead to down-regulation of surface class I expression. If this is the case, the 
truncated CRT would be expected to cause the same reduction of MHC class I expression 
in calreticulin positive cells. Therefore, the cell surface MHC class I expression of CRT 
competent K41 cells transfected with full length and truncated CRT was also examined 
by mAb Y3. Surprisingly, the surface class I expression in all K41 (CRT+/+) 
transfectants was found at the same as that of parental K41 cells (Fig. 5.7, right panel).
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Fig. 5.7 Down regulation of M HC class I moleucules by truncated CRT in the 
absence of calreticulin
K42 and K41 cells were transefcted with full length CRT and its P, PC, NP fragments 
and assigned as K42-P, K42-PC, K42-NP, K42-CRT and K41-P, K41-PC, K41-NP, K41- 
CRT. Cell-surface expression o f K6 was detected with mAb anti H-2Kb(Y3) and PE
132
conjugated sheep anti-mouse IgG (solid line). The shaded peak indicates the staining 
with secondary PE-conjugated sheep anti-mouse IgG alone, 
a-d: CRT and CRTfragment transfected K42 cells.
The MHC Class I on CRT P domain (a), PC domain (b) and NP domain (c) transfected 
K42 cells are downregulated compared with the MHC Class I level on K42 cells. But full 
length human CRT restored MHC Class I surface expression to the same level as K41 
cells (d).
e-h: CRT and CRT fragment transfected K41 cells.
All K41 transfectants (thin line) show the same surface expression level o f MHC class I 
as that o f  K41 (thick line).
5.2.3 Decreased class I cell surface expression of K42 (CRT-/-) cells 
transfected with truncated CRT due to increased empty or sub- 
optimally loaded class I
Work presented in Chapter 4 showed that K42 (CRT-/-) cells exhibited a TAP deficient 
phenotype. That is the low surface expression of MHC class I is caused by empty or sub- 
optimally loaded class I molecules, which are not stable at physiological 
temperature(Ortiz-Navarrete and Hammerling, 1991; Neefjes et al., 1992), but can be 
rescued by either incubation with exogenous class I binding peptide(Townsend and 
Bodmer, 1989; Cerundolo et al., 1990; Schumacher et al., 1990) or incubation at low 
temperature (Ljunggren et al., 1990; De Silva et al., 1999). It was hypothesised that the 
down-regulation of class I at the surface of K42 (CRT-/-) transfected with truncated CRT 
is due to more empty or sub-optimally loaded class I molecules compared with parental 
K42 (CRT-/-) cells. To test this idea the cells were pulsed with chemically synthesised 
mouse class I H-2Kb-high-affinity binding peptide- SIINFEKL and the extent to which 
cell surface H-2Kb molecules could be occupied by this immunodominant - H-2Kb 
binding peptide was analysed by staining for cell surface H-2Kb with a conformation- 
dependent class I antibody Y3. The results in Fig. 5.8 showed that the expression level of 
surface MHC class I on CRT fragment K42 transfectants all increased. However, there 
was only a slight increase in surface expression of class I on K42-CRT cells indicating
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that most of the surface class I molecules on this cell line were already loaded with high- 
affinity peptides. Thus, the H-2Kb molecules on the surface of truncated CRT transfected 
K42 were much more receptive to exogenous peptide than those on the surface of full 
length CRT-reconstituted K42. By contrast, there was no change of MHC class I 
expression level on the cells pulsed with irrelevant control peptide GILGFVFTL, which 
confirmed that the restoration of surface class I was peptide specific. The marked 
receptivity of H-2Kb molecules expressed on truncated CRT transfected K42 cells 
suggested that these molecules were empty or complexed with suboptimal peptides easily 
exchanged for the high-affinity SIINFEKL determinant(Chen et al., 1994). These results 
suggest that most MHC class I molecules in K42-P, K42-PC and K42-NP cells are empty 
sub-optimally loaded class I molecules, which would fall apart either at the cell surface or 
en route to the cell surface unless they encounter exogenous peptides to which they can 
bind.
A prediction from the above conclusion is that suboptimal peptide ligands would 
dissociate rapidly at 37 °C, but can be stabilized at 26°C. To this end, the cells were 
incubated overnight at either 26 °C or 37 °C and the surface class I expression was 
assayed by flow cytometry analysis with mAb Y3. As shown in Fig. 5.9, the surface class 
I expression of K42-P, K42-PC and K42-NP cells cultured at 26 °C dramatically 
increased compared with that of cells incubated at 37 °C. In contrast, the same class I 
expression level can be seen on K42-CRT cells cultured at either 26 °C or 37 °C. Here 
TAP deficient RMA-S and TAP competent RMA cells were used as an experiment 
control as it has been previously demonstrated that the majority of class I molecules at the 
surface of RMA-S cells were empty due to peptides shortage in the ER, and these empty 
class I could be stabilized and expressed on the cell surface at 26 °C(Ljunggren et al., 
1990; De Silva et al., 1999). Based on these data, it can be concluded that the reduction in 
the surface class I expression of K42-P, K42-PC and K42-NP was caused by high levels 
of empty or sub-optimally loaded class I molecules.
In order to further show whether the MHC class I molecules expressed on K42-P cultured 
at 26°C were truly empty or sub-optimally loaded class I molecules, two flasks of K42-P
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were cultured at 26°C and one flask at 37°C for 24 h. Then one flask of K42-P cultured at 
26°C were transferred to 37°C incubator and cultured for further 5 min. Then all the cells 
were stained by mAb Y3 and analyzed by flow cytometry. Fig. 5.10 showed that the 
amount of class I molecules expressed by K42-P cells cultured first at 26°C then 37°C 
was lower than that of cells incubated at 26°C, but still higher than that of cells cultured 
at 37°C, which further indicated that the MHC class I molecules expressed on the surface 
of K42-P cultured at 26°C were indeed suboptimally loaded MHC class I molecules, 
which dissociated rapidly at the cell surface when temperature was returned to 37 °C.
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Fig. 5.8 Incubation with exogenous peptide increased surface class I expression
Cells were pulsed with H-2Kb binding peptide SIINFEKL (thick line), with flu peptide 
GILGFVFTL (thin line) as control. After washing away free peptides, cells were stained 
by Y3 antibody and analysed by flow  cytometry.
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Fig. 5.9 Empty c la ss  I c o m e s  out in the cold
Cells cultured at 26°C (thick line) and 37°C (thin line) were evaluated by flow cytometry 
using mAb Y3. Shaded areas indicate second antibody only. Results shown are 
representative o f  three independent experiments.
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Fig. 5.10 Unstable MHC class I molecules were degraded at 37°C
K42-P cells were cultured at 26°C (thick black line) or 37°C (thin line) with 5% C 02 for 24 h. One flask o f  
K42-P cultured at 26°C were then transferred to 37°C incubator and cultured for further 5 min (thick grey 
line). Then all the cells were stained by mAb Y3 (recognize H-2Kb) and analyzed by flow cytometry. 
Shaded areas indicate second antibody only.
5 .2 .4  Normal TAP fu n c t io n  in tru n cated  CRT tr a n s fe c te d  K42 (CRT-/-) 
c e l l s
Peptide supply to the ER can regulate cell surface expression of class I. Virally induced 
inhibition of TAP function decreases class I surface expression(Fruh et al., 1995; Lehner 
et al., 1997), while increased TAP levels can increase it(Russ et al., 1995). It is possible 
that the increased empty or sub-optimally loaded class I molecules in K42-P, K42-PC and 
K42-NP cells might be due to peptide supply in the ER caused by dysfunction of TAP 
either at the protein level or at the functional level. CRT is an important molecular 
chaperone and plays a critical role in the folding, oligomeric assembly and quality control 
of newly synthesized gIycoproteins(Peterson et al., 1995; Wada et al., 1995). Moreover,
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although the N domain and P domain of CRT are responsible for its chaperone 
function(Nakamura et al., 2001b), studies suggest that the chaperone function of N and P 
domains are modulated by Ca2+ binding to the C-domain of CRT(Corbett et al., 1999; 
Corbett et al., 2000; Lodish and Kong, 1990; Lodish et al., 1992; Booth and Koch, 1989). 
Without the support of other domains, individual CRT fragments might not perform their 
chaperone function properly, leading to misfolded or misassembled proteins, which are 
eventually targeted into the cytoplasm for degradation. To this end, the steady-state 
protein expression level of TAP was assessed by western blot analysis using serial 
dilution of the cell lysates of K42 (CRT-/-) and its transfectants. Fig. 5.12 showed that the 
band intensity at each dilution level for truncated CRT transfected K42 (CRT-/-) and 
parental K42 (CRT-/-) cells was the same, demonstrating that there was no difference in 
the protein expression level of TAP between K42 transfectants and its parental cells.
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Fig. 5.11 TAP function is norm al in truncated CRT transfected K42 cells
Cells were permeabilized and incubated with FITC-labelled peptide (RRYQNSTEL), 
which were subsequently transported by TAP from cytosol into the lumen o f ER, where 
the peptides were glycosylated. Cells were then lysed, and glycosylated peptides bound 
to Con-A beads were eluted. The fluorescent intensity o f  FITC labelled RRYQNSTEL 
was quantified using a fluorescence spectrometer as described in material and methods. 
Data are presented as the percentage o f peptides transported and shown as means ±SD 
o f three independent experiments.
Next, a peptide transport assay was carried out to compare TAP function in K42-P, K42- 
PC and K42-NP with that of parental K42 (CRT-/-) cells. Cells were permeabilized with 
streptolysin O, then incubated with FITC labelled peptide RRYQNSTEL containing an 
N-linked glycosylation motif. In the presence of functional TAP, the peptide was 
translocated into the ER, where it is glycosylated and can be recovered by binding to 
concanavalin A-Sepharose beads(Neefjes et al., 1993). The fluorescent intensity of eluted 
peptide from concanavalin A beads were quantitatively analysed by fluorescence 
spectrometer. As shown in Fig. 5.11, an equal amount of FITC labelled peptides were
transported into the ER for all the truncated CRT K42 transfectants and K42 cells. This 
suggests that the ability of TAP to carry out the function of translocating peptide from 
cytosol into the ER remains unchanged. This is consistent with the normal protein 
synthesis of TAP in K42-P, K42-PC and K42-NP cells (Fig 5.12).
5.2.5 Unchanged chaperone content in truncated CRT transfected 
K42 cells
As mentioned above, the individual CRT fragments might not perform the chaperone 
function properly without the support of other domains. As a consequence of this, 
membrane bound or secreted proteins may not fold or assemble efficiently, and 
subsequently these misfolded or misassembled proteins would undergo ER-associated 
protein degradation. The other components of the MHC class I loading complex, such as 
calnexin, tapasin, HC and ERp57, also need the assistance of CRT for the folding and 
assembly. Therefore, it was conceivable that the expression of truncated CRT in K42 
(CRT-/-) may alter the content of these chaperones in the cells.
To identify any differences in chaperone expression, the levels of calnexin, tapasin, HC 
and ERp57 from K42 (CRT-/-) cells transfected with truncated CRTs and the parent cell 
line K42 (CRT-/-) were compared by western blot analysis using serial 2-fold diluted 
samples of cell lysates (Fig 5.12). This analysis demonstrated that the steady state 
expression of calnexin, tapasin and ERp57 were all the same for K42-P, K42-PC, K42- 
NP and K42 cells. However, the overall protein expression level of HC in truncated CRT 
transfected K42 cells was lower than that of parent K42 cells. The reason for this 
deference is not clear. As discussed in section 4.2.6, the level of total HC detected by 
western blot is very sensitive to minor changes in experimental procedure, such as the 
length of time the cells were digested by trypsin, and even the amount of time the cells 
were kept in suspension before lysis (unpublished observation). Alternatively, the 
truncated CRT may affect the protein synthesis of HC and/or its degradation. For 
example, if the peptide loading onto class I is not efficient, there would be more empty or 
sub-optimally loaded class I molecules produced, which are subjected to ER associated
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degradation by proteasomes. Further investigation is needed to clarify the underlying 
mechanism.
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Fig. 5.12 Chaperone content in K42 transfectants
The relative amounts o f  ER chaperons were analysed by western blot. Two fold  serial 
dilutions o f cell lysates for each cell line were subjected to 12% SDS-PAGE and 
transferred onto Hybond Extra membrane (Amersham), and probed with specific 
antibodies for calnexin, tapasin, HC, ERp57 and TAP. The results shown are 
representative o f those obtained in three separate experiments.
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5.2.6 Unimpaired TAP-independent peptide loading in truncated CRT 
transfected K42 cells
Up to now, our results suggest that the increased empty or sub-optimally loaded MHC 
class I molecules in K42-P, K42-PC and K42-NP cells are not caused by reduced peptide 
supply into the ER from cytosol by TAP since both the protein expression and function of 
TAP are normal, and the protein content of other members of PLC is unchanged. 
However, the normal protein expression of TAP, tapasin, calnexin and ERp57 doesn’t 
mean that they can function properly as a complex to load peptides into the peptide 
binding groove of MHC class I molecules. Accordingly, the ability of peptide loading 
onto class I was examined in K42-P, K42-PC and K42-NP cells and the parent K42 
(CRT-/-) cells. All the cells were infected with recombinant vaccinia virus expressing a 
mini-gene encoding the mouse class I H-2K* binding epitope SIINFEKL with an ER 
leader sequence. In this way, SIINFEKL was delivered directly into the ER in a TAP- 
independent manner and loaded onto H2-K* to form KVSIINFEKL complex, then 
trafficked to the cell surface. The K^/SIINFEKL complexes at the cell surface were 
stained with 25-D1.16, a TCR-like monoclonal antibody specific for the K/7SIINFEKL 
complex(Porgador et al., 1997). There was not much difference in the ability of K42-P, 
K42-PC, K42-NP, K42-CRT and the parent K42 (CRT-/-) cells to present SIINFEKL 
peptide at the cell surface when it was delivered to the ER (Fig 5.13). In contrast, surface 
staining by 25-D1.16 was minimal on cells infected by control vaccinia virus expressing 
an irrelevant protein, indicating the staining by 25-D1.16 was SIINFEKL specific. Since 
it is not possible to determination the exact amount of SIINFEKL delivered to the ER 
during these experiments it is a possibility that a high lumenal abundance of SIINFEKL 
could compensate for the yet unknown defect in class I peptide loading in K42-P, K42- 
PC, K42-NP. However, the ability to present ER targeted SIINFEKL means that the 
truncated CRT proteins in K42-P, K42-PC, K42-NP cells do not cause a global defect in 
intracellular peptide loading.
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Fig. 5.13 Direct delivery of peptides into the ER rescued surface class I expression
Cells were infected with the same amount o f vaccinia virus expressing either SIINFEKL 
(thick line) with a leader sequence to the ER or expressing irrelevant protein (thin line). 
Surface MHC class I was analysed by flow  cytometry using a TCR-like mAb 25-D1.16, 
which is specific for SIINFEKL/IC complex. Shaded peak indicates second antibody only. 
Data are representative o f  three independent experiments.
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Virus infection rate was appeared to be lower in K42-NP cells than the other cell lines 
since a proportion of these cells weren’t stained by 25-D1.16. This may be caused by the 
lower number of surface receptors that are responsible for taking in vaccinia virus. This 
notion is supported by a study showing impaired bradykinin receptor in CRT deficient 
cells(Nakamura et al., 2001b). They suggested that CRT may play a role in folding of the 
bradykinin receptors. Nevertheless, the reason behind the low virus infection of K42-NP 
requires further investigation.
5.2.7 Inefficient class I antigen presentation of cytosolically derived 
peptides in truncated CRT transfected K42 cells
Transfection of truncated CRT into K42 (CRT-/-) cells resulted in failure to load the 
majority of class I molecules with high-affinity peptides and then were exported in an 
unstable state, leading to the reduced cell surface expression of class I. However, as Fig. 
5.13 showed, when class I binding peptide SIINFEKL was delivered directly into the ER, 
K42-P, K42-PC and K42-NP cells can present SIINFEKL in the context of K* as 
efficiently as the parental K42 (CRT-/-) cells. To determine the effect of the expression of 
full length and truncated forms of CRT in K42 (CRT-/-) cells on antigen presentation, 
their ability to present the ovalbumin derived epitope SIINFEKL to a T cell hybridoma 
B3Z was assessed(Karttunen et al., 1992; Sanderson and Shastri, 1994). K42 (CRT-/-) 
cells transfected with truncated CRT presented SIINFEKL derived from cytosolic OVA 
less efficiently than the parent K42 (CRT-/-) cells (Fig 5.14). K42-P and K42-NP cells 
were particularly affected. B3Z responses obtained with these cell lines at all OVA 
concentrations were comparable to cells pulsed with control protein BSA. In contrast, the 
introduction of CRT into K42 (CRT-/-) cells dramatically increased the efficiency of 
conventional cytosolic class I antigen presentation. Collectively, these data suggest that 
CRT fragments in CRT deficient cells have a profoundly negative effect on TAP- 
dependent peptide loading.
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Fig. 5.14 MHC class I presentation of the OVA derived peptide SIINFEKL to B3Z is 
markedly reduced in truncated CRT K42 transfectants
Streptolysin O permeabilized cells were incubated with different concentrations o f  
ovalbumin, and then co-cultured with the lacZ-inducible, SIINFEKL/K*-specific B3Z T 
cell hybridoma overnight. B3Z activation was evaluated by ELISA as described in 
materials and methods. The experiment was carried out in triplicate at each time and 
repeated at least three times for each cell line. Data was combined for the plot, and error 
bars show the SD from the mean.
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5.3 Discussion
CRT has been demonstrated to play a central role in the formation of the MHC class I 
PLC(Sadasivan et al., 1996; Harris et al., 1998; Turnquist et al., 2002) and in MHC class 
I assembly and its subsequent antigen presentation(Gao et al., 2002). In Chapter 4 it was 
shown that CRT also maintains the low peptide concentration threshold required in the 
ER for efficient antigen presentation. To further investigate the functional role CRT plays 
in the MHC class I antigen presentation and the underlying mechanism, full length 
human CRT and three separate fragments were cloned: the central P domain, the NP 
fragment (N+P domains of CRT) and PC fragment (P+C domains of CRT). Using an ER 
leader sequence these were then targeted into the ER of both CRT deficient K42 cells and 
CRT competent K41 cells. Expression of full length CRT and its fragments in cells with 
or without CRT had a different impact on cell surface expression of MHC class I. In K42 
(CRT-/-) cells, while reintroduction of full length CRT completely restored the cell 
surface expression of MHC class I, expression of CRT fragments down-regulated the 
class I expression at the surface of K42 (CRT-/-). In contrast, all the K41 (CRT+/+) 
transfectants had the same class I expression level seen in the wild-type K41 (+/+) cells 
(Fig. 5.7). The results further support the notion that calreticulin is important in MHC 
class I antigen presentation and also provide some clues to the function of calreticulin. 
For example, calreticulin might act as a bridge to link other functional components of 
class I assembly machinery. Alternatively, one domain of calreticulin may be required for 
interaction with a functional molecule while the other executes another unidentified 
function. ERp57 could be one such interaction partner in this regard. There are several 
reports suggesting that the P-domain of calreticulin is responsible for binding to ERp57, 
which catalyses the formation of disulfide bonds of class I molecules(Farmery et al., 
2000; Corbett et al., 1999; Ellgaard and Helenius, 2001).
Calcium storage and homoeostasis are among the important roles that calreticulin 
plays(Camacho and Lechleiter, 1995; Vassilakos et al., 1998). A change of calcium 
homeostasis by individual fragments of calreticulin might be one possible reason for the 
observed changes in surface expression of class I. Kimitoshi et al studied the functions of
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individual CRT domains on bradykinin binding and bradykinin-induced Ca 
release(Nakamura et al., 2001b). They demonstrated that bradykinin binding and 
bradykinin-induced Ca2+ release is restored by expression of the N+P domain of CRT. 
But in this study, the MHC class I expression in CRT deficient cells could not be restored 
by either P domain or N+P domain of CRT. Instead all three domains o f CRT were 
required to restore the surface expression level of class I on CRT deficient K42 cells . It 
is not surprising that the C-domain of CRT alone cannot rescue the defect in class I 
expression in K42 (CRT-/-) cells, as this domain has not been reported to have chaperone 
function. However, the N+P fragment of CRT could not restore the surface class I 
expression in K42 (CRT-/-) cells either, although previous studies have suggested that 
both the N-domain and the P-domain o f CRT are responsible for its chaperone function. 
The distinct domains of CRT have been shown to perform specialised functions, but the 
chaperone function o f the N+P domain of CRT are tightly linked to its role in Ca2+ 
homeostasis the C-domain plays(Nakamura et al., 2001b). For example, Corbett and co­
workers have showed that the Ca2+ concentration in the lumen of the ER affects the 
structure, conformation and the chaperone function o f CRT, as indicated by changes in its 
sensitivity to protease digestion in the absence or presence of different concentrations of 
Ca2+ (Corbett et al., 2000). Another study from the same group found that Ca2+ 
concentration in the ER regulated the interactions between ER chaperones. CRT was 
shown to interact with protein disulfide isomerase (PDI) at low Ca2+ concentration (below 
100 pM), whereas the protein complex dissociates when Ca2+ concentration increases 
above 400 pM. They suggested that Ca2+ binding to the C-domain o f CRT is responsible 
for the Ca2+ sensitivity o f the interaction between the N-domain of CRT with PDI. 
Furthermore, the association of CRT with another class I accessory molecule, ERp57, 
was also modulated by Ca2+ binding to the C-domain o f CRT(Corbett et al., 1999). As a 
consequence o f the changes in these protein-protein interactions, the chaperone function 
o f the protein in assisting class I assembly also changes. Taken together, it seems the 
chaperone function of either the P domain or the NP fragment o f CRT is supported by the 
function o f its C-domain in binding Ca2+. The work presented in this chapter is also 
consistent with the idea that the chaperone functions carried out by the N and P domains 
o f calreticulin are supported by the C domain, since without the C domain the expression
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of either P or NP fragment of CRT in K42 (CRT-/-) cells failed to rescue the deficiency 
in surface class I expression in the parent cell line.
The cell surface expression of MHC class I on the CRT deficient K42 cells was 25%- 
30% of the level seen in CRT competent K41(Gao et al., 2002). The data presented here 
shows that expression of P, PC and NP domains of CRT further reduced surface 
expression o f MHC class I molecules in K42 cells. It was demonstrated that the down- 
regulation of MHC class I was due to an increase in empty or sub-optimal peptide loaded 
class I molecules (Fig 5.9), which were not stable at physiological temperature, but could 
be stabilized by incubation either at low temperature or with exogenously added class I 
binding peptide. There are a few possible mechanisms by which truncated CRT could 
affect MHC class I molecules being loaded with high affinity peptide. Firstly, poor 
peptide supply in the ER due to dysfunction o f TAP leads to empty or sub-optimal 
peptide loaded class I, as demonstrated by the mouse TAP-2 mutant RMA-S cell line 
(Ljunggren et al., 1990; De Silva et al., 1999) or human TAP mutant T2(Paulsson et al., 
2001). It is possible that TAP protein and/or TAP function in truncated CRT transfected 
K42 (CRT-/-) cells are affected because the CRT fragments cannot perform chaperone 
functions properly, which leads to the misfolding and misassembly of TAP. However, 
both the western blot experiment and peptide transport assay do not support this, since the 
truncated CRT transfected K42 (CRT-/-) cells were shown to have the same level o f TAP 
protein expression (Fig. 5.12) and peptide translocation ability seen in the parental K42 
(CRT-/-) cells (Fig. 5.11). Another possible mechanism by which more peptide receptive 
class I molecules were generated is that the presence o f truncated CRT in K42 (CRT-/-) 
cells may affect the content of other chaperones in the MHC class I loading complex, 
such as calnexin, tapasin and ERp57, due to the compromised quality control system. 
Reduced expression of these chaperones could have a negative effect on the class I 
antigen presentation. Nevertheless, this was proved not to be the case either, since the 
similar protein expression level o f these chaperones in truncated CRT transfected K42 
(CRT-/-) cells to that of parental K42 cells was found by semiquantitative western blot 
(Fig. 5.12). Alternatively, the ability o f PLC to load peptide onto class I molecules could 
affect the generation of peptide receptive class I molecules, which leads to the reduced
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surface class I expression. To determine whether loading is impaired, K* binding peptide 
SIINFEKL was delivered into the ER by vaccinia virus and the peptide loading ability of 
K42 (CRT-/-) cells transfected with CRT fragments was compared with that of parent 
K42 cells by measuring the amount o f cell surface K6/SIINFEKL complex. Surprisingly, 
direct delivery of SIINFEKL to the ER in a TAP-independent manner rescued the ability 
o f K42-P, K42-PC and K42-NP to present epitopes at the cell surface (Fig. 5.13). As 
discussed in chapter 4, although direct peptide delivery into the ER rescued the surface 
class I expression, it still cannot be excluded that the peptide optimisation process is 
impaired in these cells as the concentration of peptide expressed by vaccinia viruses is 
high, which could compensate for the defect in peptide loading(Lybarger et al., 2001). 
Nevertheless, it is reasonable to conclude that CRT deficient cells do not have a global 
defect in intracellular peptide loading of peptide. Noticeably, the infection efficiency by 
vaccinia virus for individual cell line was different as indicated by a class I negative 
population of cells in K42-NP. Since CRT participates in the quality control of both 
membrane bound or secreted proteins(Molinari et al., 2004) it is possible that the cell 
surface receptors responsible for taking up virus were affected by the presence of 
truncated CRT (especially the NP fragment of CRT) in cells without endogenous CRT. 
Further studies are needed to address this issue.
It is intriguing that truncated CRT transfected K42 (CRT-/-) cells produced more peptide 
receptive or sub-optimal peptide loaded class I molecules in comparison to the parent 
K42 cells, although the possible factors relating to the MHC class I assembly, described 
above, are normal. Nonetheless, the ultimate aim of class I pathway is to display the 
peptides generated from cytosolic proteins at the cell surface for recognition by CTLs. To 
assess the ability o f the transfectants to present endogenous antigen, the model antigen 
ovalbumin were delivered into the cytoplasm by streptolysin O, and B3Z responses were 
used to quantify the relative amount o f surface SIINFEKL/K* complex(Karttunen et al., 
1992; Sanderson and Shastri, 1994). Our results showed that at the same concentrations 
o f cytosolic ovalbumin, the truncated CRT transfected K42 (CRT-/-) cells presented 
SIINFEKL/K6 to B3Z less efficiently than the parental K42 (CRT-/-) cells. In contrast, 
expression of full length CRT in K42 cells increased the efficiency of presenting
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SIINFEKL in the context of K* to T cells (Fig. 5.14). These data revealed that the 
expression o f truncated CRT dramatically reduced the ability o f K42 (CRT-/-) cells to 
present endogenous antigen, while full length CRT increased the efficiency.
The antigen-presentation phenotype of K42 (CRT-/-) cells transfected with truncated 
CRT, described above, was reminiscent of tapasin deficient .220 cells(Lehner et al., 
1998) or T134K cell line (threonine at position 134 of HLA-A2.1 HC is changed to 
lysine)(Peace-Brewer et al., 1996; Lewis and Elliott, 1998; Lewis et al., 1996). T134K 
and .220 both express lower levels o f MHC class I at the cell surface and fail to present 
endogenously synthesized peptide to CTL, which can be overcome by direct delivery of 
peptide to the ER using an ER signal sequence. Coimmunoprecipitation experiments 
showed that MHC class I molecules in these two cell lines do not associate with TAP 
complex(Peace-Brewer et al., 1996; Lewis and Elliott, 1998; Lewis et al., 1996; Grandea, 
III et al., 1995; Greenwood et al., 1994), indicating the disruption of MHC class I loading 
complex. Accordingly, it is possible that the expression of truncated CRT in K42 (CRT-/- 
) cells affects the formation of the PLC resulting in the phenotype described above. Since 
in CRT deficient K42 cells, MHC class I is still incorporated into the PLC, although with 
lower efficiency. It is possible that an unknown redundant protein, such as calnexin, may 
compensate for the loss o f CRT function in K42 cells. Calnexin has been found to be part 
o f the PLC in mouse cells(Gao et al., 2002), but not in human cells where there is no 
interaction between calnexin and HC/|32m heterodimers. In contrast TAP associates only 
with class I-p2m dimers and not with free HCs(Ortmann et al., 1994; Nossner and 
Parham, 1995). Therefore, there may be species differences in how calnexin functions in 
peptide loading or interaction with the TAP peptide transporter. In murine cells, calnexin 
may have a more redundant function with CRT in facilitating the peptide loading onto 
MHC class I molecules. One possible mechanism by which truncated CRT could down- 
regulate class I molecules in K42 (RT-/-) cells is via a dominant negative effect by 
competing with calnexin for the formation o f a similar multi-protein complex in 
transfected K42 (CRT-/-) cells. The resulting complex, containing truncated CRT and not 
the redundant calnexin protein, would be less efficient at loading peptide onto MHC class
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I molecules, thus resulting in increased peptide receptive class I, and subsequently 
reduced class I surface expression. Another possibility is that the expression of truncated 
CRT in K42 (CRT-/-) cells could simply disrupt the interaction o f proteins in the PLC. 
To test these hypotheses, coimmunoprecipitation experiments were performed to measure 
the protein-protein interactions in PLC of K41, K42 and their CRT P domain 
transfectants. Preliminary Results showed that more calnexin was recruited into the PLC 
of K42 cells compared with that in K41 cells, supporting the idea that calnexin may 
compensate for the loss o f CRT function in the absence o f CRT (Data not shown). 
Despite the reduced surface class I expression on K42-P cells however, the same amount 
o f class I was found in the PLC of K42-P and its parental K42 cells, suggesting that the 
presence o f the CRT P-domain did not affect the formation of PLC. Thus, in the absence 
of CRT, truncated CRTs, which all contain the central proline rich P domain capable of 
interacting with ERp57 and also possessing the lectin site of CRT capable o f binding 
oligosaccharide on class I HC(Vassilakos et al., 1998), might compete with calnexin for 
the formation of PLC to block its function and the function of PLC, leading to the further 
reduced cell surface expression o f MHC class I.
Another possible mechanism by which truncated CRT could down-regulate class I 
molecules in K42 (CRT-/-) cells is that truncated CRTs may compete with calnexin at an 
early stage o f biogenesis o f MHC class I molecules to affect its assembly. As described 
before, CNX interacts with MHC class I HC upon its co-translational insertion in the ER 
membrane to facilitate the folding of HC and stabilize it from aggregation as well as 
promote its assembly with |32m(David et al., 1993; Hochstenbach et al., 1992; Degen et 
al., 1992; Degen and Williams, 1991). When the interaction of calnexin with class I HCs 
was prevented by treatment with the oligosaccharide processing inhibitor 
castanospermine, the HCs underwent a rapid degradation compared with the control 
cells(Moore and Spiro, 1993). Moreover, Vassilakos et al have demonstrated that in the 
absence o f calnexin interaction, the assembly of class I HCs with (32m was substantially 
impaired due to misfolding o f the HCs(Vassilakos et al., 1996). Transfected CRT 
fragments, containing the central P-domian with the lectin binding site, could bind the
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glycan moieties on class I HC preventing HC interaction with calnexin, which could 
result in the accelerated intracellular degradation o f the HCs without the chaperone 
function of calnexin. Indeed, our semiquantitative western blot result showed that the 
steady-state protein expression level of HCs in truncated CRT trasfected K42 cells was 
lower than that in its parental K42 cells (Fig. 5.12), indicating that the P-domain of CRT 
may compete with calnexin for binding to free class I HCs to block its function of 
facilitating the folding of HCs. In this way, the P-domain o f CRT further reduced the cell 
surface class I expression on K42 cells. Furthermore, preliminary result o f pulse-chase 
experiment indicated that there seemed to be less fully Y3 reactive molecules in K42-P 
cells, which might suggest less fully assembled Kb molecules in the ER.
It could also be argued however that calnexin may not be important in the prevention of 
intracellular degradation of the HCs as the class I assembly, transport, and cell surface 
expression is unaffected in CNX deficient cells(Sadasivan et al., 1995; Scott and Dawson, 
1995; Prasad et al., 1998). The possible reason for the normal phenotype of calnexin 
deficient cells is that in the chronic absence o f calnexin, alternative chaperones can 
compensate for the loss o f calnexin function. As mentioned in the previous chapter, 
immunoglobulin binding protein (BiP) has been proposed to be a possible redundant 
protein to assist the class I HC folding and its assembly with p2m in human cells without 
calnexin(Nossner and Parham, 1995). One study has demonstrated that prolonged 
treatment of cells with castanospermine results in increased expression of BiP mRNA. 
Another study showed that the BiP protein level is upregulated in calnexin deficient 
cells(Molinari et al., 2004). Therefore, BiP might have a redundant function with 
calnexin to promote the folding of class I HCs and its assembly with |32m. After the 
formation MHC class I heterodimers, CRT might compensate for the calnexin function 
since CRT associates with MHC class I molecules only after HC is assembled with 
p2m(Sadasivan et al., 1996; Solheim et al., 1997). The redundant function from BiP 
and/or CRT may explain why the class I assembly, transport, and cell surface expression 
is unaffected in human CNX deficient cells. However, the association of BiP with free 
mouse HC has not yet been identified in mouse cells(Nossner and Parham, 1995;
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Paulsson et al., 2001). Therefore, with the competition from transfected CRT fragments 
for binding oligosaccharide on class I HCs, calnexin may be forced out of function. 
Without the redundant functions from BiP and CRT, class I HCs in K42 truncated CRT 
transfectants are susceptible to degradation leading to reduced class I HCs in these cells 
(Fig. 5.12).
There have been conflicting reports about the lectin binding site o f CRT. Leach et al 
suggested that the primary lectin site of CRT resides within the globular N-domain, with 
a much weaker secondary site within the P-domain(Leach et al., 2002). Whereas, a study 
done by Vassilakos et al indicated that the P domain of CRT is the lectin site of CRT 
capable of binding oligosaccharide(Vassilakos et al., 1998). Our data indirectly supports 
the latter that the P-domain of CRT contains the lectin binding site of CRT.
The data derived from the truncated CRT transfected K42 cells further demonstrated that 
CRT plays an important role in MHC class I antigen presentation. However, it is unclear 
why the ER of most eukaryotic species contains both CRT and calnexin; two homologous 
chaperones with lectin properties. Calnexin is a member o f PLC containing CRT, ERp57, 
tapasin and TAP(Suh et al., 1996; Gao et al., 2002), but its exact function in class I 
antigen presentation is not clear since class I can fully assembly and transport normally in 
the absence o f calnexin(Scott and Dawson, 1995; Sadasivan et al., 1995). There are 
reports that calnexin is not required for peptide loading o f class I molecules. For example, 
Sadasivan and colleagues studied the peptide loading o f MHC class I molecules and 
showed that there is no difference in the HOLC profiles of peptides eluted from the 
calnexin deficient cell line (NKR) or NKR transfected with calnexin cDNA(Sadasivan et 
al., 1995). Likewise, Prasad et al examined the requirement for calnexin in the assembly 
o f six different class I allomorphs and addressed the quantitative effects of calnexin on 
specific MHC-peptide complexes. They found calnexin is not required for the efficient 
assembly o f class I molecules with TAP-dependent or independent peptides(Prasad et al., 
1998). Nevertheless, it was shown here that calnexin may function as a “backup” 
chaperone for CRT in the formation of the PLC and peptide loading onto class I
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molecules in mouse cells. This may reflect redundancy in the ER quality control. The 
class I peptide loading process is an adaptation o f the general quality control system 
involving CRT, calnexin and ERp57(Radcliffe et al., 2002), function of calnexin in 
assisting the formation of PLC and peptide loading, it was also shown in chapter 4, that 
ERp57 is upregulated in the absence of CRT. Taken together, the phenotype regarding 
MHC class I assembly and peptide loading in CRT deficient cells and its CRT P-domain 
transfectants further demonstrated the fidelity of ER general quality control system.
This is the first study to investigate the effect of expression of truncated CRT on class I 
antigen presentation in a CRT deficient background. The results o f these experiments 
have served to characterize the phenotype of K42 (CRT-/-) cells transfected with CRT 
fragments, and further demonstrated the importance of CRT in the formation of PLC, 
class I assembly and antigen presentation. This work also revealed that the very crucial 
nature o f structure-function relationships among the different domains of CRT. Individual 
domain cannot function properly as a molecular chaperone for class I without the support 
o f other domains.
Another interesting finding was the change in morphological appearance of CRT 
fragment transfected K42 cells. The morphological appearance of wild-type (K41), 
calreticulin-deficient (K42) and full length CRT transfected K42 cells was 
indistinguishable and typical o f fibroblasts. The cell lines all attached firmly to plastic, as 
though K42 cells grew a bit slower than K41 cells and full length CRT K42 transfectants. 
K42 transfectants with CRT fragments were more rounder than K41, K42 and K42-CRT 
cells, and did not attach well onto the solid phase of the culture flasks, suggesting that 
adherance are abnormal. CRT is a multifunctional protein. In addition to its fuction in 
chaperoning (glyco)protein and Ca2+ homeostasis, CRT also plays a role in modulating 
cell adhesiveness (Michalak et al., 1999; Johnson et al., 2001). It has been reported that 
changes in levels of CRT expression affect cell shape and motility. Overexpression of 
CRT correlates with increased cell adhesiveness, while down-regulation of CRT reduces 
cell attachment to extracellular substrates, and causes cells to be rounder and smoother
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than the control cells(Opas et al., 1996; Leung-Hagesteijn et al., 1994). Moreover, 
embryonic stem (ES) cells lacking CRT have impaired cell adhesion(Dedhar, 1994). The 
Ca2+ srorage and chaperone functions of CRT are consistent with its location to the ER 
lumen and with its structure, but it is not clear how it can affect cell adhesiveness at the 
level o f the plasma membrane. A number of different mechenisms have been proposed. 
Further studies are needed to adrress this issue. Nevertheless, the observations made in 
this chapter are consistent with the previously observed importance of calreticulin in 
these functions.
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Appendix
P domain (bold letters) similarity between human and mouse calreticulin 
Amino acids sequence for human calreticulin
mllsvplllg llglavaepa vyfkeqfldg dgwtsrwies khksdfgkfv 
lssgkfygde ekdkglqtsq darfyalsas fepfsnkgqt lwqftvkhe 
qnidcgggyv klfpnsldqt dmhgdseyni mfgpdicgpg tkkvhvifny 
kgknvlinkd irckddefth lytlivrpdn tyevkidnsq vesgsleddw 
dflppkkikd pdaskpedwd erakiddptd skpedwdkpe hipdpdakkp 
edwdeemdge weppviqnpe ykgewkprqi dnpdykgtwi hpeidnpeys 
pdpsiyaydn fgvlgldlwq vksgtifdnf litndeayae efgnetwgvt 
kaaekqmkdk qdeeqrlkee eedkkrkeee eaedkedded kdedeedeed 
keedeeedvp gqakdel
Amino acids sequence for mouse calreticulin
mllsvplllg llglaaadpa iyfkeqfldg dawtnrwves khksdfgkfv 
lssgkfygdl ekdkglqtsq darfyalsak fepfsnkgqt lwqftvkhe 
qnidcgggyv klfpsgldqk dmhgdseyni mfgpdicgpg tkkvhvifny 
kgknvlinkd irckddefth lytlivrpdn tyevkidnsq vesgsleddw 
dflppkkikd pdaakpedwd erakiddptd skpedwdkpe hipdpdakkp 
edwdeemdge weppviqnpe ykgewkprqi dnpdykgtwi hpeidnpeys 
pdaniyayds favlgldlwq vksgtifdnf litndeayae efgnetwgvt 
kaaekqmkdk qdeeqrlkee eedkkrkeee eaedkedddd rdededeede 
keedeeespg qakdel
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